the 19th Annual Scientific Sessions
Transcription
the 19th Annual Scientific Sessions
Society for Cardiovascular Magnetic Resonance 19th Annual Scientific Sessions From Innovation to Impact in Cardiovascular Care FINAL PROGRAM January 27-30, 2016 Hyatt Regency Century Plaza Los Angeles, California USA www.scmr.org 2015 Best Image Contest Winner, Lilia Sierra-Galan, MD, FACC,FSCCT (American British Cowdray Medical Center) SCMR 19th Annual Scientific Sessions Hyatt Regency Century Plaza Los Angeles, CA January 27-30, 2016 From Innovation to Impact in Cardiovascular Care S C H E D U L E AT A G L A N C E WEDNESDAY, JANUARY 27, 2016 SCMR/ISMRM Co-Provided Workshop - Quantitative CMR: From Technique Development to Practical Implementation (Location: Westside) 8:00 AM - 6:00 PM THURSDAY, JANUARY 28, 2016 LOCATION Los Angeles 8:00 AM - 1:00 PM Constellation Pacific Palisades Olympic Westwood Westside Physician's Pre-Conference Course Congenital Pre-Conference Course Clinical Trials Workshop Interventional CMR Workshop SCMR/ISMRM Co-Provided Workshop 1:00 PM - 2:00 PM 2:00 PM - 3:45 PM 4:00 PM - 5:20 PM Lunch (on own) - Exhibits and Poster Hall Open for Viewing Opening Plenary Session Invited Lecture Session 1: Big Data Oral Abstract Session 1: CAD and Enabling Healthcare Research or ACS Expensive Distraction? Case Review 1: Physiology or Pathology? Questions in Sports Oral Abstract Session 2: Translational 5:30 PM - 6:00 PM CMR Technology Update 6:00 PM - 7:00 PM Welcome Reception, Poster Group P1 and Exhibits (California Showroom) FRIDAY, JANUARY 29, 2016 LOCATION Los Angeles Constellation 7:30 AM - 8:30 AM Physics for Physicians: What Your Technologist Wants You to Know 8:40 AM - 10:00 AM Invited Lecture Session 2: Game Changers in CMR Olympic Oral Abstract Session 3 (ECA Basic Science) Invited Lecture Session 3: CMR Practice Models Around the World 12:00 PM - 12:30 PM SCMR Business Meeting Oral Abstract Session 5 (ECA Clinical) Case Review 4: The Patient Referred for Vascular Imaging 12:30 PM - 1:30 PM Westwood Technologist Track Invited Lecture Session 4: Congenital Scanning Beyond Structure and Function Walking Poster Session 2: CMR in Coronary Artery Disease Technologist Track Lunch (on own)/Exhibits/Poster Group P2 (California Showroom) Invited Lecture Session 5: Multimodality Imaging to Guide Surgical and Transcatheter Repair Oral Abstract Session 6: Tissue Characterization Case review 5: The Adult Patient Referred for Evaluation of Congenital Heart Disease Oral Abstract Session 7 New Techniques Walking Poster Session 3: Clinical Outcome and Prognosis Technologist Track Walking Poster Session 4: Mechanisms in Cardiovascular Disease Technologist Track Walking Poster Session 5: CMR in Myocardial Disease Technologist Track Refreshment Break/Exhibits 2:50 PM - 3:40 PM 5:10 PM - 6:30 PM Santa Monica Refreshment Break/Exhibits (California Showroom) 10:40 AM - 12:00 PM 3:40 PM - 5:00 PM Plaza Foyer Careers in CMR: Aligning Your Path Across Opportunities Case Review 3: The Patient Referred Walking Poster Session 1: Methods for a Cardiac Mass with Pathologic Oral Abstract Session 4: Congenital I to Analyze Tissue and Function Correlation 10:00 AM - 10:30 AM 1:30 PM - 2:50 PM Westside Cardiology for Non-Clinicians: What Case Review 2: The Patient Referred the Sick Patient in the Scanner for Evaluation of Ischemic Heart Needs You to Know Disease Invited Lecture Session 6: Reducing Case review 6: The Patient Referred Invited Lecture Session 7: Diffusion Oral Abstract Session 8: Outcomes Cost, Increasing Value, and for Evaluation of Cardiomyopathy CMR Allocating One's Time Invited Lecture Session 8: CMR in Tarnslational Science: From Pathways to Protocols Oral Abstract Session 9 (ECA Translational) Oral Abstract Session 10: Systolic and Diastolic Function Oral Abstract Session 11: Postprocessing and Modeling CMR Outreach Dinner Program (Special Registration) 6:30 PM - 8:30 PM SATURDAY, JANUARY 30, 2016 LOCATION Los Angeles Constellation 7:30 AM - 8:50 AM Invited Lecture Session 9: CMR in Multisystem Disorders 8:50 AM - 10:00 AM CMR Outreach Plenary Session: Cardiovascular Disease in Women CMR's Essential Role Pediatric and Congenital The Experts Olympic CMR: Ask 10:00 AM - 10:40 AM 10:40 AM - 12:00 PM 2 Plaza Foyer Santa Monica Westwood LIVE CASE Refreshment Break/Exhibits (California Showroom) Invited Lecture Session 10: Translating Advances in CMR to the Community Oral Abstract Session 13: Inflammatory Cardiomyopathy Invited Lecture Session 11: What Is Case Review 8: Potpourri Cases and This Congenital Patient Doing On My Best Web Case of the Week Schedule? Walking Poster Session 7: Novel CMR Strategies Technologist Track Lunch (on own)/Exhibits/Poster Group P3 (California Showroom) 12:00 PM - 1:00 PM 1:10 PM - 2:30 PM Invited Lecture Session 12: CMRGuided Management of Sudden Cardiac Death in Nonischemic Disease 2:40 PM - 4:00 PM Invited Lecture Session 15: Past, Present and Future Assessment of Myocardial Mechanics 4:15 PM - 5:30 PM CMR World Cup, A Joint SCMR/EuroCMR Event & Closing Plenary Session 5:30 PM - 6:00 PM Awards Ceremony 6:00 PM - 7:00 PM Westside Oral Abstract Session 12: Flow and Case review 7: Patients Referred for Walking Poster Session 6: Advances Hemodynamics Evaluation of Acute Chest Pain in CMR Methods Oral Abstract Session 14: Rapid Efficient Imaging Oral Abstract Session 15: Congenital II Invited Lecture Invited Lecture Session 13: CMR in CAD Best of Walking Posters Technologist Track Oral Abstract Session 16: Arrhythmia Case Review 9: The Pediatric Patient Referred for the Evaluation of the Congenital Heart Disease Oral Abstract Session 17: Clinical Trials Invited Lecture Session 14: Parametric Mapping Technologist Track Awards Reception (California Lounge) 19th Annual Scientific Sessions • January 27-30, 2016 TABLE OF CONTENTS D E A R D I S T I N G U I S H E D C O L L E AG U E S , Welcome to sunny Los Angeles for the 19th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance! This premier global CMR meeting brings together in one convenient venue the best in technology development, translational research and clinical science. Our all-star program committee and staff deserve a heartfelt Thank You for their remarkable efforts in making this year’s program a reality. Special kudos to those involved in submitting, reviewing, and organizing the best science into high-impact Abstract sessions. We thank our program’s supporters who are eager to share with you via their exhibitions ideas on how to deliver on the promise of CMR. We are especially grateful to partnering groups such as the EACVI’s Heart Imagers of Tomorrow who helped create Thursday’s session on “Training and Certification in CMR” and EuroCMR for their support of Saturday’s “World Cup: A Joint SCMR/EuroCMR Event”. Other joint endeavors such as the ISMRM/SCMR Joint Workshop “Quantitative CMR: From Technique Development to Practical Implementation” and Friday’s ESCR co-provided session “Reducing Cost, Increasing Value, and Allocating One’s Time” are designed to help you translate today’s innovations to tomorrow’s research and practice. New this year is a special Outreach Program conducted with the help of the California Chapter of the ACC and EACVI’s Cardiovascular Imaging section. The combined Friday evening dinner session and Saturday morning Outreach Plenary is a great place to engage with practitioners outside of our field to positively impact human health, focusing this year on CMR to advance women’s cardiovascular health. Our first-ever Live Case on Saturday morning complements thematicallyorganized Case Sessions, and the Technologist Track highlights the essential team approach needed to deliver on the promise of CMR. Popular preconference sessions address Congenital and Interventional CMR, and the Clinical Trials Workshop will empower attendees with critical knowledge to advance patientoriented research to improve cardiovascular outcomes. Schedule at a Glance ..........................2 Welcome .............................................3 About SCMR ........................................4 Conference Goals/Accreditation .........5 General Information ...........................7 PRE-CONFERENCE COURSES Physicians Pre-conference Course .........................................8 Congenital/Pediatric Pre-conference Course ................9 Thursday Program .............................13 Friday Program ..................................17 Saturday Program .............................30 Technologist Track .............................41 This is your meeting – we look forward to your engagement! Please participate in the many audience response queries and discussions embedded throughout the sessions, and follow us on Twitter (@SCMRorg, #SCMR2016) for breaking communications during the meeting. We hope you find this program useful as you help our society advance the science and practice of CMR around the world. Poster Directory ................................44 Sincerely, Exhibit Hall Floor Plan .......................79 Subha V. Raman, MD, MSEE Program Chair Daniel Messroghli, MD Abstract Chair Victor Ferrari, MD SCMR President www.scmr.org Author Index .....................................55 Exhibitor Directory ............................77 Hotel Floor Plan ................................80 3 From Innovation to Impact in Cardiovascular Care SC M R V I S I O N STATEM ENT The Society for Cardiovascular Magnetic Resonance (SCMR) will be the leading international representative and advocate for all physicians, scientists, and technologists working in CMR to improve patient outcomes through excellence in education, training, standards, research and development. TH E M I S S I O N O F SC M R I S TO: • Be the premier international model and provider of CMR education, training, standards development, and accreditation. • Maximize clinical effectiveness of CMR through coordinated comparative effectiveness research efforts resulting in evidence-based guidelines to enhance patient care and outcomes. • Continually enhance the accuracy, efficiency, and effectiveness of CMR in cardiovascular healthcare through technological advances. • Promote scientific exchange through organization of an annual international scientific conference, publication of the Journal of Cardiovascular Magnetic Resonance, and interactive internet-enabled tools including the SCMR website. • Build an expanding global membership of physicians, scientists, technologists, and interested healthcare partners focused on clinical applications and research in CMR. • Develop and advance close working alliances with related societies, industry partners, and governmental and regulatory agencies to more effectively integrate and elevate the use of CMR within cardiovascular healthcare. OFFICERS/ EXECUTIVE COMMITTEE University of Pennsylvania Medical Center Philadelphia, Pennsylvania, USA Vice-President Jeanette Schulz-Menger, MD Charite Universitatsmedizin and HELIOS Clinics Berlin, Germany Secretary-Treasurer Matthias G. Friedrich, MD McGill University Health Centre Montreal, Canada Ruchira Garg, MD Colin Berry, MD Nadine Kawel-Boehm, MD Chiara Bucciarelli-Ducci, MD Dara Kraitchman, DVM, PhD Carmen Chan, MBBS Daniel Lee, MD Stephen Cheung, MBBS J. Ronald Mikolich, MD Rohan Dharmakumar, PhD Steffen Petersen, MD Christopher Dyke, MD Michael Salerno, MD, PhD Robert Edelman, MD David Sosnovik, MD Daniel Ennis, PhD M. Barbara Srichai-Parsia, MD Victor Ferrari, MD Daniel Thomas, MD Alison Fletcher, RT Anne Marie Valente, MD University of Glasgow Bristol Heart Institute Brigham & Women’s Hospital Queen Mary Hospital Cedars-Sinai MC Alaska Heart Institute University of Pennsylvania Medical Center Past President Orlando P. Simonetti, PhD The Ohio State University Columbus, Ohio, USA Papworth Hospital Sohrab Fratz, MD, PhD, FESC German Heart Centre Munich University of Virginia Cedars-Sinai Medical Center University of Basel Hospital Johns Hopkins University, School of Medicine Northwestern University, Feinberg School of Medicine Northeast Ohio Medical University Queen Mary, University of London University of Virginia Health System Massachusetts General Hospital Medstar Georgetown University Hospital University of Bonn Children’s Hospital Boston Brigham & Women’s Hospital Mark Westwood, MD The London Chest Hospital Program Committee Chair Subha V. Raman, MD, MSEE 4 Andrew Arai, MD UCLA School of Medicine Lausanne University Lausanne, Switzerland German Heart Institute Berlin Berlin, Germany Brent French, PhD Lund University Hospital Evanston Hospital Vice Secretary-Treasurer Matthias Stuber, PhD Program Committee Co-Chair Daniel Messroghli, MD Anthony Aletras, PhD NHLBI - National Institutes of Health President Victor A. Ferrari, MD The Ohio State University Columbus, Ohio, USA PROGR AM COMMITTEE MEMBERS STAFF Executive Director Deborah Berkowitz Meeting Manager Maria Ramos, CMP Chief Operating Officer Pete Pomilio Meeting Coordinator Stephanie Moyer Headquarters Assistant Kearstin Rehmann 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care TH E G OA L S O F TH E SC I ENTI FI C S ES S I O N S A R E TO: • Deliver state-of-the-art information on the translational science and clinical impact of CMR • Provide a forum for the presentation of advances in CMR • Demonstrate CMR-based solutions to unmet needs in cardiovascular care and after care enhance patient care and outcomes AT TH E CO N C LU S I O N O F TH E SC I ENTI FI C S ES S I O N S , PA RTI C I PA NT S S H O U LD B E B ET TER A BLE TO: • Implement CMR services to improve cardiovascular care • Develop CMR-facilitated clinical and translational research • Apply relevant MR principles to improve image quality, data reliability and patient safety CO NTI N U I N G M EDI C A L EDUC ATI O N C R ED IT I N FO R M ATI O N – SC I ENTI FI C S ES S I O N S The SCMR 19th Annual Scientific Sessions designates this educational activity for a maximum of 24 hours of External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Society for Cardiovascular Magnetic Resonance designates this live activity for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The evaluation link will be sent at the conclusion of the meeting. There will be a CME tracking worksheet at the end of the overall evaluation to request CME credits. To access the CME tracking worksheet, you will need to complete the overall evaluation. Once you have completed the worksheet, be sure to click “done” so your certificate can be processed. Your certificate will be sent via email on or before February 12. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Healthcare Professionals who participate in this CME activity may submit their Statements of Attendance to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education. TEC H N O LOG I ST WO R K S H O P This activity has been approved for credit by the American Society of Radiologic Technology (ASRT) for a maximum of 10 CE credits. Each technologist should claim only those hours of credit actually spent in this activity. www.scmr.org 5 From Innovation to Impact in Cardiovascular Care PA ST SC M R G O LD M EDA L AWA R D EES 2015 AWA R D EES Christopher M. Kramer, MD Raymond J. Kim, MD Robert M. Judd, PhD 2016 SCMR GOLD MEDAL AWARDS The Board of Trustees of the Society for Cardiovascular Magnetic Resonance (SCMR) is pleased to announce the 2016 Gold Medal Award recipients are Joao A.C. Lima, MD, MBA, Professor of Medicine, Radiology and Epidemiology at Johns Hopkins University and Eike Nagel, MD, PhD, Director of the Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, at Goethe University Frankfurt. The award is presented annually by the SCMR for outstanding achievement in the field of CMR as well as exemplary service to the Society. 2014 AWA R D EE: Warren J. Manning, MD 2013 AWA R D EE: Stefan Neubauer, MD 2012 AWA R D EE: Dudley Pennell, MD 2011 AWA R D EES: Charles Higgins, MD Gerald Pohost, MD Joao Lima Eike Nagel Dr. Lima is very well known to the field of CMR, as a leader over the past 25 years. He has a strong history of service to the SCMR, beginning with the very first organizational meeting hosted by Gerald Pohost, extending through his service on the SCMR Board of Trustees, and including his tireless attendance and presentations at most if not all of the SCMR’s scientific sessions. Dr. Lima has been a major contributor to the field. In particular among his research contributions over the past two and half decades, marked by nearly 160 peer-reviewed papers, those on myocardial function, late gadolinium enhancement, LV contractile function, and delayed enhancement imaging and his many contributions from the 10-year, 7,000-patient Multi-Ethnic Study of Atherosclerosis (MESA) study have been central to advances in our field. This landmark epidemiology study has published over 1,000 papers over the past 15 years. The CMR data has been the component of that study which has produced the most publications of any single sub-unit within MESA. In addition, Dr. Lima has authored 39 high‐level editorials and guidelines directly related to CMR. Perhaps most importantly, Dr. Lima has helped mentor and guide numerous others in the field. “From lectures to daily discussions and supervising research projects in CMR he was not only the most visionary researcher that I have ever known, but the best mentor any fellow could ask for.” - Carlos Eduardo Rochitte, MD, PhD Dr. Nagel has been deeply involved in SCMR for over two decades, including serving as President from 2008-2009. He has also been instrumental in furthering CMR recognition by holding leadership positions within the American College of Cardiology, American Heart Association, European Society of Cardiology, British Society of Cardiovascular Magnetic Resonance, German Society of Cardiovascular Magnetic Resonance, and as a Founding Member of the Asian Society for Cardiovascular Imaging. From a scientific perspective, Dr. Nagel has been a distinguished leader bringing recognition of the clinical applications of CMR across the spectrum of disease entities including left ventricular remodeling, viability, atherosclerosis, quantitative myocardial perfusion, and dobutamine stress ischemia CMR. Most recently, Dr. Nagel has been the Global Chief Investigator of MRINFORM, a large international randomized controlled outcome study assessing whether patients with stable chest pain can be guided noninvasively by CMR perfusion rather than invasive angiography supported by fractional flow reserve. These efforts have been critical in elevating CMR’s diagnostic and prognostic role. Finally, Dr.Nagel has also been at the forefront of training/mentoring a large number of CMR clinician researchers, as well as establishing multiple training programs throughout the world. It should be noted that many of his trainees have gone on to establish highly productive and widely recognized CMR centers of their own. “It is hard to find any aspect of the SCMR that has not been touched in some manner by Eike.” – Warren Manning, MD The SCMR is honored to recognize both individuals for their invaluable contributions to CMR and to the Society. Each has contributed in their own way, but all have made an indelible mark on the field deserving of the highest recognition. 6 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care G EN ER A L I N FO R M ATIO N ADMISSION PHOTOGRAPHY Conference name badges are required for admission to all activities related to the 19th Annual Scientific Sessions, including the exhibit hall and social events. Any photography, filming, taping, recording or reproduction in any medium including via the use of tripod-based equipment of any of the programs and/or posters presented at the 19th Annual Scientific Sessions without the express written consent of the Society for Cardiovascular Magnetic Resonance is strictly prohibited. REGISTRATION HOURS The Registration Desk is located in the California Lounge and will be open and staffed during the following hours: Wednesday, January 27 Thursday, January 28 Friday, January 29 Saturday, January 30 3:00 PM 7:00 AM 7:00 AM 7:00 AM SPEAKER READY ROOM The 2016 Program Committee is committed to providing attendees’ cutting edge technology and coordinated presentations at the Scientific Sessions. To be fully prepared for your session, each presenter is requested to visit the Speaker Ready Room at least 24 hours prior to your presentation. The Speaker Ready Room is located in the meeting room Sherman Oaks and will be open the following days and times: – 6:30 PM – 6:00 PM – 6:30 PM – 4:30 PM DISCLOSURE STATEMENT It is the policy of the Society for Cardiovascular Magnetic Resonance to insure balance, independence, objectivity and scientific rigor in all of its sponsored educational activities. All participating speakers and moderators, course directors, and planning committee members are required to disclose to the program audience any financial relationships related to the subject matter of this program. Relationships of spouse/partner with proprietary entities producing healthcare goods or services should be disclosed if they are of a nature that may influence the objectivity of the individual in a position to control the content of the CME activity. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. Specific faculty disclosure information for each speaker, course director, and planning committee member will be shared with the audience prior to the speaker’s presentation. A complete list of disclosures is available on the website. Tuesday, January 26 Wednesday, January 27 Thursday, January 28 Friday, January 29 Saturday, January 30 The Society for Cardiovascular Magnetic Resonance gratefully acknowledges the 2016 support of the following industry partners: PL ATINUM LEVEL: Siemens GOLD LEVEL: Philips At the conclusion of the SCMR Scientific Sessions, you will receive an invitation to complete the meeting survey. Please take the time to complete this survey as it provides very important feedback for future programming. Thank you, in advance, for completing the evaluation…your opinion and feedback matter! EXHIBITS Educational and informational exhibits will be available in the California Showroom during the Scientific Sessions. Exhibiting company representatives will be available to answer your questions about their products and services. Please visit the exhibits and thank the representatives for their support. The complete list of exhibits can be found on pages XX. Thursday, January 28 1:00 PM – 7:00 PM Friday, January 29 10:00 AM – 10:30 AM 12:30 PM – 1:30 PM 2:50 PM – 3:40 PM Saturday, January 30 10:00 AM – 10:30 AM 12:00 PM – 1:00 PM – 8:00 PM – 8:00 PM – 6:00 PM – 6:00 PM – 5:00 PM ACKNOWLEDGEMENTS EVALUATIONS AND CME TRACKING FORMS You must complete the CME Tracking Form in order to receive your CME certificate. After completing the Tracking Form, please return it to the Registration Desk or email it to [email protected]. 5:00 PM 7:00 AM 7:00 AM 7:00 AM 7:00 AM SILVER LEVEL: General Electric Heart Imaging Technologies SOCIAL MEDIA Continue the online conversation this year on Twitter with hashtag #SCMR2016. Share your thoughts about the conference and see what everyone is saying! Follow @SCMRorg on Twitter and Like Us on Facebook, SCMRorg. MOBILE DEVICES As a courtesy to the speakers and your fellow attendees, please switch your mobile device(s) to silent while attending sessions. www.scmr.org 7 From Innovation to Impact in Cardiovascular Care PR E- CO N FER EN C E S ES S IO N S THURSDAY, JANUARY 28, 2016 PHYSICIAN’S PRE-CONFERENCE COURSE Location: Constellation Co-Chairs:Chiara Bucciarelli-Ducci, MD, FESC (Bristol Heart Institute) and Katherine Wu, MD (Johns Hopkins Medical Institutions) SESSION 1: :00 AM –10:00 AM Physics and How-to’s of CMR 8 Moderators: Robert Biederman, MD (Allegheny General Hospital) Yuchi Han, MD (University of Pennsylvania) At the conclusion of this session, participants will be better able to: • Appreciate the key aspects of the Fourier Transform and other essential physics for CMR • Recognize typical scanning techniques to image myocardium and cardiovascular structures • Recognize typical scanning techniques to image functional and dynamic processes 8:00 AM Physics Made Easy and Fourier Transform for the Clinician Anthony Aletras, PhD (University of Thessaly) 8:20 AM The Essential Techniques for Cardiac Structure and Function Patrizia Pedrotti, MD (Niguarda Hospital) 8:40 AM Myocardial Tissue Characterization Martin Ugander, MD, PhD (Karolinska Institute) 9:00 AM Blood Flow Imaging and Angiography Robert Edelman, MD (Evanston Hospital) 9:20 AM How to Perform High Quality CMR Stress Imaging Manish Motwani, MB ChB (University of Leeds) 9:40 AM How To Assess Cardiac Chamber Sizes and Global vs. Regional Function Dipan Shah, MD (Methodist DeBakey Heart & Vascular Center) 10:00 AM BREAK SESSION 2: 10:20 AM–11:40 AM Clinical Scenarios (Part 1) Moderator: Ingo Eitel, MD (University Leipzig) At the conclusion of this session, participants will be better able to: • Recommend CMR vs. other diagnostic options • Prescribe CMR approaches to common questions in myocardial and valvular disease 10:20 AM Choosing CMR in a Multi-modality Imaging Climate Lilia M. Sierra-Galan, MD (ABC Medical Center) 10:40 AM Detecting Causes of Acute Myocardial Injury Erik Schelbert, MD, MS (University of Pittsburgh) 11:00 AM Assessment of New Onset Heart Failure or Cardiomyopathy of Unknown Cause Vinayak Hegde, MD (Akron General Medical Center) 11:20 AM Comprehensive Assessment of Valvular Heart Disease Clerio Azevedo, MD, PhD (Clínica de Diagnóstico por Imagem - CDPI/DASA) 11:40 AM BREAK SESSION 3: 1:50 AM– 1:00 PM 1 8 Interesting Cases Moderator: Nuno Bettencourt (Porto, Portugal) At the conclusion of this session, participants will be better able to: • Identify essential CMR protocol components in imaging the adult with congenital heart disease • Construct CMR-based strategies to address common clinical questions in cardiovascular care 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care PR E- CO N FER EN C E S ES S IO N S 12:10 PM “Why is my patient short of breath?” Viviana Maestrini, MD (The Heart Hospital) 12:30 PM “Why does my patient have chest pain?” Afshin Farzaneh-Far, MD, PhD (University of Illinois, Chicago) 12:50 PM Q&A Session CONGENITAL PRE-CONFERENCE COURSE Location: Pacific Palisades PRE-CONFERENCE 11:50 AM “What should I do with this adult with congenital heart disease?” Marcus Carlsson, MD (Lund University) Co-Chairs: Rajesh Krishnamurthy, MD (Texas Children’s Hospital), Emanuela Valsangiacomo, MD (University Children’s Hospital), and Adam Dorfman, MD (University of Michigan) SESSION 1: :00 AM –10:00 AM CMR in Congenital Heart Disease: Adding Clinical Value 8 Moderators: Adam Dorfman, MD (University of Michigan C.S. Mott Children’s Hospital) Willem Helbing, MD, PhD (Erasmus Medical Center, Rotterdam) At the conclusion of this session, participants will be better able to: • Understand the clinical value of CMR imaging in congenital heart disease • Learn how to adopt protocols to address the clinically relevant issues for various congenital heart lesions • Recognize common themes in the CMR approach to imaging various forms of congenital heart disease 8:00 AM Tetralogy of Fallot Shiraz Maskatia, MD (Texas Children’s Hospital) 8:15 AM D-Looped Transposition of the Great Arteries Andrew Crean, MD (Toronto General Hospital) 8:30 AM Single Ventricle Prior to Stage II and Stage III Palliation Matthew Harris, MD (Children’s Hospital of Philadelphia) 8:45 AM Fontan Adam Dorfman, MD (University of Michigan) 9:00 AM Shunt Lesions Beth Printz, MD, PhD (Rady Children’s Hospital) 9:15 AM Neonates with Congenital Heart Disease Emanuela Valsangiacomo-Buechel, MD (University Children’s Hospital Zurich) 9:30 AM Aortic Coarctation Ashwin Prakash, MD (Children’s Hospital Boston) 9:45 AM Vascular Rings and Slings Jimmy Lu, MD (University of Michigan) 10:00 AM BREAK SESSION 2: 0:20 AM–11:35 AM CMR in Acquired Pediatric Disease: A Beginner’s Guide 1 Moderators: Tal Geva, MD (Children’s Hospital) Shi-Joon Yoo, MD (The Hospital for Sick Children) At the conclusion of this session, participants will be better able to: • Understand the use of CMR for imaging acquired heart disease in children • Recognize key elements that are specific to imaging children with these diseases • Learn to adopt strategies to maintain the safety of pediatric patients during CMR scans 10:20 AM Keeping Children Safe in the MR Environment Ramkumar Krishnamurthy, PhD (Texas Children’s Hospital) 10:35 AM Evaluating the Valves Jonathan Soslow, MD (Vanderbilt University) www.scmr.org 9 From Innovation to Impact in Cardiovascular Care PR E- CO N FER EN C E S ES S IO N S 10:50 AM Myocarditis in Children Sohrab Fratz, MD, PhD (Deutsches Herzzentrum Munchen) 11:05 AM Pediatric Heart Transplant Michael Taylor, MD, PhD (Cincinnati Children’s Hospital) 11:20 AM Pulmonary Hypertension Vivek Muthurangu, MD (University College London) 11:35 AM BREAK SESSION 3: 1:45 AM– 1:00 PM Advanced Clinical Techniques: How do I start these programs? 1 Moderators: Emanuela Valsangiacomo Buechel, MD (University Children’s Hospital, Zurich) Kevin Whitehead, MD, PhD (Children’s Hospital of Philadelphia) At the conclusion of this session, participants will be better able to: • Learn key elements to implementing advanced imaging techniques in a pediatric CMR practice • Understand how the use of these imaging techniques may differ in a pediatric population compared to adults • Recognize the challenges of imaging infants and young children and learn strategies for successful imaging in this population 11:45 AM Blood Pool Contrast Imaging Joshua Robinson, MD (Lurie Children’s Hospital) 12:00 PM Myocardial Mechanics Kan Hor, MD (Nationwide Children’s Hospital) 12:15 PM Tissue Characterization Lars Grosse-Wortmann, MD (University of Toronto) 12:30 PM 4D Flow Shreyas Vasanawala, MD, PhD (Stanford University) 12:45 PM Imaging Young Patients Emanuela Valsangiacomo-Buechel, MD (University Children’s Hospital- Zurich) CLINICAL TRIALS WORKSHOP Location: Olympic Co-Chairs: Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London) and John Greenwood, MBChB, PhD, FRCP (University of Leeds) 8:00 AMWelcome – Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London) and John Greenwood, MBChB,PhD, FRCP (University of Leeds) SESSION 1: :05 AM – 9:45 AM Trial Design & Analysis Part 1 8 Moderators: Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London) John Greenwood, MBChB, PhD, FRCP (University of Leeds) At the conclusion of this session, participants will be better able to: • Formulate clinical research questions that take advantage of CMR-afforded opportunities • Differentiate various approaches to clinical research and their respective strengths/weaknesses • Identify strategies for successful design and execution of single-center randomized trials 8:05 AM Patient-Centered Outcomes Research: Expectations for Cardiovascular Imaging Diane Bild, MD, PhD (Patient-Centered Outcomes Research Institute) 8:25 AM Portfolio of CMR Opportunities in Clinical Research Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London) 8:45 AM Pros and Cons of Observational Studies and Registries Christopher Kramer, MD (University of Virginia Health System) 9:05 AM Pros and Cons of RCT’S and Systematic Reviews Mohammed Khanji, MB BCh (Queen Mary University of London ) 10 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care 9:25 AM New and Emerging Trial Designs John Greenwood, MD, PhD (University of Leeds) 9:45 AM BREAK SESSION 2: 0:00 AM–11:20 AM 1 Trial Design & Analysis Part 2 Moderator: Valentina Puntmann, MD, PhD, MRCP (University Hospital Frankfurt) At the conclusion of this session, participants will be better able to: • Use and interpret p values appropriately in clinical trials • Construct adequately-powered study samples and prescribe suitable univariate and multivariate analyses • Recognize the factors involved in survival curve and net reclassification analyses 10:00 AM What Do We Mean By p<0.05 Hyun Kim, PhD (UCLA) 10:20 AM How to do a Sample Size Calculation Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London) 10:40 AM Univariate and Multivariate Analysis Hyun Kim, PhD (UCLA) 11:00 AM Kaplan Meier Curves and Net Reclassification Hyun Kim, PhD (UCLA) 11:20 AM BREAK PRE-CONFERENCE PR E- CO N FER EN C E S ES S IO N S SESSION 3: 1:30 AM– 1:10 PM Clinical Applications 1 Moderators: Eike Nagel, MD, PhD, FACC, FESC (Goethe University Frankfurt) Colin Berry, MD (University of Glasgow) At the conclusion of this session, participants will be better able to: • Coordinate use or implementation of core lab services for clinical trial image analysis • Investigate the distinct needs of vascular vs. cardiac-focused clinical trials that use CMR • Assess opportunities and mechanisms to incorporate comparative effectiveness measures in clinical trials 11:30 AM Vascular MRI in Atherosclerosis Clinical Trials Denise Yates, PhD (Novartis Institutes for Biomedical Research) 11:50 AM CMR Core Labs: Pros and Cons for Multi-centre Clinical Trials Joao Lima, MD (Johns Hopkins) 12:10 PM CMR in Clinical ACS Trials: Challenges and Opportunities Gerry McCann, MD, BSc, MB, ChB, MRCP (University Hospitals Leicester) 12:30 PM Comparative Effectiveness Research Rory Hachamovitch, MD, MSc (Cleveland Clinic) 12:50 PM Clinical Trials Committee Update and Closing remarks John Greenwood, MD, PhD (University of Leeds) I NTERVENTIONAL CMR Location: Westwood o-Chairs: Robert Lederman, MD (National Heart, Blood, and Lung Institute) and Kanishka Ratnayaka, MD (Children’s National Health System) C This activity will not be CME accredited. 8:00 AM Welcome Robert Lederman, MD (National Heart, Blood, and Lung Institute) and Kanishka Ratnayaka, MD (Children’s National Health System) SESSION 1: TUTORIAL AND VENDOR SESSIONS 8:04 AM How to Start an Electrophysiology iCMR program Philipp Sommer, MD (Heart Center) www.scmr.org 11 From Innovation to Impact in Cardiovascular Care PR E- CO N FER EN C E S ES S IO N S 8:19 AM How to Begin MRI Cath in Patients Including Commercial Catheters Kanishka Ratnayaka, MD (Children’s National Medical Center) 8:40 AM Vendor Panel 1: Large Vendors & Conversations 8:40 AM Martin Ostermeier (Siemens Healthcare) 8:45 AM Jouke Smink (Philips Healthcare) 8:50 AM Anja Brau (GE Healthcare) 8:55 AM Dahan Meir (Imris by Deerfield Imaging, Inc.) 9:00 AM Juan Santos (HeartVista, Inc.) 9:05 AM Vendor Panel 2: Infrastructure 9:05 AM Jeff Griebel (Mallinckrodt Pharmaceuticals) 9:10 AM Yuvi Kahana (Optoacoustics) 9:15 AM Vendor Panel 3: Hemodynamics & EP 9:15 AM Vladimir Shusterman (PinMed, Inc) 9:20 AM John Kakareka (National Institutes of Health) 9:25 AM Jay Ward, MS (E-TROLZ) 9:30 AM Steve Wedan (Imricor EP Systems) 9:35 AM BREAK & MODERATED CONVERSATION SESSION 2: CATH AND CONGENITAL SESSIONS 10:00 AM VISION by Outsider: What I Need to Do Howaida El-Said (University of California San Diego) 10:10 AM XFM to Guide Transitional iCMR Procedures Amish Raval, MD (University of Wisconsin- Madison) 10:20 AM Guidewires Update for MRI Catheterization Ozgur Kocaturk, PhD (Boğaziçi University) 10:30 AM Real-Time, Image-Based Motion Compensation Graham Wright, PhD (Sunnybrook University of Toronto) 10:40 AM Technology: New Designs & Sequences for Device Tracking Ehud Schmidt, PhD (Brigham and Women’s Hospital) 10:50 AM Application: Extraanatomic Bypass for Congenital Kanishka Ratnayaka (Children’s National Medical Center) 11:00 AM Application: MRI Myocardial Biopsy Toby Rogers, BMBCh (NIH) 11:10 AM Human: MRI Cath for Pulmonary Hypertension Vivek Muthurangu (Great Ormond Street London) 11:20 AM Human: MRI Cath for Aortic Coarctation Update 2016 Sohrab Fratz (DHZ Munich) 11:30 AM Newcomers & Open Mic 1 MD Anderson Juan Lopez-Mattei, MD (University of Texas Anderson Cancer Center) 11:35 AM Newcomers & Open Mic 2 Update Houston Methodist C Huie Lin, MD, PhD (Methodist DeBakey Heart & Vascular Center) 11:40 AM BREAK & MODERATED CONVERSATION SESSION 3: EP SESSIONS 12:00 AM VISION by Outsider: What I Need to Do Kalyanam Shivkumar, MD, PhD (University of California Los Angeles) 12:10 PM Chemoablation for iCMR EP: A Completely New Approach Toby Rogers, BMBCh (NIH) 12:20 PM RFA for iCMR EP: Preclinical and Imaging Elena Grant (Children’s National Medical Center) 12 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care PR E- CO N FER EN C E S ES S IO N S Human iCMR EP Update 1 Henry Halperin, MD, MA (Johns Hopkins University) PRE-CONFERENCE 12:30 PM 12:40 PM Human iCMR EP Update 2 Marco Götte, MD, PhD (Haga Teaching Hospital) 12:50 PM Human iCMR EP Update 3: Active Catheter Afib Ablation Philipp Sommer, MD (Heart Center) 1:00 PM Human iCMR EP Update 4: How to Begin MRI EP Mapping and Ablation in Patients Reza Razavi (King’s College London) 1:10 PM BREAK & MODERATED CONVERSATION 1:00 PM –7:00 PM EXHIBIT HALL OPEN Location: California Showroom TRAINING AND CERTIFICATION IN CMR JOINTLY WITH EACVI oderators: Manish Motwani, MB ChB (Cedars Sinai Hospital) and Gina LaRocca, MD (Mount Sinai Hospital) M This activity will not be CME accredited. 1:00 PM Location: Encino Training and Research with CMR within United States Gina LaRocca, MD (Mount Sinai Hospital) 1:20 PM The European Experience Manish Motwani, MB ChB (Cedars Sinai Hospital) 1:40 PM The Importance of Certification for CMR: How to Achieve Standards of Excellence? Chiara Bucciarelli-Ducci, MD, PhD (Bristol Heart Institute) SC I ENTI FIC S ES S IO N S THURSDAY, JANUARY 28, 2016 2:00 PM – 3:45 PM OPENING PLENARY SESSION Location: Los Angeles Ballroom Delivering on the Promise of CMR Moderators: Victor A. Ferrari, MD (University of Pennsylvania Medical Center) Subha V. Raman, MD (The Ohio State University) At the conclusion of this session, participants will be better able to: • Recognize opportunities to leverage innovations in CMR to advance cardiovascular science and clinical care • Learn about key elements contributing to successful partnerships in CMR • Identify strategies to deliver on the promise of CMR through education and collaboration 2:00 PM Welcome from the President of the Society for Cardiovascular Magnetic Resonance and Program Chair Victor A. Ferrari, MD (University of Pennsylvania Medical Center) Subha V. Raman, MD, MSEE (The Ohio State University) 2:10 PM Cardiovascular Practice Needs and CMR Solutions: The Practitioner’s Perspective Patrick O’Gara,MD (Brigham and Women’s Hospital) 2:29 PM Advancing Cardiovascular Care through Innovation, Teaching, and Community Engagement Christopher Kramer, MD (University of Virginia) 2:48 PM The Translational Science Perspective on Myocardial Edema José Palomares, MD on behalf of David Garcia-Dorado, MD-PhD (Universitat Autònoma de Barcelona) 3:07 PM Collaboration to Deliver Impact: The LGE Story Robert Judd, PhD (Duke University) and Raymond Kim, MD (Duke University) 3:26 PM Team CMR Advances the Care of Patients with Congenital Heart Disease Andrew Powell, MD (Boston Children’s Hospital) Mehdi Hedjazi Moghari, PhD (Boston Children’s Hospital) www.scmr.org 13 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 4:00 PM – 5:20 PM INVITED LECTURE SESSION 1: Location: Los Angeles Ballroom Big Data and Computational Models Moderators: Steffen Petersen, MD, DPhil, MPH (Queen Mary University London) Declan O’Regan, PhD (Imperial College London) At the conclusion of this session, participants will be better able to: • Recognize the motivation of applying computational approaches to heart disease • Identify methods for acquisition and analysis of large datasets that include CMR • Integrate the application of big data and computational methods to mechanistic and interventional studies 4:00 PM How Can Computational Models Lead to Better Cardiovascular Care? Declan O’Regan, PhD (Imperial College London) 4:12 PM UK Biobank- First Experiences Steffen Petersen, MD, DPhil, MPH (Queen Mary University London) 4:24 PM The Cardiac Atlas Project Alistair Young, PhD (University of Auckland) 4:36 PM Cardiovascular Image Understanding via Big Data Tanveer Mahmood, PhD (Almaden Research Center) 4:48 PM Big Data in MESA: Challenges and Successes for CMR David Bluemke, MD, PhD (National Institute of Health) 5:00 PM Computational Biofluid Dynamics Based on Four-Dimensional Flow Michael Markl, PhD (Northwestern University) 5:12 PM Panel Discussion: Is CMR Ready for Big Data? 4:00 PM – 5:20 PM ORAL ABSTRACT SESSION 1: Coronary Artery Disease and Acute Coronary Syndrome Moderators: Mark Westwood, MD (The London Chest Hospital) Sebastian Kelle, MD (German Heart Institute Berlin) Location: Constellation 4:00 PM O 001 Prevalence of Dysfunctional but Viable Myocardium in Patients with Ischemic Cardiomyopathy – Results from Clinical Scans Performed in 2010-2014 at Four U.S. Hospitals Aditya Mandawat, MD (Duke University Hospital) 4:10 PM O 002 The Clinical Value of Stress Cardiac Magnetic Resonance Imaging in Symptomatic Patients with Low to Intermediate Acute Coronary Syndrome Risk Wei Dong (Beijing Anzhen Hospital) 4:20 PM O 003 Subclinical Systolic and Diastolic Dysfunction in Women with Signs and Symptoms of Ischemia But No Obstructive Coronary Disease: Novel Insights Using Myocardial Feature Tracking in the NHLBI WISE Study Michael Nelson, PhD (Barbra Streisand Women’s Heart Center, Cedars-Sinai Medical Center) 4:30 PM O 004 3D-Dixon Cardiac Magnetic Resonance Detects an Increased Epicardial Fat Volume in Hypertensive Men with Myocardial Infarction Rami Homsi (University Hospital Bonn) 4:40 PM O 005 Assessment of Coronary Wall Thickening in Autosomal Dominant Hyper- immunoglobin E Syndrome (AD-HIES) Using TRAPD-MRI Khaled Abd-Elmoniem, PhD (NIH) 4:50 PM O 006 Markers of Abnormal Tissue Deformation and Fibrosis in Remote Myocardium Following Acute Myocardial Infarction: A Comparison of Diabetics Versus Non-diabetics Performed Using Spatially Matched 4D Strain and Native T1 Mapping Alessandro Satriano, PhD (Stephenson Cardiac Imaging Centre, University of Calgary) 5:00 PM O 007 Non-contrast Myocardial Perfusion Assessment in Porcine Acute Myocardial Infarction using Arterial Spin Labeled CMR Hung Do, PhD (University of Southern California) 5:10 PM O 008 Nonlinear Myocardial Perfusion Imaging with Motion Corrected Reconstruction: Validation via Quantitative Flow Mapping Hui Xue, PhD (National Institutes of Health) 14 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 4:00 PM – 5:20 PM CASE REVIEW 1: Physiology or Pathology? Questions in Sports Moderators: Gerry McCann, MD (Leicester, UK) Clerio Avezedo, MD (Rio de Janeiro, Brazil) Location: Pacific Palisades 4:10 PM CR 02 Relative Apical Hypertrophy – Disease or Incidental Finding? Paul Scully, MBBS MRes (Ashford and St Peter’s Hospitals NHS Foundation Trust) 4:20 PM CR 03 Time to Play? A Subtype of Apical Hypertrophic Cardiomyopathy Presenting as Chest Pain in a Professional Athlete Tendoh Timoh, MD (Medstar Georgetown University Hospital and Washington Hospital Center) THURSDAY PROGRAM 4:00 PM CR 01 Trabeculations of The Left Ventricle; Novel Cardiomyopathy or Physiological Adaptation to Exercise Sabiha Gati, MRCP (St. Georges’ University) 4:30 PM CR 04 Myocarditis or Physiologic T2 Increase in a Swimmer Emily A Ruden, MD (The Ohio State Univeristy) 4:40 PM CR 05 PVCs in a Soccer Player Clerio Azevedo, MD, PhD (Clínica de Diagnóstico por Imagem - CDPI/DASA) 4:50 PM CR 06 Focal Fibrosis and Lipomatous Metaplasia Seen in a 77 Year Old Former Marthon Runner and Athlete with Palpitations Daniel W Groves, MD (Cardiovascular Pulmonary Branch, NIH/NHLBI) 5:00 PM CR 07 Asymptomatic Athlete with Family History of DCM Christopher Miller, MBChB (University Hospital of South Manchester) 5:10 PM CR 08 Time to Quit? Apical Hypertrophic Cardiomyopathy in a Marathon Runner Justin H. Beckett. MD (Medstar Georgetown UniversityHospital) 4:00 PM – 5:20 PM ORAL ABSTRACT SESSION 2: Translational CMR Moderators: Allison Hays, MD (Johns Hopkins) Wolfgang Rehwald, PhD (Siemens Medical Solutions) Location: Olympic 4:00 PM O 009 Differential Responses of Post-Exercise Recovery Leg Blood Flow and Oxygen Uptake Kinetics in HFPEF versus HFREF Richard Thompson, PhD (University of Alberta) 4:10 PM O 010 An Interactive Videogame Designed to Optimize Respiratory Navigator Efficiency in Children Undergoing Cardiac Magnetic Resonance Sean Hamlet, MS (University of Kentucky, University of Kentucky) 4:20 PM O 011 Quantitative Myocardial Perfusion Imaging Using a Step Arterial-Input Function Richard Thompson, PhD (University of Alberta) 4:30 PM O 012 Reliable Detection of Subendocardial Ischemia by High-Resolution End-Systolic First-Pass Perfusion Imaging in the Absence of Obstructive Coronary Disease Behzad Sharif, PhD (Cedars-Sinai Medical Center) 4:40 PM O 013 Regional Coronary Endothelial Dysfunction is Related to Local Epicardial Fat in HIV+ Patients Allison Hays, MD (Johns Hopkins) 4:50 PM O 014 Standardised Postprocessing of Native T2 in Detection and Discrimination of Myocarditis Comparison with Native T1 Mapping Valentina Puntmann, MD, PhD, FRCP (University Hospital Frankfurt) 5:00 PM O 015 The Incretin Axis offers a Novel Therapeutic Target to Preserve Myocardial Energy Metabolism in Cardiorenal Syndrome Marie Schroeder, DPhil (Sunnybrook Health Sciences Centre) 5:10 PM O 016 Molecular MRI of Myocardial Peroxidase Activity in Ischemic Injury Reveals a Chemical Milieu Incompatible with Stem Cell Survival Howard Chen, PhD (Massachusetts General Hospital, Harvard Medical School) 5:30 PM – 6:00 PM CMR TECHNOLOGY UPDATE 6:00 PM – 7:00 PM Welcome Reception, Poster Group P 1 & Exhibits www.scmr.org Location: Westwood Location: California Showroom 15 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S FRIDAY, JANUARY 29, 2016 7:30 AM – 8:30 AM Physics for Physicians: What Your Technologist Wish You Knew Location: Los Angeles Moderators: Stephen Darty, BS, RT(N)(MR) (Duke University Medical Center) Elizabeth Jenista, PhD (Duke University Medical Center) At the conclusion of this session, participants will be better able to: • Identify key scan types and parameters influencing MR image weightings • Consider alternate scanning approaches to deliver a useful CMR exam when triggering and breath-holding are limited • Address MR safety questions that arise before and during scanning 7:30 AM T1, T2, and Other Weightings in Typical CMR Acquisitions Elizabeth Jenista, PhD (Duke University Medical Center) 7:50 AM When Good Triggering and Breathholding Go Bad: What are your Options? Stephen Darty, BS, RT(N) (MR) (Duke University Medical Center) 8:10 AM Is It Safe To Put This Patient (Back) in The Scanner? Questions That Arise During Screening and Scanning Anna Lisa Crowley, MD (Duke University Medical Center) 7:30 AM – 8:30 AM Cardiology for Non-Clinicians: Location: Constellation What the Sick Patient in the Scanner Needs You to Know Moderators: Daniel Lee, MD (Northwestern University) Daniel Messroghli, MD (German Heart Institute Berlin) At the conclusion of this session, participants will be better able to: • Recognize CMR’s value in the sick patient with cardiovascular disease • Prescribe practical CMR approaches when scanning sick patients • Develop strategies for inpatient care coordination guided by CMR 7:30 AM High Risk, High Reward: CMR in The Hospitalized Patient with Cardiovascular Disease Sharon Roble, MD (The Ohio State University) 7:45 AM Get What You Need, Then Get Out of Dodge: Fast Scanning Techniques Deborah Kwon, MD (Cleveland Clinic) 8:00 AM To Stress or Not To Stress, That Is The Question Pairoj Rerkpattanapipat, MD (Piedmont Cardiology Associates) 8:15 AM Panel Discussion: My Biggest Disasters: What I Learned 7:30 AM – 8:30 AM CASE REVIEW 2: Location: Olympic The Patient Referred for Evaluation of Ischemic Heart Disease Moderators: Christopher Dyke, MD (Alaska Heart Institute) Chiara Bucciarelli-Ducci, MD, PhD (Bristol Heart Institute) 7:30 AM CR 09 Ventricular Intramyocardial Dissection, Ventricular Aneurysm and Ventricular Septal Rupture Presenting as a Delayed Complication of Inferoseptal Myocardial Infarction: The Value of Cardiac MR in Multimodality Imaging Correlation for Diagnosis and Management Joao Inacio, MD (The Ottawa Hospital, Ottawa Hospital Research Institute) 7:40 AM CR 10 Stress CMR in a Device Patient; A Viable option? Ashley Nickerson, DO (University of Kentucky) 7:50 AM CR 11 Unlikely Events are Very Likely as Soon as They Have Occurred Britt-Marie Ahlander, RN (Divisions of Medical Diagnostics, Linkoping University) 8:00 AM CR 12 Global Myocardial Hibernation Gabriella Di Giovine, MD (A.O.U. Maggiore della Carità in Novara, Italy) 8:10 AM CR 13 Expansion of Left Ventricular Inferior Wall Pseudoaneurysm Following Myocardial Infarction Amita Singh, MD (University of Chicago Hospitals) 8:20 AM CR 14 MTHFR and G20210A Prothrombin Gene Mutations as a cause of Early Coronary Artery Disease and Ventricular Thrombi: CMRI Assessment of Viability and Thrombus Characterization Menhel Kinno, MD (Rutgers University - New Jersey Medical School) 16 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 7:30 AM – 8:30 AM Careers in CMR: Aligning Your Path Across Opportunities Location: Westside Moderators: Timothy Albert, MD (Tanner Health System) Yiu-Cho Chung, PhD (Lauterbur Research Center Shenzhen) At the conclusion of this session, participants will be better able to: • Construct CMR-related career development strategies • Recognize common and distinct expectations across career pathways • Establish inter-disciplinary partnerships that foster career development 7:30 AM Academics Eike Nagel, MD, PhD (Goethe University) 8:00 AM Community Practice Michael Elliott, MD (Sanger Heart and Vascular Institute) 8:15 AM Resonant Frequencies and Overlapping Bandwidths: Matching Interests to Job Opportunities 8:40 AM – 10:00 AM ORAL ABSTRACT SESSION 3: Basic Science (Early Career Awards) Moderators: Michael Jerosch-Herold, PhD (Brigham and Women’s Hospital) Albert de Roos (Leiden University) Location: Constellation 8:40 AM O 017 Quantifying Passive Myocardial Stiffness and Wall Stress in Heart Failure Patients Using Personalized Ventricular Mechanics Zhinuo Jenny Wang, PhD (University of Auckland) FRIDAY PROGRAM 7:45 AM Industry Denise Yates, PhD (Novartis Institutes for Biomedical Research) 8:50 AM O 018 In Vivo Cardiac DTI on a Widely Available 3T Clinical Scanner: an Optimized M2 Approach Christopher Nguyen, PhD (Cedars-Sinai Medical Center) 9:00 AM O 019 Towards Reliable Myocardial Blood-Oxygen-Level-Dependent (BOLD) CMR Using Late Effects of Regadenoson with Simultaneous 13N-ammonia PET Validation in a Whole-body Hybrid PET/MR System Hsin-Jung Yang, MS (Cedars Sinai Medical Center) 9:10 AM O 020 Combining Acquisition and Image Processing Methods to Improve Evaluation of Arial Wall Scar Patterns after Pulmonary Vein Isolation Adrian Lam (Georgia Institute of Technology) 9:20 AM O 021 Comparison of Oscillatory Wall Shear Stress in the Abdominal Aorta of Men and Women: Relationship to Abdominal Aortic Aneurysm (AAA) Development Elizabeth Iffrig (Emory University, Georgia Institute of Technology) 9:30 AM O 022 Coronary Atherosclerosis T1-weighed Characterization with integrated anatomical reference (CATCH) Yibin Xie (Cedars-Sinai Medical Center) 9:40 AM O 023 The Shape of the Healthy Heart Is Optimized for Vortex Ring Formation Per Arvidsson, MD (Lund University) 9:50 AM O 024 Assessment of Metformin Induced Changes in Cardiac Redox State Using Hyperpolarized[1-13C]pyruvate Andrew Lewis (University of Oxford) 8 :40 AM – 10:00 AM INVITED LECTURE SESSION 2: Game Changers in CMR Location: Los Angeles Moderators: Stefan Neubauer, MD (Oxford University) Michael Salerno MD, PhD (University of Virginia) At the conclusion of this session, participants will be better able to: • Investigate novel approaches that offer significant advances in CMR • Summarize new techniques for myocardial tissue characterization and their basis • Recognize novel methods to shorten scan time and overcome gating and breathholding limitations 8:40 AM New Frontiers in Advanced Image Reconstruction Leon Axel, PhD, MD (New York University School of Medicine) www.scmr.org 17 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 8:56 AM Novel Non-Contrast CMR Approaches Andreas Kumar, MD (Laval University) 9:12 AM Advanced Applications and Techniques for First Pass Perfusion CMR Behzad Sharif, PhD (Cedars-Sinai Medical Center) 9:28 AM ECV: What Are We Really Measuring? Håkan Arheden, MD, PhD (Lund University) 9:44 AM The Future of Non-ECG and Non-Breath-hold Techniques Debiao Li, PhD (Cedars-Sinai) 8 :40 AM – 10:00 AM CASE REVIEW 3: Location: Olympic The Patient Referred for a Cardiac Mass with Pathologic Correlation Moderators: M. Barbara Srichai-Parsia, MD (Georgetown University) Jennifer Dickerson, MD (The Ohio State University) 8:40 AM CR 15 Papillary Fibroelastoma: A Known Cause of TIA in an Uncommon Location Rajesh Janardhanan, MD, MRCP, FACC, FASE (Sarver Heart Center, University of Arizona) 8:50 AM CR 16 An Unusual Case of Biventricular Hypertrophy Anna Baritussio (Bristol Heart Institute) 9:00 AM CR 17 The Case of the Pulsating Pimple Nayla Chaptini, MD (Advocate Heart Institute, Advocate Lutheran General Hospital) 9:10 AM CR 18 Intrapericardial Paraganglioma Lorenzo Monti, MD (Humanitas Research Hospital) 9:20 AM CR 19 Unusual Cause of Angina in a Young Male Elizabeth Joseph (Christian Medical College) 9:30 AM CR 20 A Rare Case of Left Atrial Sarcoma: Role of CMR in the Diagnosis and Management Naveen Rajpurohit, MD (Piedmont Heart Institute) 9:40 AM CR 21 An Unusual Case of a Usual Suspect Jorge Gonzalez, MD (University of Virginia) 9:50 AM CR 22 Multimodality Imaging of an Unusual Presentation of LV Lipoma Roy Sasil (Philippine Heart Center) 8:40 AM – 1 0:00 AM ORAL ABSTRACT SESSION 4: Congenital Heart Disease I Moderators: Brian Soriano, MD (Seattle Children’s Hospital) David Parra, MD (Vanderbilt Children’s Hospital) Location: Westside 8:40 AM O 025 The Right Ventricle in Congenital Heart Disease - Cardiac T1 Mapping for Measurements of Diffuse Myocardial Fibrosis Nadya Al-Wakeel (Deutsches Herzzentrum Berlin) 8:50 AM O 026 Quantifying Right Ventricular Diffuse Fibrosis in Tetralogy of Fallot - A Novel Customised Approach for The Challenges of the Right Ventricle Ee Ling Heng, MBBS BSc MRCP (Royal Brompton & Harefield NHS Foundation Trust and Imperial College London) 9:00 AM O 027 Diffuse Myocardial Fibrosis Using Native T1 Mapping in Children with Repaired Tetralogy of Fallot: Correlation with Surgical Factors and Exercise Capacity Deane Yim, MBchB (Hospital for Sick Children) 9:10 AM O 028 Diffuse Myocardial Fibrosis in Patients After Fontan Operation: A T1 Relaxometry Magnetic Resonance Pilot Study Atsuko Kato, MD (The Hospital for Sick Children) 9:20 AM O 029 The Relative Importance and Interactions of CMR-Derived Parameters of Ventricular Mechanics in the Prediction of Death and Transplant Late after the Fontan Operation Rahul Rathod, MD (Boston Children’s Hospital, Harvard Medical School) 9:30 AM O 030 The Impact of Ventricular Morphology on Wall Stress and Ventricular Strain in Fontan Patients Sunil Ghelani, MD (Boston Children’s Hospital) 18 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 9:40 AM O 031 Feature Tracking (Ft) and Extracelluar Volume (Ecv) by Cardiac Magnetic Resonance Segmentally Analyze Change of Lv in Ebstein: A Novel Perspective in Myocardial Remodeling Dan Yang (West China Hospita Sichuan University) 9:50 AM O 032 Association of Ventricular Dyssynchrony and Strain with Cardiac Function in Patients with Repaired Tetralogy of Fallot Linyuan Jing, PhD (Geisinger Health System University of Kentucky) Location: Plaza Foyer 8:40 AM Q 01 Realtime Cardiac Function Using Compressed Sensing: Initial Clinical Evaluation Volker Rasche (University Hospital of Ulm) 8:48 AM Q 02 CMR-Based 3D Statistical Shape Modelling Reveals Left Ventricular Morphological Differences Between Healthy Controls and Arterial Switch Operation Survivors Jan Bruse, MSc (UCL Institute of Cardiovascular Science) 8:56 AM Q 03 Aging and Gender Effects in Native T1 and Extracellular Volume Fraction Assessment Using Sasha Joseph Pagano, MD (University of Alberta) 9:04 AM Q 04 Epicardial Adipose Tissue, Aortic Stiffness and Myocardial Fibrosis in Healthy Individuals: A Quantitative Cardiac Magnetic Resonance Study Rami Homsi (University Hospital) FRIDAY PROGRAM 8:40 AM – 10:00 AM WALKING POSTER SESSION 1: Methods to Analyze Tissue and Function Moderators: Victor A. Ferrari, MD (University of Pennsylvania Medical Center) Orlando P. Simonetti, PhD (The Ohio State University) 9:12 AM Q 05 T1 and T2 Mapping Reveal Contribution of Hemorrhage in Myocardial Remodeling Following Acute Myocardial Infarction Nilesh Ghugre, PhD (Sunnybrook Research Institute, University of Toronto) 9:20 AM Q 06 Validation of a Novel Dark-Blood Delayed Enhancement Technique for the Detection of Papillary Muscle Scar Dave Wendell, PhD (Duke University) 9:28 AM Q 07 Withdrawn 9:36 AM Q 08 Accuracy of Ecv Imaging for the Detection of Subendocardial Infarction – Comparison with Black Blood Delayed Enhancement and Pathology Elizabeth Jenista, PhD (Duke University) 9:44 AM Q 09 Comparison of T1-Mapping and T2-Weighted Imaging for Diagnostic Oedema Assessment in St-Segment Elevation Myocardial Infarction Sheraz Nazir, BSc, MB BChir, MRCP (University of Leicester) 9:52 AM Q 10 Comparison of T2-Preparation and Magnetization-Transfer Preparation for Black Blood Delayed Enhancement Elizabeth Jenista, PhD (Duke University) 10:00 AM–10:30 AM REFRESHMENT BREAK/EXHIBITS 10:40 AM–12:00 PM INVITED LECTURE SESSION 3: CMR Practice Models Around the World Location: Los Angeles Moderators: Lilia M Sierra-Galan, MD (ABC Medical Center) Carmen Chan, MBBS (University of Hong Kong) At the conclusion of this session, participants will be better able to: • Recognize distinct health care system factors that impact the delivery of CMR to appropriate patients around the world • Examine regional differences in employment opportunities and staffing needs to deliver CMR services • Summarize current training opportunities and mechanisms to address training gaps 10:40 AM Latin America: Challenges and Opportunities Lilia Sierra-Galan, MD, FACC, FSCCT (American British Cowdray Medical Center) 10:52 AM India: Challenges and Opportunities Elizabeth Joseph, MBBS, DMRD, DNB (Christian Medical College) www.scmr.org 19 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 11:04 AM Australia and New Zealand: Challenges and Opportunities Sylvia Chen, MBBS (The Northern and The Epworth Hospitals) 11:16 AM Japan: Challenges and Opportunities Hajime Sakuma, MD, PhD (Mie University Hospital) 11:28 AM China: Challenges and Opportunities Yucheng Chen, MD (West China Hospital, Sichuan University) 11:40 AM CMR in Medical Tourism Vimal Raj, MBBS (Narayana Hrudayalaya Hospitals) 11:52 AM Rapid-Fire Roundtable: Appropriate, Inappropriate, Uncertain 10:40 AM–12:00 PM ORAL ABSTRACT SESSION 5: Clinical CMR (Early Career Awards) Moderators: W. Gregory Hundley, MD (Wake Forest University) Joao Lima, MD (Johns Hopkins) Location: Constellation 10:40 AM O 033 Right Atrial Volume Indexed by Cardiovascular Magnetic Resonance as a Predictor of Mortality in Patients with Heart Failure with Reduced Ejection Fraction Alexander Ivanov, MD (New York Methodist Hospital) 10:50 AM O 034 Prognostic Value of MRI T2 Quantification in Heart Transplant Patients: A 5-year Outcome Study Varun Chowdhary, MD (Northwestern University, Staten Island University Hospital) 11:00 AM O 035 Successful Ablation of Atrial Fibrillation does not Normalise Left Ventricular Function, Reverse Impaired Myocardial Energetics or Increase Perfusion Reserve: Novel Mechanistic Insights with Clinical Implications Rohan Wijesurendra, MB BChir MA (Cantab) MRCP (University of Oxford) 11:10 AM O 036 Myocardial Perfusion Reserve but not fibrosis Predicts Outcomes in Initially Asymptomatic Patients with Moderate to Severe Aortic Stenosis: The PRognostic Importance of MIcrovascular Dysfunction in AS study- PRIMID AS Anvesha Singh, MBChB (University of Leicester and the NIHR Leicester Cardiovascular Biomedical Research Unit) 11:20 AM O 037 Diffuse Myocardial Fibrosis – A Therapeutic Target? Proof of Regression At 1-Year Following Aortic Valve Replacement: The RELIEF-AS Study Thomas Treibel, MBBS (Barts Heart Centre, Institute for Cardiovascular Sciences, University College London) 11:30 AM O 038 CMR Findings in High Endurance Veteran Athletes – a 247 subject study Viviana Maestrini, MD (La Sapienza) 11:40 AM O 039 Ultrafast CMR to Deliver High Volume Screening of an at Risk Thalassemia Population in the Developing World: Preliminary Results from the TIC-TOC Study (Thailand and UK International Collaboration in Thalassaemia Using an Optimised Ultrafast CMR Protocol) Amna Abdel-Gadir, MBBS, MRCP (University College London, Barts Heart Centre) 11:50 AM O 040 Occult Senile Cardiac Amyloid in Severe Calcific Aortic Stenosis is Not Rare and has a Poor Prognosis: A 146 Patient CMR Biopsy Study Thomas Treibel, MBBS (Barts Heart Centre, Institute of Cardiovascular Sciences, University College London) 10:40 AM–12:00 PM CASE REVIEW 4: The Patient Referred for Vascular Imaging Moderators: John Heitner, MD (New York Methodist Hospital) Robert Edelman, MD (Evanston Hospital) Location: Olympic 10:40 AM CR 23 Aortitis Masquerading as Chest Pain Clint Walters, MD (Georgia Regents University) 10:50 AM CR 24 A Man with Broad-complex Tachycardia and Dilated Cardiomyopathy Anna Baritussio (Bristol Heart Institute) 11:00 AM CR 25 Is This a Vascular Ring? Tiffanie Johnson, MD (Riley Hospital for Children/Indiana University) 11:10 AM CR 26 Evaluation of Severe Pulmonary Arterial Hypertension Using Cardiovascular Magnetic Resonance El-Sayed Ibrahim (University of Michigan) 20 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 11:20 AM CR 27 3D Printing from Cardiac Magnetic Resonance Imaging for Surgical Planning in a Patient with Superior-Inferior Ventricles, Criss-Cross Atrio-Ventricular Inflows, Atrial and Ventricular Septal Defects and Left Lung Collapse Shafkat Anwar, MD (St. Louis Children’s Hospital, Washington University School of Medicine) 11:30 AM CR 28 Venous Confluence in an Adult Alexander Ivanov, MD (New York Methodist Hospital) 11:40 AM CR 29 Usefulness of Cardiac MRI in Assessment of Aortic Stenosis Amitabh Parashar, MD (VAMC Salem, Virginia Tech Carilion SOM) 10:40 AM–12:00 PM INVITED LECTURE SESSION 4: Location: Westside Congenital Scanning: Beyond Structure and Function Moderators: Lars Grosse-Wortman, MD (University of Toronto) Gerald Greil, MD, PhD, UT (Southwestern, Dallas, TX) At the conclusion of this session, participants will be better able to: • Differentiate submaximal from maximal stress, and when each can be used in pediatric and congenital heart disease • Determine the predictive utility of late gadolinium enhancement for poor outcomes in pediatric and congenital heart disease • Evaluate the role for assessment of vascular function by CMR in the pediatric and congenital heart patient population 10:40 AM FRIDAY PROGRAM 11:50 AM CR 30 Pulmonary Artery Dissection in Patients with Eisenmenger’s Syndrome and Conservative Medical Treatment Kyung-Hee Kim, MD, PhD (Sejong General Hospital) Congenital and Pediatric Stress CMR: What Should I Do, When, and When Not? Cory Noel, MD (Texas Children’s Hospital) 10:55 AM Stress Testing for Functional Capacity, Not Ischemia, in Congenital Heart Disease Heiko Stern, PhD (German Heart Center) 11:10 AM Myocardial Viability in Pediatric and Congenital Heart Disease, Can We Risk Stratify? Rahul Rathod, MD (Boston Children’s Hospital) 11:25 AM Vascular Function and Vessel Wall Imaging: Fad or Future for Pediatric and Congenital Heart Disease? Tarique Hussain, MD, PhD (King’s College London) 11:40 AM Catheterization and CMR for Congenital Heart Disease Kanishka Ratnayaka, MD (National Institutes of Health) Location: Plaza Foyer 10:40 AM–12:00 PM WALKING POSTER SESSION 2: CMR in Coronary Artery Disease Moderators: Jeanette Schulz-Menger, MD (Charite Universitatsmedizin and HELIOS Clinics) Peter Kellman, PhD (National Institute of Health) 10:40 AM Q 11 Diagnostic Accuracy of Dixon Water Fat Suppression Coronary Artery Magnetic Resonance Angiography at 3.0 Tesla David Ripley, MBChB (University of Leeds) 10:48 AM Q 12 The Feasibility of Combining Low-Level Exercise with Vasodilator Stress in Patients Referred for Stress Perfusion Cardiac MRI Jason Craft, MD (Advocate Christ Medical Center) 10:56 AM Q 13 Diagnosis of Chronic Allograft Vasculopathy Using Semiquantitative Stress Perfusion CMR in Heart Transplant Patients Madeline Schwid (Northwestern University) 11:04 AM Q 14 Correcting T2* Effects in the Myocardial Perfusion Arterial Input Function Avoids Overestimation of Myocardial Blood Flow Hui Xue, PhD (National Institutes of Health) 11:12 AM Q 15 Combined High-resolution Assessment of Quantitative Perfusion and Late Enhancement. Towards Accurate Estimation of the Ischaemic Burden in Patients with Coronary Artery Disease. Adriana Villa, MD (King’s College London) 11:20 AM Q 16 Comparison of Derived Strain Values of Myocardial Regions, Levels, and Segments by Field Strength and Temporal Resolution via Cine bSSFP MR Imaging Eric Keller, MA (Northwestern University) www.scmr.org 21 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 11:28 AM Q 17 Correlations and Validations of Dual-Bolus and Dual-Sequence Quantification of First-Pass Myocardial Perfusion CMR in Humans and Canines Li-Yueh Hsu, D.Sc (National Heart Lung and Blood Institute, National Institutes of Health) 11:36 AM Q 18 T1 Measurements in a Rat Model of Acute Myocardial Ischemia/reperfusion Darach O h-Ici, MB (German Heart Institute) 11:44 AM Q 19 Association of Smoking with Myocardial Injury and Clinical Outcome in Patients Undergoing Mechanical Reperfusion for ST-Elevation Myocardial Infarction Ingo Eitel, MD (University Heart Center Lübeck) 11:52 AM Q 20 Overall Impact of Outpatient Stress Cardiac Magnetic Resonance (CMR) Imaging on Clinical Care is Independent of Appropriate Use Criteria Sloane McGraw, DO (University of Illinois- Chicago) SCMR BUSINESS MEETING 2:00 PM–12:30 PM 1 Moderator: Victor Ferrari, MD, SCMR President (University of Pennsylvania) SCMR Leadership will present important society updates including the progress of the Global CMR Registry and the activities of the U.S. Working Group. All members are encouraged to attend. 12:30 PM– 1:30 PM LUNCH/EXHIBITS/POSTER GROUP P 2 1:30 PM – 2:50 PM INVITED LECTURE SESSION 5: Location: Los Angeles Multimodality Imaging to Guide Surgical and Transcatheter Valve Repair Moderators: Yuchi Han, MD (University of Pennsylvania) Ingo Eitel, MD (University of Leipzig - Heart Center) At the conclusion of this session, participants will be better able to: • Recognize various modalities’ roles in evaluating valvular heart disease • Identify key questions for cardiovascular imaging in planning transcatheter valve interventions • Develop integrated approaches to imaging the patient with aortic stenosis 1:30 PM CMR Advances in Valvular Regurgitation Seth Uretsky, MD (Atlantic Health System) 1:44 PM Echocardiography in Low Gradient Aortic Stenosis Jiwon Kim, MD (Weill-Cornell University) 1:58 PM CTA in Transcatheter Interventional Planning Jonathon Leipsic, MD (University of British Columbia) 2:12 PM Nuclear Imaging of the Right Heart in Valvular Disease Daniel Berman, MD (Cedars-Sinai Medical Center) 2:26 PM Valvular Heart Disease: When I Must Have Invasive Data Florian Boenner, MD (University of Duesseldorf) 2:40 PM Panel Discussion: an 85 Year-Old Woman Presents with Severe AS: What Is Your Workflow? 1:30 PM – 2:50 PM ORAL ABSTRACT SESSION 6: Tissue Characterization Moderators: Christopher Miller, MBChB (University Hospital of South Manchester) Marianna Fontana (The Heart Hospital) 1:30 PM O 041 Location: Constellation Apparent Diffusion Coefficient (ADC), T1 and T2 Quantitative Indexes of the Myocardium in Athletes Before, Duringand After Extreme Mountain Ultra-marathon: Correlation with Myocardial Damages and Inflammation Biomarkers Magalie Viallon, PhD (CREATIS/ CHU de Saint Etienne) 1:40 PM O 042 Native Myocardial T1 and ECV with Age and Gender Developing Normal Reference Ranges – A 94 Healthy Volunteer Study Stefania Rosmini, MD (Cardiac Imaging) 1:50 PM O 043 Tissue Characterization with Native T1 Mapping in Suspected Coronary Microvascular Dysfunction and No Obstructive Coronary Artery Disease: Results from the NHLBI-sponsored WISE Study Jaime Shaw, PhD (Cedars-Sinai Medical Center, UCLA) 22 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 2:00 PM O 044 Relationship Between the Transmural Extent of High Resolution Parametric (T1- and T2) Mapping and the Ischemic Area at Risk Defined by Pathology Dave Wendell, PhD (Duke University) 2:10 PM O 045 Does T1-mapping in Border-Zone and/or Remote Regions can Help to Predict Functional Recovery After Revascularization in Chronic Coronary Total Occlusion (CTO) patients? Pierre Croisille, MD PhD (CHU Saint-Etienne) 2:30 PM O 047 Cardiac Magnetic Resonance in Heart Transplant Patients: Diagnostic Value of Quantitative Tissue Markers (T2 Mapping and ECV) for Acute Cardiac Rejection Diagnosis Emmanuelle Vermes, MD (CHU TROUSSEAU) 2:40 PM O 048 Incremental Benefit in Correlation with Histology of Native T1 Mapping, Partition Coefficient and Extracellular Volume Fraction in Patients with Aortic Stenosis Vassilis Vassiliou, MA, MBBS, MRCP (Royal Brompton Hospital, Imperial College London) 1:30 PM – 2:50 PM CASE REVIEW 5: The Adult Patient Referred for Evaluation of Congenital Heart Disease Moderators: Ali Zaidi, MD (Montefiore Medical Center) Sharon Roble, MD (The Ohio State University) Location: Olympic FRIDAY PROGRAM 2:20 PM O 046 Quantitative Assessment of Diffuse Myocardial Fibrosis in II-Type Diabetes Mellitus Patients Using T1 Mapping Technique: Preliminary Data Iacopo Carbone, MD (Sapienza - University of Rome) 1:30 PM CR 31 Unusual Findings in a Patient with Chronic Pulmonary Hypertension: Diagnostic Value of Cardiac MRI/MRA Mohit Pahuja, MD (St. Josephs Hospital and Medical Center) 1:40 PM CR 32 A Young Man with Dilated Right Ventricle Anna Baritussio (Bristol Heart Institute) 1:50 PM CR 33 Sub-Aortic Membrane: Role of Multi-Modality Imaging Ruchit Shah, MD (Georgia Regents University) 2:00 PM CR 34 Aortopulmonary Window: A Rare Etiology of Dyspnea in an Adult Lindsey McPhillips, DO (Northshore Long Island Jewish- Cohen Children’s Medical Center) 2:10 PM CR 35 An Extremely Rare Congenital Cardiomyopathy Presenting in an Adult (<15 reported cases): “Apical Hypotrophy” Arash Seratnahaei, MD (UKMC) 2:20 PM CR 36 Double Chambered Right Ventricle: Initial Presentation in Adulthood Olga Toro-Salazar, MD (Connecticut Children’s Medical Center, University of Connecticut) 2:30 PM CR 37 An Unusual Case of ‘Dextrocardia’ Jonathan Rodrigues, BSc(Hons), MBChB(Hons), MRCP, FRCR (NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute) 2:40 PM CR 38 Evaluation of Left Main Coronary Artery and Left Ventricular Scar in a Patient who Underwent Takeuchi Procedure Ruchit Shah, MD (Georgia Regents University) 1:30 PM – 2:50 PM ORAL ABSTRACT SESSION 7: New Techniques Moderators: Anthony Aletras, PhD (Aristotle University) Krishna Nayak, PhD (University of Southern California) Location: Westside 1:30 PM O 049 Quantification of Pulmonary Edema in Heart Failure using MRI: Invasive Validation and Evaluation in HFpEF and HFrEF Patients Richard Thompson, PhD (University of Alberta) 1:40 PM O 050 Accelerating Cine DENSE Using a Zonal Excitation Andrew Scott (The Royal Brompton Hospital, Imperial College London) 1:50 PM O 051 Cardiac and Respiratory Self-Gated 4D Multi-phase Steady-state Imaging with Ferumoxytol Contrast (MUSIC) Fei Han, MS (University of California, Los Angeles) www.scmr.org 23 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 2:00 PM O 052 Accelerated Free-Breathing Diffusion Tensor MRI of the Entire Human Heart Using Spatiotemporal Registration and Retrospective Image Selection Choukri Mekkaoui, PhD (Harvard Medical School - Massachussets General Hospital) 2:10 PM O 053 Coronary Artery Distensibility is Impaired in HIV Patients without Significant Coronary Atherosclerosis Lia Petrose (Johns Hopkins) 2:20 PM O 054 Phase-Sensitive Chemical Selection (PiSCES) Method for Fat Signal Removal in LGE Martin Janich, PhD (GE Global Research) 2:30 PM O 055 Flow-Independent Dark-blood DeLayed Enhancement (FIDDLE): Validation of a Novel Black Blood Technique for the Diagnosis of Myocardial Infarction Han Kim, MD (Duke University Medical Center/Duke Cardiovascular Magnetic Resonance Center) 2:40 PM O 056 High-Resolution Late Gadolinium Enhancement Imaging with Compressed Sensing: A Single-Center Clinical Study Mehmet Akcakaya, PhD (University of Minnesota, University of Minnesota) 1:30 PM – 2:50 PM WALKING POSTER SESSION 3: Clinical Outcome and Prognosis Moderators: Dudley J Pennell, MD (Royal Brompton Hospital) Michael Jerosch-Herold (Brigham and Women’s Hospital) Location: Plaza Foyer 1:30 PM Q 21 Left Atrial Volume and Function Are Predictive of Cardiac Death or Appropriate Device Therapy in Patients with Non-Ischemic Dilated Cardiomyopathy Punitha Arasaratnam, MRCP (Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta) 1:38 PM Q 22 Cardiac Magnetic Resonance Imaging in Healthy Volunteers in Normoxic and Hypoxic Exercise Shareen Jaijee, MBBS, FRACP (Medical Research Council) 1:46 PM Q 23 Pulmonary Blood Volume Variation Indexed to Stroke Volume and Perfusion Gradients: Novel Diagnostic Tools in Heart Failure Mariam Al-Mashat, MSc (Skane University Hospital, Lund University) 1:54 PM Q 24 Acute Cellular Rejection in Pediatric Heart Transplant Recipients is Associated with Abnormal Left Ventricular Mechanics by CMR Heynric Grotenhuis, MD, PhD (The Hospital for Sick Children, The Wilhelmina Children’s Hospital) 2:02 PM Q 25 Higher Extracellular Volume is Associated with Longer Bypass Times at Corrective Surgery and Reduced Exercise Tolerance in Children Late After Repair of Tetralogy of Fallot Eugenie Riesenkampff, MD (Hospital for Sick Children) 2:10 PM Q 26 Electrocardiographic Detection of Left Atrial Enlargement in Arterial Hypertension: Re-Calibration Against Cardiac Magnetic Resonance Jonathan Rodrigues, BSc(Hons), MBChB(Hons), MRCP, FRCR (NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute) 2:18 PM Q 27 Initial Cardiac Diagnostic Imaging Choicesfor Obese Patients: Cost and Outcomes with Cardiac MRI John Lisko, MD, MPH (Northeast Ohio Medical University (NEOMED)) 2:26 PM Q 28 Reproducibility of Late Gadolidium Enhancement of Atrial Ablation Scar Henry Chubb, MBBS (King’s College London) 2:34 PM Q 29 Cardiovascular Magnetic Resonance Characterisation of Pericardial and Myocardial Involvement in Patients with Tuberculous Pericardial Constriction with and without HIV Co-Infection Ntobeko Ntusi, FCP(SA) DPhil (University of Cape Town & Groote Schuur Hospital) 2:42 PM Q 30 High Spatiotemporal Resolution Hyperpolarized 13C Angiography Galen Reed (HeartVista) 2:50 PM – 3:40 PM 24 REFRESHMENT BREAK/EXHIBITS 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 3:40 PM – 5:00 PM INVITED LECTURE SESSION 6: Location: Los Angeles Reducing Cost, Increasing Value, and Allocating One’s Time, Co-provided by ESCR Moderators: Patricia Bandettini, MD (National Institutes of Health) Nadine Kawel-Boehm, MD (University Hospital Basel) At the conclusion of this session, participants will be better able to: • Identify methods to improve efficiency and increase value of CMR for patients, providers and payors • Adapt the delivery of CMR services to changing compensation models • Recognize areas where CMR delivers unique value for cardiovascular care 3:52 PM Efficiency and Throughput on the MR Scanner in Brazil Paulo Schvartzman, MD, PhD (Federal University of Rio Grande do Sul) 4:04 PM Delivering CMR to my Practice as a Cardiologist Timothy Albert, MD (Tanner Health System) 4:16 PM Delivering CMR to my Practice as a Radiologist Jens Bremerich, MD (University Hospital Basel) 4:28 PM Cost-Effectiveness for Patients, Payers and Providers Karine Moschetti, PhD (IEMS, Unil and UET, CHUV) FRIDAY PROGRAM 3:40 PM Efficiency and Throughput on the MR Scanner in the US Edward Martin, MD (Oklahoma Heart Institute) 4:40 PM Values-Driven Reimbursement: Precertification of CMR Gerald Pohost, MD (University of Southern California) 4:52 PM Roundtable Discussion: More vs. Less CMR to Lower Healthcare Costs and Improve Outcomes 3:40 PM – 5:00 PM ORAL ABSTRACT SESSION 8: CMR and Outcome Moderators: Daniel Lee, MD (Northwestern University) Niels Vejlstrup, PhD (Rigshospitalet) Location: Constellation 3:40 PM O 057 MRI Relaxation Parameters Predict Functional Outcome After Experimental Myocardial Infarction Sebastian Haberkorn, MD (University Hospital Duesseldorf) 3:50 PM O 058 Risk Prediction in Stable Coronary Artery Disease Using Quantified Myocardial Ischemia and Necrosis By Cardiac Magnetic Resonance Imaging – A Prospective Long-Term Follow-Up Trial Dominik Buckert (Uniklinik Ulm) 4:00 PM O 059 Does Revascularisation for Residual Ischaemia in Patients with ACS Influence Prognosis? Kenneth Fung, MBBS, BSc (Barts Heart Centre, Barts Health NHS Trust) 4:10 PM O 060 Prognostic Value of CMR and Spect in Suspected Coronary Heart Disease: Long Term Follow-Up of The CE-Marc Study John Greenwood, MD, PhD (Leeds University, Leeds General Infirmary) 4:20 PM O 061 Prevalence and Prognosis of Non-Ischemic Patterns of Late Gadolinium Enhancement in Older Adults by Cardiovascular MR in the Iceland-Mi Study Sujata Shanbhag, MD, MPH (NIH/NHLBI) 4:30 PM O 062 Out of Hospital Cardiac Arrest Survivors with Inconclusive Coronary Angiogram: Impact of Cardiovascular Magnetic Resonance on Clinical Management and Decision-Making Anna Baritussio (Bristol Heart Institute, University of Padua) 4:40 PM O 063 Prognostic Impact of Late Gadolinium Enhancement Cardiac Magnetic Resonance in the Risk Stratification of Heart Transplant Patients Patrizia Pedrotti, MD (Ospedale Niguarda) 4:50 PM O 064 Prognostic Value of Dual T1 Mapping to Predict Adverse Events in Tavr-Patients: Extra Cellular Volume as a Possible Predictor for Peri- and Post-Tavr Adverse Events Jonathan Nadjiri (Klinikum rechts der Isar, Technische Universität München) www.scmr.org 25 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 3:40 PM – 5:00 PM CASE REVIEW 6: The Patient Referred for Evaluation of Cardiomyopathy Moderators: Andrew Crean, MD (Toronto General Hospital) Karen Ordovas, MD (University of California San Francisco) Location: Olympic 3:40 PM CR 39 Native T1 in Deciphering the Reversible Myocardial Inflammation in Cardiac Sarcoidosis with Anti-inflammatory Treatment Alexander Isted (King’s College London) 3:50 PM CR 40 20 Year Old Female with Pulmonary Hypertension: A Presentation of Mitral Valve Disease or a Rare Form of Cardiomyopathy? Jason Johnson, MD MHS (University of Tennessee, LeBonheur Children’s Hospital) 4:00 PM CR 41 Out of The Frying Pan, Into The Fire: From Untreated Thalassemia to Severe Iron Overload. A Reflection on Modern Healthcare Amna Abdel-Gadir, MBBS, MRCP (Institue of Cardiovascular Science, UCL, Barts Heart Centre) 4:10 PM CR 42 Serial T1 Mapping in Cardiac Amyloidosis: Can It Provide Evidence of Clinical Response to Treatment and Reversal of Amyloid Deposition in the Myocardium? David Hur, MD (Yale School of Medicine) 4:20 PM CR 43 A Case of Combined Arrhythmogenic Left Ventricular Cardiomyopathy with Noncompaction of the Myocardium Harshal Patil, MD (University of Missouri Kansas City/Saint Luke’s Mid America Heart Institute Kansas City) 4:30 PM CR 44 Acute Florid HIV-related Myocarditis with Rapid Response of Clinical and CMR Parameters to Anti-retroviral Therapy Sabrina Nordin (Barts Heart Centre) 4:40 PM CR 45 Dobutamine Stress Cardiac MRI for the Evaluation of Outflow Obstruction and Mitral Regurgitation in Hypertrophic Cardiomyopathy Edward Hulten, MD MPH (Walter Reed National Military Medical Center) 4:50 PM CR 46 Withdrawn 3:40 PM – 5:00 PM INVITED LECTURE SESSION 7: Diffusion Cardiac Magnetic Resonance Location: Westside Moderators: Robert R. Edelman, MD (NorthShore University Health System Research Institute) Dudley Pennell, MD (Imperial College London) At the conclusion of this session, participants will be better able to: • Summarize the scientific and clinical value of diffusion-mediated effects in the heart • Identify the inherent technical challenges associated with diffusion CMR • Recognize the advances (pulse sequences, processing methods and validation standards) that form basis for the current state of the art 3:40 PM Myocardial Microstructure: What Is There To See? Jurgen Schneider, PhD (Oxford University) 3:54 PM Diffusion Weighted Cardiac Sequences: Will It Work? Christopher Nguyen, PhD (Cedars-Sinai Medical Center) 4:08 PM Post Processing Pipelines: What Does It Take to See Anything? Elizabeth Tunnicliffe, PhD (Oxford University) 4:22 PM Pre clinical Results: What Can Be Visualized? Sebastian Kozerke, PhD (Institute for Biomedical Engineering University and ETH Zurich) 4:36 PM Clinical Findings: Do You See What I See? Sonia Nielles-Vallespin, PhD (National Institute of Health) 4:52 PM Panel Discussion – What Resources Are Available to Shorten the Development Cycle in Diffusion CMR? 26 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 3:40 PM–5:00 PMWALKING POSTER SESSION 4: Mechanisms in Cardiovascular Disease Moderators: Warren J. Manning, MD (Beth Israel Deaconess Medical Center) Carlos Rochitte, MD (Heart Institute - InCor) Location: Plaza Foyer 3:40 PM Q 31 Free-Breathing Myocardial T2* Mapping Using Gre-Epi and Moco for Myocardial and Hepatic Iron Overload Assessment: A Multi-Center Study Ning Jin, PhD (Siemens Healthcare) 3:48 PM Q 32 Altering Substrate Availability Profoundly Affects Left Ventricular Function in the Normal Heart Andrew Lewis (University of Oxford) 4:04 PM Q 34 Transgenic Mice with Mutations in Nkx2.5 Gene: Animal Model Proposal to Study Non Compaction Julien Frandon, MD (Grenoble University Hospital, France) 4:12 PM Q 35 Using CMR To Improve the Diagnostic Accuracy of the ECG for the Detection of Left Ventricular Hypertrophy; Production of a Simple Adjustment for Body Mass Index Oliver Rider, BMBCH, MRCP, DPhil (University of Oxford) 4:20 PM Q 36 La Structural Remodeling is Predicted by Arterial Stiffening Independently of Conventional Risk Factors Miguel Vieira, MD (King’s College London British Heart Foundation Centre) 4:28 PM Q 37 FRIDAY PROGRAM 3:56 PM Q 33 Prevalence of Regional and Whole-Heart Viability in Patients with Myocardial Akinesis Consecutively Enrolled from 4 U.S. Hospitals Dina Labib (Duke University) It’s Not Just The Mitral Valve - Abnormal Motion of the Whole Aorto-Mitral Apparatus Occurs in Both Overt and Subclinical Hypertrophic Cardiomyopathy Chinwe Obianyo (University College London, Bart’s Heart Centre and Centre for Biostatistics and Epidemiology) 4:36 PM Q 38 Differential Effects of Body Composition on Left Ventricular Geometric Remodelling and Aortic Elastic Dysfunction in Obesity Jennifer Rayner (University of Oxford) 4:44 PM Q 39 A Pathway Linking Liver Fat and Arterial Stiffness – Direct as Well as Indirect Effects Jennifer Rayner (University of Oxford) 4:52 PM Q 40 Utility of The Signal Intensity Ratio of The Spleen and Myocardium (SMR) On T2-Weighted Short Tau Inversion Recovery Black-Blood (T2-Stir Bb) Images Compared to Semi-Quantitative Analysis in Patients with Images with Diffuse High T2 Signal Intensity, Such as that with Takotsubo Cardiomyopathy, Cardiac Amyloidosis, Hypereosinophilic Myocarditis, and Apical Hypertrophic Cardiomyopathy. Ryosuke Aoki (Saitama Cardiovasucular and Respiratory Center) 5:10 PM – 6:30 PM INVITED LECTURE SESSION 8: From Molecular Pathways to Clinical Protocols Location: Los Angeles Moderators: David E. Sosnovik, MD (Massachusetts General Hospital, Harvard Medical School) Brent French, PhD (University of Virginia) At the conclusion of this session, participants will be better able to: • Summarize key concepts in the molecular and genetic understanding of common diseases in cardiovascular medicine • Review emerging techniques in CMR and the potential they have to provide novel molecular, cellular and genetic information in these disease states • Connect basic science, translational and clinical participants to foster bench-to-bedside cross-talk and communication 5:10 PM The Biology of Myocardial Regeneration Eduardo Marbán, MD, PhD (Cedars-Sinai, UCLA) 5:22 PM Emerging Techniques to Image Myocardial Regeneration Dara Kraitchman, VMD, PhD (Johns Hopkins University) 5:34 PM Molecular Pathways and Substrate for Atrial Fibrillation Akoum Nazem, MD (University of Washington School of Medicine) www.scmr.org 27 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 5:46 PM Imaging the Left Atrium Nassir Marrouche, MD (University of Utah) 5:58 PM The Biology of Atherosclerotic Plaque and Valvular Heart Disease Marcella Press (UCLA) 6:10 PM MRI of Coronary Plaque and Valves: Are We There Yet? Rene Botnar, PhD (Kings College) 5:10 PM – 6:30 PM ORAL ABSTRACT SESSION 9: Translational CMR (Early Career Awards) Moderators: Andrew Arai, MD (NHLBI - National Institutes of Health) Rohan Dharmakumar, PhD (Cedars-Sinai Medical Center) Location: Constellation 5:10 PM O 065 The Association of Left Atrial Volume with Age, Ethnicity and Cardiovascular Risk Factors in Men and Women: The Multi-Ethnic Study of Atherosclerosis (Mesa) Filip Zemrak, MD, MRCP (Queen Mary University of London, Barts Heart Centre) 5:20 PM O 066 Adenosine Stress and Rest T1-Mapping Differentiates Ischemic, Infarcted, Remote and Normal Myocardium – A Novel Gadolinium-Free Method for Ischemia Detection with Immediate Applications in Coronary Artery Disease Alexander Liu, MBBS, BSc, MRCP (University of Oxford) 5:30 PM O 067 Multiparametric Mapping in The Diagnosis and Management of Cardiac Transplant Rejection: A Prospective, Histologically-Validated Study Muhammad Imran, MBBS, FRACP (St. Vincent`s Hospital, Victor Chang Cardiac Research Institute) 5:40 PM O 068 The Kinetic Energies of Left Ventricular 4D Flow Components Correlate with Established Markers of Prognosis and Represent Novel Imaging Biomarkers in Both Ischaemic and Dilated Cardiomyopathy Victoria Stoll (OCMR, University of Oxford) 5:50 PM O 069 MR-Augmented Cardiopulmonary Exercise Testing- A Proof of Concept in Sickle Cell Disease (SCD) Emmanuel Ako, MBBS (University College London, Institute of Cardiovascular Science) 6:00 PM O 070 Optimized Cardiac Cest MRI for Assessment of Metabolic Activity in the Heart Zhengwei Zhou, MS (Cedars-Sinai Medical Center, University of California, Los Angeles) 6:10 PM O 071 Combined Ventricular Output and Oxygen Delivery Are Reduced While Oxygen Extraction Fraction is Increased in Fetuses with Ebstein’S Anomaly by MRI Meng Yuan Zhu (University of Toronto, The Hospital for Sick Children) 6:20 PM O 072 Improvement of Computational Fluid Dynamics Simulations of Flow in Patients with Total Cavo Pulmonary Connection and Predicting Interventional Outcomes Petter Frieberg, MSc (Lund University) 5:10 PM – 6:30 PM ORAL ABSTRACT SESSION 10: Systolic and Diastolic Function Moderators: Daniel Ennis, PhD (University of California- Los Angeles, CA) Sotirios Tsaftaris (The University of Edinburgh) Location: Olympic 5:10 PM O 073 Pharmacologic Immunomodulation via Adenosine 2a Receptor Stimulation Improves LV Remodeling and Systolic Strain in Regions Adjacent to the Infarct as Assessed by Cardiac MRI Brent French, PhD (University of Virginia) 5:20 PM O 074 A Comparison of Real-time Radial GRAPPA and Standard Cine Imaging for the Evaluation of Cardiac Function in Children and Young Adults Jooho Kim (Northwestern University Feinberg School of Medicine) 5:30 PM O 075 Derivation of Consolidated Normal Reference Values for Right and Left Ventricular Quantification by Cardiac Magnetic Resonance using a Novel Meta-Analytic Approach Jonathan Afilalo, MD, MSc (Jewish General Hospital, McGill University) 5:40 PM O 076 Differences in Left Ventricular Strain Measurements between Cine DENSE Cardiac Magnetic Resonance and SSFP Feature Tracking Christopher Haggerty, PhD (Geisinger Clinic) 28 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 5:50 PM O 077 Relationship of Regional Myocardial Deformation and Myocardial Fibrosis to Myocardial Trabeculation: The Multi-Ethnic Study of Atherosclerosis Nadine Kawel-Boehm, MD (National Institutes of Health, Kantonsspital Graubuenden) 6:00 PM O 078 Relative Influence of Peak Strain Delay and Peak Strain Amplitude of Non-Scarred Myocardium in Response to Cardiac Resynchronization Therapy: Insights from Segmental 4D Strain Analysis Alessandro Satriano, PhD (Stephenson Cardiac Imaging Centre, University of Calgary) 6:20 PM O 080 Left Atrial Dynamics During in-scanner Exercise: A CMR Myocardial Feature Tracking Study Vera-Christine Stahnke, MD (Institute of Diagnostic and Interventional Radiology) 5:10 PM – 6:30 PM ORAL ABSTRACT SESSION 11: Post-processing and Modeling Moderators: Rob van der Geest, PhD (Leiden University Medical Center) Alistair Young, PhD (Univeristy of Auckland) Location: Westside 5:10 PM O 081 Longitudinal Automated Assessments of Myocardial Strain from Cine MR in Cancer Patients Receiving Cardiotoxic Chemotherapy Marie-Pierre Jolly, PhD (Siemens Healthcare) FRIDAY PROGRAM 6:10 PM O 079 MRI Feature Tracking Strain Profiles Distinguish Patients with Left Ventricular Systolic and Diastolic Dysfunction with and without Clinical Heart Failure Naila Choudhary (University of Florida College of Medicine) 5:20 PM O 082 CMR Myocardial Texture Analysis Tracks Different Etiologies of Left Ventricular Hypertrophy Rebecca Schofield (Barts Heart Centre) 5:30 PM O 083 Right Ventricular Strain, Torsion and Synchrony in Healthy Subjects Using 3D Spiral Cine Dense Jonathan Suever, PhD (Geisinger Health System) 5:40 PM O 084 Fully Automated Segmentation of Left Atrium and Pulmonary Veins in Late Gadolinium Enhanced MRI Qian Tao (Leiden University Medical Center) 5:50 PM O 085 Ultrafast Computation of Left Ventricular Ejection Fraction Using Temporal Intensity Variation in Cine Steady-State Free Precession Cardiac MR Images with or without Contrast Amol Pednekar, PhD (Philips Healthcare) 6:00 PM O 086 Hematocrit, Iron and Hdl-Cholesterol Explain 90% of Variation in Native Blood T1 Stefania Rosmini, MD ( Barts Heart Centre ) 6:10 PM O 087 Fully Automated Pixel-Wise Myocardial Blood Flow Quantification with First-Pass Perfusion CMR Li-Yueh Hsu (National Heart Lung and Blood Institute, National Institutes of Health) 6:20 PM O 088 In-Vivo Validation of Interpolation-Based Phase offset Correction in MR Flow Quantification: A Multi-Vendor, Multi-Center Study Mark Hofman, PhD (VU University Medical Center) 5:10 PM – 6:30 PM WALKING POSTER SESSION 5: CMR in Myocardial Disease Moderators: Stefan Neubauer, MD (University of Oxford) Andrew Flett, MBBS, MD (University Hospital Southampton) Location: Plaza Foyer 5:10 PM Q 41 Native Left Ventricular Myocardial T1 Spatial Heterogeneity in Non-Ischemic Dilated Cardiomyopathy Abyaad Kashem (Beth Israel Deaconess Medical Center) 5:18 PM Q 42 Cardiovascular Magnetic Resonance Can Detect Occult Anthracycline Cardiotoxicity in Adolescents and Young Adults Cancer Survivors with Normal Ejection Fraction Miguel Vieira, MD (King’s College London British Heart Foundation Centre) 5:26 PM Q 43 Native T1 Mapping Versus CMR Feature Tracking (Ft) Derived Strain Analysis for the Assessment of Cardiac Disease Manifestation in anderson Fabry Anna Reid, MBChB (University Hospital of South Manchester) 5:34 PM Q 44 Native T1 Mapping in Children and Young Adults with Hypertrophic Cardiomyopathy Keyur Parekh, MD (Northwestern University) www.scmr.org 29 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 5:42 PM Q 45 Abnormal Myocardial T1 Mapping of Hypertrophic Cardiomyopathy in Areas without Delayed Enhancement, as Compared to NICM and Controls at Both 1.5 and 3T Orhan Sancaktar, MD (Medical College of Wisconsin) 5:50 PM Q 46 Evaluation of Myocardial Strain in Patients with Myocardial Amyloidosis Using Feature-Tracking Technique Mohan Mallikarjuna Rao Edupuganti, MD, FRACP (University of Arkansas for Medical Sciences) 5:58 PM Q 47 There is No Association Between Autosomal Dominant Polycystic Kidney Disease and Left Ventricular Non-Compaction Cardiomyopathy: A Cardiac Magnetic Resonance Imaging Study Shadi Akhtari, MD (Beth Israel Deaconess Medical Center) 6:06 PM Q 48 ECG, LVH and T1 Changes in Fabry Disease – Implications for Screening and Understanding of the Disease Model Sabrina Nordin (Barts Heart Centre) 6:14 PM Q 49 3D T1-Weighted Self-Gated Cardiac MRI for Assessing Myocardial Infarction in Mouse Models Xin Liu, MD, PhD (Shenzhen Institutes of Advanced Technology) 6:22 PM Q 50 Free-Breathing Real-Time Cardiac Cine MR for Evaluation of Left-Ventricular Function: Comparison to Standard Multi-Breath-Hold Cardiac Cine Mr in 50 Patients Masashi Nakamura (Saiseikai Matsuyama Hospital) 6:30 PM – 8:30 PM CMR OUTREACH DINNER PROGRAM (Special Registration) Moderators: Puja Mehta, MD (Cedars-Sinai Women’s Heart Center) Lauren Baldassarre, MD (Yale CMR) At the conclusion of this session, participants will be better able to: • Identify solutions for cardiovascular imaging in women • Integrate key advances in CMR to evaluate cardiovascular disease in women • Describe steps for practice implementation of CMR Location: Santa Monica 6:30 PM Cardiovascular Imaging in Women: Who, When, How Leslee Shaw, PhD (Emory) 7:10 PM Q&A: What Evidence is Missing to Demonstrate Value? Leslee Shaw, PhD (Emory) 7:20 PM CMR in 2016: Key Advances for Women Chiara Bucciarelli-Ducci, MD, PhD (Bristol Heart Institute) 8:00 PM Q&A: How Do You Implement CMR in a Women’s Cardiovascular Care Practice? Chiara Bucciarelli-Ducci, MD, PhD (Bristol Heart Institute) 8:10 PM Roundtable Discussion and Audience Q&A SATURDAY, JANUARY 30, 2016 7:30 AM – 8:50 AM LIVE CASE Location: Santa Monica Moderators: J. Paul Finn, MD (UCLA) Ibrahim Saeed, MD (Saint Luke’s Mid America Heart Institute Cardiovascular Consultants) At the conclusion of this session, participants will be better able to: • Plan appropriate localization scans to identify standard short axis and long axis cardiac planes • Generate reliable steady-state free precession cine images suitable for measuring left ventricular volumes and ejection fraction • Formulate a strategy to do phase contrast imaging through the aortic root and main pulmonary artery • Explore additional right heart imaging planes and acquisition techniques 7:30 AM – 8:50 AM INVITED LECTURE SESSION 9: CMR in Multisystem Disorders Moderators: Sabha Bhatti, MD (University of Arkansas) Ali Ylimaz, MD (University Hospital Münster) 30 Location: Los Angeles 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S At the conclusion of this session, participants will be better able to: • Recognize CMR’s role in the management of multisystem disorders • Integrate CMR in a comprehensive approach to understanding human health and disease • Use CMR to identify novel mechanisms of disease and treatment targets 7:30 AM Cardio-Oncology W.Gregory Hundley, MD (Wake Forest University) 7:44 AM Comprehensive Metabolic Imaging Robert Weiss, MD (Johns Hopkins University) 7:58 AM CMR in Infiltrative Diseases James Moon (University College London) 8:26 AM Heart-Brain Interactions Albert de Roos, PhD (Leiden University) 8:40 AM Roundtable Discussion: Approaches to Multisystem Understanding with Magnetic Resonance 7:30 AM – 8:50 AM PEDIATRIC AND CONGENITAL CMR: ASK THE EXPERTS Location: Constellation Moderators: Emanuela Valsangiacomo, MD (Children’s Hospital Zurich) Ruchira Garg, MD (Cedars-Sinai Medical Center) At the conclusion of this session, participants will be better able to: • Identify methods to improve assessment of cardiac flow in congenital heart disease • Prescribe optimized CMR coronary angiography sequences for the pediatric population • Appraise the utility of different contrast agents for various indications in congenital and pediatric CMR 7:30 AM How Do I Do Flow? Mark Fogel, MD, FACC, FAHA, FAAP (Children’s Hospital of Philadelphia) 7:50 AM How Do I Do Coronary Angiography? Taylor Chung, MD (Children’s Hospital of Oakland) 8:10 AM How Do I Do Structural/Cine Imaging? Andrew Powell, MD (Boston Children’s Hospital) 8:30 AM How Do I Do Contrast Angiography and What Do I Know About Contrast Agents? Cynthia Rigsby, MD (Northwestern University) 8:40 AM How I Use Contrast: Panelists Responses and Audience Q&A 7:30 AM – 8:50 AM ORAL ABSTRACT SESSION 12: Flow and Hemodynamics Moderators: Florian von Knobelsdorff-Brenkenhoff, MD (Charité Medical University Berlin) Michael Markl, PhD (Northwestern University) SATURDAY PROGRAM 8:12 AM Muscle is Muscle: CMR in the Dystrophies Ali Yilmaz, MD (University Hospital Münster) Location: Olympic 7:30 AM O 089 4D flow CMR detects progressive improvement in ventricular function following cardioversion of atrial fibrillation Hanna Erixon (Linköping University) 7:40 AM O 090 Left Atrial and Left Atrial Appendage 4D Blood Flow Dynamics in Atrial Fibrillation Michael Markl (Northwestern University) 7:50 AM O 091 Left Ventricular Kinetic Energy as a Marker of Mechanical Dyssynchrony in Failing Hearts with LBBB: A 4D Flow CMR Study Jakub Zajac (Division of Cardiovascular Medicine, Department of Medical and Health Sciences, Linköping University) 8:00 AM O 092 Redistribution of Organ Specific Blood Flow in Response to Food Ingestion Measured by R-R-Interval Averaged Golden-Angle Spiral Phase Contrast MRI Jakob Hauser, MB (University College London) 8:10 AM O 093 Effect of Respiratory Suspension on the Computation of Volume-based Early Peak Filling Rate to Late Peak Filling Rate Ratio Amol Pednekar, PhD (Philips Healthcare) www.scmr.org 31 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 8:20 AM O 094 Background Phase Correction in Congenital Heart Disease: Does Reliability Vary Based on Underlying Disease Type? Sassan Hashemi, MD (Children’s Healthcare of Atlanta) 8:30 AM O 095 Influence of Right Ventricular Remodeling on Ventricular Function, Flow and Energetics in Pulmonary Regurgitation Vs. Stenosis: A 4-Dimensional Phase Contrast MRI and Admittance Catheterization Study Filip Konecny (Transonic Scisense, Inc. , University of Nebraska Medical Center, Chiildren’s Hospital and Medical Center) 8:40 AM O 096 Improved Assessment of Aortic Hemodynamics by k-t Accelerated Dual-Venc 4D flow MRI in Pediatric Patients Susanne Schnell, PhD (Northwestern University, Feinberg Medical School) 7:30 AM – 8:50 AM CASE REVIEW 7: Patient Referred for Evaluation of Acute Chest Pain Moderators: Nadine Kawel-Boehm, MD (University Basel Hospital) Timothy Wong, MD (University of Pitttsburgh) Location: Westside 7:30 AM CR 47 Cardiomyopathy from Methamphetamine Abuse: Rare Presentation with Multiple Bi-Ventricular Thrombi Rajesh Janardhanan, MD, MRCP, FACC, FASE (Sarver Heart Center, University of Arizona) 7:40 AM CR 48 Pheochromocytoma Presenting as Acute Myocarditis Pranav Bhagirath, MD (HAGA Teaching Hospital) 7:50 AM CR 49 Is Always Echocardiography the Best Choice in the Assessment of Pericardial Effusion? Tamas Erdei, PhD (Bristol Heart Institute) 8:00 AM CR 50 An Unusual Case of Acute Heart Failure and Left Ventricular Hypertrophy Anna Baritussio (Bristol Heart Institute) 8:10 AM CR 51 CMR Findings in Giant Cell Myocarditis Sowmya Pinnamaneni, MD (Geisinger Clinic and Health System ) 8:20 AM CR 52 Depot Medroxyprogesterone Acetate Induced Myocardial Infarction Detected by Cardiac Magnetic Resonance Imaging Osama Niazi, DO (Rutgers New Jersey Medical School) 8:30 AM CR 53 Importance of Full Thoracic Overview in Cardiac MRI Christina Unterberg-Buchwald (University Clinic Goettingen, Institute of Diagnostic and Interventional Radiology) 8:40 AM CR 54 Atypical Chest Pain, Atypical Perfusion CMR Scan Heerajnarain Bulluck, MBBS (University College London, Barts Heart Centre) 7:30 AM – 8:50 AM WALKING POSTER SESSION 6: Advances in CMR Methods Moderators: Matthias G. Friedrich, MD (Montreal Heart Institute) Reza Nezafat, PhD (Harvard Medical School) 7:30 AM Q 51 Location: Plaza Foyer Would Adding Two Left Atrial Piloted Images to a Cardiac Magnetic Resonance Protocol Enable Rapid, Accurate Calculation of Left Atrial Volume? Use of 320 Slice Cardiac CT as Proof of Concept Stuart Moir, MBBS, FRACP, PhD (Monash Health) 7:38 AM Q 52 Systolic T1 Mapping for Estimation of Myocardial Diffuse Fibrosis Vassilis Vassiliou, MA, MBBS, MRCP (Royal Brompton Hospital, Imperial College London) 7:46 AM Q 53 Use of T2 Maps for Rapid Prediction of Stress Effectiveness Before the Injection of Contrast in Myocardial Perfusion Studies at 3.0T Juliano Fernandes, MD, PhD, MBA (Jose Michel Kalaf Research Institute) 7:54 AM Q 54 Left Ventricular Myocardial Deformation Measurements by Magnetic Resonance Tissue Tracking Agrees with Tagging (HARP) in Healthy Volunteers Kanae Mukai, MD (University of California, San Francisco) 32 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 8:02 AM Q 55 Late Gadolinium Enhancement is not Related to the Severity of Aortic Regurgitation: A Single Center Study Henrique Trad, MD (HCFMRP) 8:10 AM Q 56 Histological Validation of a New CMR T1-Mapping-Based Protocol to Improve Accuracy for Fibrosis Assessment in Patients with Aortic Stenosis Vassilis Vassiliou, MA, MBBS, MRCP (Royal Brompton Hospital, Imperial College London) 8:18 AM Q 57 Aortic Flow and Wall Shear Stress in Aortic Stenosis is Associated with Left Ventricular Remodeling Florian von Knobelsdorff-Brenkenhoff, MD (Working group Cardiovascular MRI) 8:26 AM Q 58 Diagnosis of Deep Vein Thrombosis using 3D Black-Blood Thrombus Imaging (BTI): Preliminary Clinical Experience Qi Yang, MD, PhD (Xuanwu Hospital, Cedars-Sinai Medical Center) 8:42 AM Q 60 An Extended 3D Whole-Heart Myocardial First-Pass Perfusion Sequence: Alternate-Cycle Views with Isotropic and High-Resolution Imaging Merlin Fair (Imperial College London, Royal Brompton Hospital) Location: Los Angeles Ballroom 8 :50 AM –10:00 AM CMR OUTREACH PLENARY SESSION: Cardiovascular Disease in Women - CMR’s Essential Role Moderators: Puja Mehta, MD (Cedars-Sinai Medical Center) Lauren Baldassarre, MD (Yale School of Medicine) At the conclusion of this session, participants will be better able to: • Recognize opportunities for CMR to address unmet needs in women’s cardiovascular disease management • Design CMR protocols to address major conditions affecting women’s heart health 8:50 AM Cardiovascular Disease in Women: Where We Are Going and What We Need from CMR C Noel Bairey Merz, MD (Cedars-Sinai) Chest Pain and Troponin Elevation: What Does CMR Have to offer? Jeanette Schulz-Menger, MD (Charite Universitatsmedizin and HELIOS Clinics) 9:14 AM 9:26 AM CMR in Infiltrative Diseases Karen Ordovas, MD (University of California San Francisco) 9:38 AM CMR in Connective Tissue Diseases Sophie Mavrogeni, MD (Onassis Cardiac Surgery Center) 10:00 AM–10:40 AM REFRESHMENT BREAK/EXHIBITS/POSTER VIEWING SATURDAY PROGRAM 8:34 AM Q 59 Ferumoxytol MRA and Non-Contrast CT Fusion in TAVR Candidates with Renal Failure Takegawa Yoshida, MD (David Geffen School of Medicine at UCLA) 10:40 AM–12:00 PM INVITED LECTURE SESSION 10: Location: Los Angeles Translating Advances in CMR to the Community Moderators: Christopher Dyke, MD (Alaska Heart Institute) Stephen Cheung, MBBS (Radiology Queen Mary Hospital) At the conclusion of this session, participants will be better able to: • Identify the essential protocols for a new clinical CMR service • Develop strategies to overcome barriers to translating CMR advances to community practices • Leverage relationships among physicists, technology providers and physicians to deliver CMR with impact 10:40 AM You Have to Be Able to Do This and Do It Well Timothy Wong, MD, MS (University of Pittsburgh Medical Center) 10:52 AM Tissue Mapping vs. Traditional Weighted Imaging in Practice Erik Schelbert, MD, MS (University of Pittsburgh) 11:04 AM Expanding Your Referral Base and Educating Practitioners on Appropriate Use Ashish Aneja, MD (MetroHealth heart and Vascular Center) 11:16 AM Quantitative Reporting: Guidelines vs. Real-World Practice Ibrahim Saeed, MD (University of Missouri - Kansas City) www.scmr.org 33 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 11:28 AM Making the Case for CMR Amidst Advances in Other Modalities Sharmila Dorbala, MD, MPH (Brigham and Women’s Hospital) 11:40 AM Relationships That Matter: What I Need from My Physicist and Technology Partners Jason Craft, MD (Advocate Healthcare) 11:52 AM Roundtable Discussion: Team-Based Care – Where Does CMR Fit in? 10:40 AM–12:00 PM ORAL ABSTRACT SESSION 13: Inflammatory Cardiomyopathy Moderators: Vanessa Ferreira, MD, DPhil (University of Oxford) Kai Muellerleile, MD (University Heart Center Hamburg) Location: Constellation 10:40 AM O 097 Viral Myocarditis vs Lupus Myocarditis, Distinctive Features in Cardiovascular Magnetic Resonance. Maria Espinoza Barillas (Instituto Nacional De Ciencias Medicas Y Nutricion Salvador Zubiran) 10:50 AM O 098 Performance of Comprehensive Cardiac Magnetic Resonance Imaging including T1 and T2 mapping on 1.5 vs. 3.0 Tesla as Compared to Biventricular Endomyocardial Biopsy in Patients with Suspected Myocarditis - The MyoRacer Trial Philipp Lurz, MD, PhD (Heart Center of the University Leipzig) 11:00 AM O 099 T1 and T2 Mapping Cardiovascular Magnetic Resonance to Monitor the Course of Myocarditis Kai Muellerleile, MD (University Heart Center Hamburg) 11:10 AM O 100 Myocarditis and Colchicine: A New Perspective From Cardiac MRI Daniel Morgenstern (Sharon Regional Health System) 11:20 AM O 101 Sarcoidosis: Comprehensive CMR Evaluation and Major Adverse Cardiac Events Thomas Hauser, MD, MPH, MMSc (BIDMC) 11:30 AM O 102 Assessment of Left Ventricular Systolic and Diastolic Function in Patients with Sarcoidosis with and without Cardiac Involvement by Magnetic Resonance Feature Tracking at 1.5T: A Follow Up Study Darius Dabir, MD (University of Bonn) 11:40 AM O 103 Extracellular Volume By CMR is Associated with Serum Biomarkers of Extracellular Matrix Turnover and Inflammation in Hypertensive Heart Disease Peter Shaw, MD (University of Virginia) 11:50 AM O 104 HIV-1-Related Cardiovascular Disease is Associated with Chronic Inflammation, Frequent Pericardial Effusions and Increased Myocardial Oedema Ntobeko Ntusi, MB.ChB FCP(SA) MD (University of Oxford) 0:40 AM–12:00 PM CASE REVIEW 8: Potpourri Case Session + Best Web Case of the Week 1 Moderators: Vikas Rathi, MD (Bon Secours Richmond Health System) Juliano Lara Fernandes, MD, PhD (Jose Michel Kalaf Research Institute) Location: Olympic 10:40 AM CR 55 Coxsackie Myocarditis Presenting with Sustained Ventricular Tachycardia and Slow Coronary Flow: Role of Cardiac Magnetic Resonance Imaging in Diagnosis Menhel Kinno, MD (Rutgers - New Jersey Medical School) 10:50 AM CR 56 Tissue Characterization of a Giant Isolated Aneurysm of the Right Coronary Artery by CMR Lilia Sierra-Galan, MD, FACC, FSCCT (American British Cowdray Medical Center) 11:00 AM CR 57 Rosai-Dorfman Disease: A Rare Case of Histiocytosis with Infiltrative Polyserositis Leading to Reversible Constrictive Pericarditis Girish Dwivedi (UOHI) 11:10 AM CR 58 COTW 15-13: Budd-Chiari: an unexpected imaging journey that ends with congenital CMR Daniel Devos, MD (UZ Gent) 11:20 AM CR 59 COTW 15-04: Metastatic Renal Cell Carcinoma Presenting as ST-Segment Elevation Myocardial Infarction Michael Mikolaj, MD (Gill Heart Institute, University of Kentucky) 11:30 AM CR 60 COTW 15-17: CMR for Suspected Pulmonary Embolism Lilia Sierra-Galan, MD, FACC, FSCCT (American British Cowdray Medical Center) 11:40 AM CR 61 COTW 15-09: Are Myocardial Crypts a genetic phenomenon related to Hypertrophic Cardiomyopathy? Heiko Kindler (Cork University Hospital) 34 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 11:50 AM CR 62 COTW 15-15: Contained Cardiac Rupture Presenting with Syncope Mariano Estefan (Hospital de Sant Pau, Universitat Autònoma de Barcelona) 10:40 AM–12:00 PM INVITED LECTURE SESSION 11: Location: Westside What is this Congenital Patient Doing on My Schedule? Moderators: Andrew Crean, MD (Toronto General Hospital) Anne Marie Valente, MD (Boston Children’s Hospital) At the conclusion of this session, participants will be better able to: • Integrate the most recent recommendations for CMR in the evaluation and management of adult congenital heart disease • Identify critical elements of the adult congenital CMR scan and adopt protocols to address the clinically relevant issues • Recognize technical challenges in scanning adults with congenital heart disease to adopt strategies to scan these patients optimally 10:40 AM Get with the Guidelines: How CMR is Incorporated into Various ACHD Guidelines Craig Broberg, MD, MCR (Oregon Health & Sciences University) 11:12 AM Tetralogy of Fallot Sara Partington, MD (Children’s Hospital of Philadelphia) 11:28 AM Congenital Aortic Problems: Imaging Left Ventricular Outflow Tract Obstructive Lesions and Beyond Ali Zaidi, MD (Montefiore Medical Center) 11:44 AM Pearls and Pitfalls in Imaging Adults with Congenital Heart Disease Andrew Taylor, MD (Cardiovascular Imaging at University College London) 10:40 AM–12:00 PM WALKING POSTER SESSION 7: Novel CMR Strategies Moderators: Andrew E. Arai, MD (National Institutes of Health) Matthias Stuber, PhD (CIBM/CHUV/UNIL) Location: Plaza Foyer SATURDAY PROGRAM 10:56 AM The CMR approach to Determining Congenital Etiologies of Right Heart Dilation Sonya Babu-Narayan, MD (Royal Brompton Hospital) 10:40 AM Q 61 Intracardiac Hemodynamic Forces Using 4D Flow: A New Reproducible Method Applied To Healthy Controls, Elite Athletes and Heart Failure Patients Johannes Töger, PhD (Lund University and Lund University Hospital) 10:48 AM Q 62 Characterization of Myocardial Fiber Orientation to Assess Therapeutic Exosomes from Cardiosphere-derived Cells (CDCs) in Myocardial Infarcted Porcine with in Vivo Diffusion-Tensor CMR on a Clinical Scanner Christopher Nguyen, PhD (Cedars-Sinai Medical Center) 10:56 AM Q 63 Genome Wide Association Analysis of the Heart Using High-resolution 3D Cardiac MRI Identifies New Genetic loci Underlying Cardiac Structure and Function Antonio de Marvao, MB ChB (Imperial College London) 11:04 AM Q 64 Equivalence of Conventional and Fast Late Gadolinium Enhancement (LGE) Techniques for Quantitative Evaluation of Fibrosis in Ischemic and Non-ischemic Cardiac Disease – Save the Time! Fabian Muehlberg, MD (Charité University Medicine and HELIOS Clinics) 11:12 AM Q 65 Accuracy of a Prototype Dark Blood Late Gadolinium Enhancement Technique for the Detection and Quantification of Myocardial Infarction Akos Varga-Szemes, MD, PhD (Medical University of South Carolina) 11:20 AM Q 66 Extracellular Volume Fraction Correlates with Myocardial Stiffness and Allows for Differentiation Between Impaired Active Relaxation and Passive Stiffness in Heart Failure with Preserved Ejection Fraction Karl-Philipp Rommel, MD (Heartcentre Leipzig) 11:28 AM Q 67 Left Ventricular Remodeling After Reperfused Acute Myocardial Infarction: Insights from Automated ECV Mapping Heerajnarain Bulluck, MBBS ( University College London, Barts Heart Centre) 11:36 AM Q 68 Transcatheter Real-time MRI Guided Myocardial Chemoablation Using Acetic Acid Toby Rogers, MA, BM BCh, MRCP (National Institutes of Health) 11:44 AM Q 69 Real-time Magnetic Resonance Imaging Guidance Improves the Yield of Endomyocardial Biopsy Toby Rogers, MA, BM BCh, MRCP (National Institutes of Health) www.scmr.org 35 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 11:52 AM Q 70 A Semi-automatic Method for Quantification of Respiratory Variation in Early Mitral Inflow Velocity Using Real Time Phase Contrast Cardiac Magnetic Resonance – Normal Values and Clinical Feasibility Simon Thalén (Karolinska Institute) 12:00 PM– 1:00 PM LUNCH/EXHIBITS/POSTER GROUP P 3 1:10 PM – 2:30 PM INVITED LECTURE SESSION 12: 1:10 PM CMR Tissue Characterization in Hypertrophic Cardiomyopathy to Calibrate Sudden Death Risk Martin Maron, MD (Tufts Medical Center) Location: Los Angeles CMR Guided Management of Sudden Cardiac Death in Nonischemic Disease Moderators: Christopher Kramer, MD (University of Virginia) Jon Kalman, MBBS, PhD, FACC (Royal Melbourne Hospital) At the conclusion of this session, participants will be better able to: • Recognize how CMR may inform treatment planning for patients with hypertrophic cardiomyopathy • Address management questions in nonischemic cardiomyopathy with appropriate CMR acquisitions and reporting • Coordinate CMR in patients at risk for sudden cardiac death as well as SCD survivors 1:24 PM Ventricular Morphology in HCM by CMR guides surgical therapy Milind Desai, MD (Cleveland Clinic) 1:38 PM Sudden Death Risk in Patients with Nonischemic Cardiomyopathy and Midwall Fibrosis Dudley Pennell, MD (Royal Brompton Hospital) 1:52 PM Myocarditis: Acute vs. Long-Term CMR-Guided Management Matthias Friedrich, MD (McGill University Health Centre) 2:06 PM Before and After the Defibrillator Goes in – What CMR Adds and How Sharath Subramanian, MD (St Cloud Hospital) 2:20 PM Roundtable Discussion: When Does (and Does Not) CMR Alter Management? 1:10 PM – 2:30 PM ORAL ABSTRACT SESSION 14: Rapid Efficient Imaging Location: Constellation Moderators: Sebastian Kozerke, PhD (Institute for Biomedical Engineering University and ETH Zurich) Kelvin Chow, PhD (University of Virginia) 1:10 PM O 105 Free-Breathing 3D Whole-Heart Coronary MRA Using Respiratory Motion-Resolved Sparse Reconstruction Davide Piccini (Siemens Healthcare, University Hospital (CHUV) and University of Lausanne (UNIL)) 1:20 PM O 106 Whole Heart Free Breathing Phase Sensitive Inversion Recovery MRI Integrated with Iterative Self Navigation for 100% Scan Efficiency; a First Patient Study Giulia Ginami, MSC (Department of Radiology, University Hospital (CHUV) and University of Lausanne (UNIL)) 1:30 PM O 107 High Efficiency Coronary MRA with Non-rigid Cardiac Motion Correction: Beyond the Quiescent Period Jianing Pang, PhD (Cedars-Sinai Medical Center) 1:40 PM O 108 Improved Scan Efficiency for Golden-Angle Radial CMR with Anisotropic Field-of-View Ziyue Wu (University of Southern California) 1:50 PM O 109 Simultaneous Multi-Slice Excitation for Single Breath Hold Estimates of Left Ventricular Rotational Mechanics Zhe Wang, PhD (University of California Los Angeles) 2:00 PM O 110 Motion Compensated Reconstruction From Free Breathing 2D Radial Cardiac MRI Data André Fischer (GE Global Research, GE Healthcare) 2:10 PM O 111 Radial Simultaneous Multi Slice imaging for Rapid Cardiac Imaging Ganesh Adluru, PhD (University of Utah) 2:20 PM O 112 Improved Dynamic Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA) Using Iterative Data Reconstruction Luigia D’Errico, MD (University of Toronto) 1:10 PM – 2:30 PM ORAL ABSTRACT SESSION 15: Congenital Heart Disease 2 Moderators: Shelby Kutty, MD (University of Nebraska) Piers Barker, MD (Duke University) 36 Location: Olympic 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 1:10 PM O 113 4D Multiphase Steady State Imaging with Contrast (MUSIC) Enhancement Using Ferumoxytol: A New Paradigm in Pediatric Congenital Heart Disease Kim-Lien Nguyen, MD (David Geffen School of Medicine at UCLA) 1:20 PM O 114 Multicontrast 3D Automated Segmentation of Cardiovascular Images Matthew Bramlet, MD (Children’s Hospital of Illinois, University of Illinois College of Medicine at Peoria) 1:30 PM O 115 Imaging Insights from the Bifurcated Y-Graft Fontan Procedure Tim Slesnick, MD (Emory University) 1:40 PM O 116 Impaired Cardiac Growth and Function in Children and Adolescents After Heart Transplantation Assessed by Cardiac Magnetic Resonance Heiner Latus (Pediatric Heart Centre) 2:00 PM O 118 New Insights in Ventriculo-Arterial Coupling and Ventricular Shape in Repaired Tetralogy of Fallot: A Retrospective Cohort Study Giovanni Biglino, PhD (University College London, Great Ormond Street Hospital for Children) 2:10 PM O 119 Atrio-Ventricular Mechanics and Heart Failure in Ebstein’S Anomaly – A Cardiac Magnetic Resonance Study Marike Broder (University Medical Center of he Georg-August-Uiversity) 2:20 PM O 120 Cardiac Magnetic Resonance Imaging Can Be Performed without the Use of Anesthesia in Patients 7-10 Years of Age with Child Life Support and MRI Video Goggles Jon Detterich, MD (Children’s Hospital Los Angeles) Location: Westside 1:10 PM – 2:30 PM INVITED LECTURE SESSION 13: CMR’s Role in Coronary Artery Disease Moderators: Sven Plein, MD, PhD (University of Leeds) Ronald Blankstein, MD (Brigham & Women’s Hospital) At the conclusion of this session, participants will be better able to: • Review current understanding of coronary artery disease • Evaluate the utility of available CMR methods in different stages of CAD • Relate CMR approaches to different aspects of CAD 1:10 PM SATURDAY PROGRAM 1:50 PM O 117 MRI of the Fetal Heart: Comparison of the Obstetric Sonography and Fetal Magnetic Resonance Imaging Findings Flavia Junqueira, PhD (DASA-SP) Coronary Artery and Myocardium: Current Concepts in CAD Pathophysiology and Guidelines John Greenwood, MD, PhD (University of Leeds) 1:22 PM CMR Techniques for the Assessment of Coronary Plaques and Stenosis Rene Botnar, PhD (King’s College London ) 1:34 PM CMR Techniques for the Assessment of Ischemia Rolf Gebker, MD, PhD (National Institutes of Health Laboratory of Cardiac Energetics) 1:46 PM CMR techniques for the assessment of myocardial state Peter Kellman, PhD (National Institute of Health) 1:58 PM Clinical application of CMR in acute chest pain John Heitner, MD (New York Methodist Hospital) Clinical Application of CMR in Chronic Chest Pain Ronald Blankstein, MD (Brigham & Women’s Hospital) 2:10 PM 2:22 PM Roundtable Discussion: What Could We Do Better for CAD Patients? BEST OF WALKING POSTER SESSION The top-rated posters from the previous Walking Poster Sessions will be presented and 1:10 PM – 2:30 PM compete for the Best Poster Award of the Walking Poster Sessions 2:30 PM – 2:40 PM BREAK Location: Santa Monica 2:40 PM – 4:00 PM INVITED LECTURE SESSION 14: Parametric Mapping Location: Santa Monica Moderators: James Moon, MD (Heart Hospital London) Peter Kellman, PhD (National Institutes of Health Laboratory of Cardiac Energetics) www.scmr.org 37 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S At the conclusion of this session, participants will be better able to: • Recognize common principles behind various parametric imaging approaches • Assign specific patterns of T1, T2, and T2star to different myocardial diseases • Select appropriate mapping strategies for clinical CMR protocols 2:40 PM Parametric Mapping: Basic Concepts Steven White, BSc MBChB MRCP (The Heart Hospital London) 2:52 PM T1 Mapping: Overview on Acquisition Strategies Sebastian Weingärtner, MSc (Israel Deaconess Medical Center, Harvard) 3:04 PM Workflow and Analysis Strategies Marianna Fontana, MD (Heart Hospital London) What’s Normal in Parametric Mapping? Michael Salerno, MD, PhD (University of Virginia) 3:16 PM 3:28 PM Clinical Role of T1 Mapping and ECV Vanessa Ferreira, MD DPhil (University of Oxford) 3:40 PM Clinical Role of T2 and T2star Mapping Karolina Zareba, MD (The Ohio State University) 3:52 PM Roundtable Discussion: What Do You Report, and What Do You Limit to Research? 2:40 PM – 4:00 PM ORAL ABSTRACT SESSION 16: CMR in Arrhythmia and Devices Moderators: Edward DiBella, PhD (University of Utah) Matthias Gutberlet, MD (University of Leipzig – Heart Center) Location: Constellation 2:40 PM O 121 RF Induced Heating of Pacemaker/ICD Lead-Tips During MRI Scans at 1.5T and 3T: Evaluation in Cadavers Volkan Acikel, PhD (University of California Los Angeles) 2:50 PM O 122 An MRI-compatible Defibrillator: Initial Testing in Volunteers and Swine Ehud Schmidt, PhD (Brigham and Womens Hospital) 3:00 PM O 123 Safety of CMR in Patients with Cardiac Implanted Electronic Devices El-Sayed Ibrahim (University of Michigan) 3:10 PM O 124 Clinical Utility of Cardiovascular Magnetic Resonance in Patients with Cardiac Rhythm Management Devices Nikhil Jariwala, MD (Loyola University) 3:20 PM O 125 Current Provision for MRI Scanning of Patients with Cardiac Implantable Electronic Devices - A National Survey of Hospitals in England James Oldman (University College London) 3:30 PM O 126 Comparison of CMR DENSE Strain Imaging and 2D Speckle Tracking Echocardiography for Cardiac Resynchronization Therapy (CRT) Response Jorge Gonzalez, MD (University of Virginia) 3:40 PM O 127 Incremental Diagnostic Role of Cardiac MRI in Young-middle aged Patients with High-grade Atrio-ventricular Block Anna Baritussio (Bristol Heart Institute) 3:50 PM O 128 T2*-weighted MRI Technique for Visualization of RF Ablation Lesions Eugene Kholmovski, PhD (University of Utah, CARMA Center) 2:40 PM – 4:00 PM INVITED LECTURE SESSION 15: Location: Los Angeles Myocardial Mechanics: No Strain No Gain Moderators: Nathaniel Reichek, MD (St. Francis Hospital) Kan Hor, MD (Nationwide Children’s Hospital) At the conclusion of this session, participants will be better able to: • Summarize different methods for assessing myocardial strain • Recognize strengths and weaknesses of routine cine-derived strain estimation • Identify opportunities to incorporate strain assessment in clinical practice 2:40 PM 38 Current Methods and Applications of Tagging-Based Techniques El-Sayed Ibrahim, PhD (Department of Radiology, University of Florida) 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 2:54 PM Current Methods and Applications of Tissue Phase Mapping Daniela Föll, PD Dr. (Freiburg) 3:08 PM Current Methods and Clinical Applications of Echocardiography – Based Strain Assessment Kan Hor, MD (Nationwide Children’s Hospital) 3:22 PM Current Methods and Clinical Applications of Cine-Based Strain Techniques Andreas Schuster, MD PhD (Georg-August-University Göttingen) 3:36 PM Assessing Myocardial Mechanics for Diastolic Function Pierre Croisille, MD, PhD (CHU Saint-Etienne) 3:50 PM Panel Discussion: How to Overcome the Strain of Clinical Translation? 2:40 PM – 4:00 PM ORAL ABSTRACT SESSION 17: Clinical Trials Moderators: Joseph Selvanayagam (Flinders Medical Centre) Juerg Schwitter, MD (University Hospital Lausanne – CHUV) Location: Westside 2:50 PM O 130 ST2 is Reduced By High-Dose Omega-3 Fatty Acid Treatment Following Acute MI and is Correlated with Reduction of the Extracellular Volume Fraction of Non-Infarcted Myocardium Bobby Heydari (Brigham and Women’s Hospital, University of Calgary) 3:00 PM O 131 Prevalence of Unrecognized Myocardial Scarring in Patients with Normal Contractile Function Across Four U.S. Hospitals Han Kim, MD (Duke University Medical Center/Duke Cardiovascular Magnetic Resonance Center) 3:10 PM O 132 Diagnostic Performance of Treadmill Exercise Cardiac Magnetic Resonance: The Prospective, Multicenter EXACT Trial Subha V. Raman, MD (Ohio State University) SATURDAY PROGRAM 2:40 PM O 129 Absence of DNA Double Strand Breaks in Human Peripheral Blood Mononuclear Cells After Magnetic Resonance Imaging Assessed by H2AX Flow Cytometry: A Prospective Blinded Trial Martin Fasshauer (University Medical Center Göttingen) 3:20 PM O 133 Association of Myocardial Fibrosis and Prior Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (Mesa) Bharath Ambale Venkatesh, MD, PhD (Johns Hopkins University) 3:30 PM O 134 Cost Savings Associated with an MRI Based Strategy in Suspected Severe Mitral Regurgitation Cindy Comeau, R.T. (N)(MR) (Carnegie Hill Radiology) 3:40 PM O 135 Disproportionate Abdominal Visceral Fat Mass Reduction and Complete Reversal of Cardiovascular Remodelling Accompany Roux-En-Y Gastric Bypass but not Gastric Banding - Benefits Beyond Simply Weight Loss Jennifer Rayner (University of Oxford) 3:50 PM O 136 Does Late Gadolinium Enhancement Still Have Value for the Rv? Rv Internal Mechanical Work, Ea/Emax (Vvc) and Lge as Prognostic Markers in Pulmonary Hypertension; A CMR Study Robert Biederman, MD (Temple School of Medicine) 2:40 PM – 4:00 PM CASE REVIEW 9: The Pediatric Patient Referred for Congenital Heart Disease Moderators: Tiffanie Johnson, MD (Riley Hospital for Children/Indiana University) Nancy Halnon, MD (University of California- Los Angeles) Location: Olympic 2:40 PM CR 63 An Unusual Case of Congenital Partial Absence of Pericardium, Partial Anomalous Pulmonary Venous Return, Sinus Venosus Defect and Systemic Venous Anomalies in a Teenager with Marfanoid Habitus Supriya Jain, MD (Maria Fareri Children’s Hospital at WMC, New York Medical College) 2:50 PM CR 64 Dual Contrast Cardiac Magnetic Resonance: Utility in Long-Term Survivors of the Fontan Operation Amitabh Parashar, MD (VAMC Salem, Virginia Tech Carilion SOM) 3:00 PM CR 65 Combined Cardiac MRI and Cardiac Catheterization Plays A Key Role in the Differentiation Between Pulmonary and Cardiac Causes of Pulmonary Hypertension in Patients with Complex, Multifactorial Disease Bram Ruijsink (King’s College London ) 3:10 PM CR 66 Infected Ventricular Pseudoaneurysm in a Single Ventricle Patient Detected Just in Time Using Cardiac MR Divya Shakti, MBBS, MPH (Batson Children’s Hospital, University of Mississippi) www.scmr.org 39 From Innovation to Impact in Cardiovascular Care SC I ENTI FIC S ES S IO N S 3:20 PM CR 67 3D Printing from Cardiac Magnetic Resonance Imaging or Surgical Planning in a Patient with Situs Inversus, Dextrocardia and Double Outlet Right Ventricle Shafkat Anwar, MD (St. Louis Children’s Hospital, Washington University School of Medicine) 3:30 PM CR 68 CMR-Based 3D Printed Heart Model of Complex Single Ventricle Anatomy Assists with Pre-Procedural Planning of Combined Atrial Maze and Extracardiac Fontan Conduit Procedure Ryan Moore, MD (Cincinnati Children’s Medical Center) 3:40 PM CR 69 Two Cases of a Prenatally Diagnosed Double Aortic Arch with a Postnatal Obliteration of the Left Aortic Arch Tam Doan, MD, MS (Connecticut Children’s Medical Center) 3:50 PM CR 70 Extensive Evaluation of a Benign Murmur Shiraz Maskatia, MD (Baylor College of Medicine) 4:15 PM – 6:00 PM CMR WORLD CUP: A Joint SCMR/EuroCMR Event Location: Los Angeles & CLOSING PLENARY SESSION Moderators: Mark Westwood, MD (The London Chest Hospital) Patricia Bandettini, MD (National Heart, Lung, and Blood Institute) At the conclusion of this session, participants will be better able to: • Interpret challenging CMR cases in a time-sensitive setting • Evaluate CMR’s performance in clinical trials • Summarize future trends and advances in CMR 4:15 PM Late-Breaking Clinical Trials: Current State and Future Directions Colin Berry, BSc PhD (University of Glasgow) 4:23 PM World Cup Case Competition: Soccer vs. Football Soccer: Matthew Martinez, MD (Lehigh Valley Health Center) Scott Flamm, MD (Cleveland Clinic) Craig Broberg, MD (Oregon Health Sciences) Football: Christopher Miller, MBChB (University Hospital of South Manchester) Robin Nijveldt, MD, PhD (VU University Medical Center) Oliver Tann, FRCR (Great Ormond Street Hospital) 5:03 PM Point/Counterpoint: The Future of CMR is High Field/Low Field Moderator: Roderic Pettigrew (National Institute of Biomedical Imaging and Bioengineering) Thoralf Niendorf (Max-Delbrück Center for Molecular Medicine) Orlando P. Simonetti, PhD (The Ohio State University) Carrying SCMR ’16 Forward: Practical Takeaways Juliano Fernandes, MD, PhD (Jose Michel Kalaf Research Institute) Daniel Ennis, PhD (UCLA) 5:15 PM 5:25 PM Closing Remarks from the Incoming President Jeanette Schulz-Menger, MD (Berlin) 5:30 PM Awards Ceremony 6:00 PM – 7:00 PM AWARDS RECEPTION TEC H N OLOG I ST TR AC K FRIDAY, JANUARY 29, 2016 8:40 AM –10:00 AM SESSION 1: The Basics Moderator: Beth Goddu (Beth Israel Deaconess Medical Center) Location: Westwood 8:40 AM Welcome Alison Fletcher, DCRR, PG Dip (Papworth Hospital) 8:45 AM CMR Physics Elizabeth Jenista, PhD (Duke University Medical Center) 40 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care TEC H N O LOG I ST TR AC K At the conclusion of this session, participants will be better able to: • Identify and describe common CMR pulse sequences • Describe image contrast differences among common CMR pulse sequences • Describe differences in acquisition strategies for CMR vs. MRI of other body parts 9:10 AM Anatomy and Slice Positioning Ralph Gentry (William Beaumont Hospital) At the conclusion of this session, participants will be better able to: • Recognize how to acquire a CMRI basic exam for LV function • Recognize the normal cardiac anatomy and some abnormal cardiac anatomy • Recognize the normal EKG pattern and how it relates to acquiring a CMRI exam and how each segment relates to the function of the heart 9:35 AM Why do we want CMR? The Cardiologists Point of View Oliver Rider, MRCP DHIL (University of Oxford) At the conclusion of this session, participants will be better able to: • Understand the role of CMR to help differentiate the hypertrophied heart • Understand the role of CMR to help differentiate the dilated heart • Understand the role of CMR to help differentiate a segment of hypokinesia 10:30 AM Tips and Tricks Alison Fletcher, DCRR, PG Dip (Papworth Hospital) At the conclusion of this session, participants will be better able to: • Optimise pulse sequences prior to scanning • Manipulate pulse sequences in line with physiological findings • Obtain diagnostic images in the non compliant patient 11:00 AM Optimizing 3T Imaging Patricia Feuchter, MSc (St. Bartholomew’s Hospital) At the conclusion of this session, participants will be better able to: • Identify common technical issues with CMR on 3T • Learn most common fixes for 3T scanning • Learn how to identify and implement the correct delta frequency for your cine images for 3T scanning 11:30 AM Optimization for the Pediatric Patient George Englehardt (Children’s Hospital of Philadelphia) At the conclusion of this session, participants will be better able to: • Be able to describe the different sedation/anesthesia techniques and how they affect the image quality • Know the different ways to communicate to the pediatric patient to successfully allow them to undergo an MRI • Understand the factors that go into image quality in children and how to optimize them in pediatrics TECHNOLOGIST TRACK 10:30 AM –12:00 PM SESSION 2: Optimizing Your Imaging Moderator: Ron Williams (Allegheny General Hospital) 1:00 PM – 2:20 PM SESSION 3: Running a CMR Service Moderator: Ron Williams (Allegheny General Hospital) 1:00 PM Clinical CMR Unit Anne Garcia (Ohio State University) At the conclusion of this session, participants will be better able to: • Establish tools for more efficient workflow- pre procedural and intra procedural techniques • Understand benefits of a dedicated team 1:25 PM Research CMR Unit Chris Lawton (Bristol Heart Institute) At the conclusion of this session, participants will be better able to: • Cardiovascular Disease - Why perform Research? • What are the many types of Research? • Research design and implantation - the Technologists role www.scmr.org 41 From Innovation to Impact in Cardiovascular Care TEC H N OLOG I ST TR AC K 1:50 PM Post Processing and the Extended Role Christine Mancini (Suburban Hospital) At the conclusion of this session, participants will be better able to: • Recognize which applications should have a qualitative vs quantified assessment • Understand the appropriateness of the study requested • Identify and understand the guidelines set by the SCMR for standardizing the post processing and interpretation of CMR 3:10 PM – 4:30 PM 3:10 PM SESSION 4: Cardiomyopathy Moderator: Robert Biederman, MD, FACC, FAHA (Allegheny General Hospital) Non Ischemia Heart Failure Andrew Flett, MBBS (University Hospital Southampton) At the conclusion of this session, participants will be better able to: • Understand the basic pathophysiology of non ischemic heart failure • Understand the role of CMR in the diagnosis of various aetiologies of heart failure • Understand the prognostic significance of CMR in non ischemic heart failure • Understand the ability of CMR to guide management 3:35 PM The Hypertrophied Heart Amardeep Dastidar, MBBS,MRCP (University of Bristol) At the conclusion of this session, participants will be better able to: • Define and quantify left ventricular hypertrophy (LVH) by CMR • Describe the diagnostic approach when investigating a patient with LVH. • Discuss and illustrate the usefulness of CMR in identifying the cause and prognosis of LVH 4:00 PM Oral Abstracts 4:00 PM T 1 Acute Detection of VENtricular Thrombus by Technologists (ADVENTT study) and the impact of an image interpretation teaching intervention Chris Lawton (Bristol Heart Institute) 4:10 PM T 2 Exercise CMR: real-time assessment of cardiac performance with phase contrast imaging Marina Quinlan (Imperial College London) At the conclusion of this session, participants will be better able to: • Learn the principles and applications of exercise CMR • Understand the techniques for assessing cardiac function during exercise • Appreciate the future role of exercise CMR 4:20 PM T 3 Translating CMR Innovations to Impact Cardiovascular Care with a Dedicated Team Elliot Hembree (Ohio State University) At the conclusion of this session, participants will be better able to: • Establish an understanding of a dedicated CMR team • Recognize measurable impact on staff satisfaction, throughput, and volume 42 4:40 PM – 6:00 PM 4:40 PM SESSION 5: Ischemia and Viability 5:05 PM Adenosine Stress CMR Bobak Heydari, MD, MPH (University of Calgary) At the conclusion of this session, participants will be better able to: • Importance of ischemia and imaging of ischemia in clinical decision making • Learn standard views and techniques for assess ischemia with stress CMR • Clinical application for acute and stable chest pain syndromes / suspected ischemic heart disease Moderator: Stephen Darty (Duke University Medical Center) Late Gadolinium Enhancement Gerry McCann, MD (University Hospitals Leicester) At the conclusion of this session, participants will be better able to: • Understand the importance of viability imaging in patients with coronary artery disease • Understand the different techniques for assessing myocardial viability with MRI • Understand the principles of late gadolinium enhanced (LGE) sequences for scar detection • Understand how to optimize image quality of LGE sequences • Understand how LGE sequences are analysed and reported for myocardial viability 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care TEC H N O LOG I ST TR AC K 5:30 PM Dobutamine Stress CMR Dan Augustine, MD (Royal United Hospital Bath NHS) At the conclusion of this session, participants will be better able to: • Understand the indications, advantages and disadvantages of using dobutamine for pharmacological stress • Gain knowledge in how to prepare patients for dobutamine stress (what to avoid pre-hand, what to expect, risks, common side effects) • Describe a commonly used dobutamine stress protocol including the use of adjunct medications • Understand dobutamine stress image interpretation and analysis SATURDAY, JANUARY 30, 2016 10:40 AM –12:00 PM SESSION 6: Congenital Imaging - What You Need To Image and Why Moderator: Alison Fletcher, DCRR, PG Dip (Papworth Hospital) The Unexpected Congenital Patient Vivek Muthurangu, MD (University College London) At the conclusion of this session, participants will be better able to: • How to be alert to possible congenital defects • Mains causes of right and left ventricular dilation • Mains causes of right and left ventricular hypertrophy • Simple shunt calculations TGA- Atrial and Arterial Switch Michael J. Campbell, MD (Duke University Hospital) At the conclusion of this session, participants will be better able to: • Understand the basics of cardiac anatomy and cardiac interrelationships • Have knowledge of common abnormalities of cardiac anatomy • Comprehend the basics of congenital heart disease and common congenital cardiac defects The Univentricular Heart Charles Peebles, MBBS, MRCP, FRCR (Southampton University Hospital) At the conclusion of this session, participants will be better able to: • Understand the spectrum of anatomy of the single ventricular circulation • Appreciate the imaging requirements for follow-up of the Fontan patient • Develop a practical CMR imaging strategy for the Fontan circuit 1:10 PM – 2:30 PM 1:10 PM 1:35 PM 2:00 PM SESSION 7: Imaging The Right Heart TECHNOLOGIST TRACK 10:40 AM 11:05 AM 11:30 AM Moderator: Ralph Gentry (William Beaumont Hospital) Right Heart Cardiomyopathy Erica Dall’Armellina, MD, DPhil (University of Oxford) At the conclusion of this session, participants will be better able to: • Assessment of RV abnormalities by CMR: when the RV looks abnormal • Potential differential diagnosis and focused CMR scanning Right Heart Cardiomyopathy Michael Gallagher, MD (William Beaumont Hospital) At the conclusion of this session, participants will be better able to: • Appreciate the spectrum of right heart cardiomyopathies. • Discuss CMR techniques used to evaluate right heart cardiomyopathies. • Recognise CMR findings in respect to right heart cardiomyopathies CMR in Pulmonary Hypertension Uyen Truong, MD (Children’s Hospital Colorado) At the conclusion of this session, participants will be better able to: • Understanding myocardial analysis in pediatric pulmonary hypertension • Understanding vascular analysis in pediatric pulmonary hypertension • Understanding comparison of MRI to cardiac catheterization in pediatric pulmonary hypertension www.scmr.org 43 From Innovation to Impact in Cardiovascular Care TEC H N OLOG I ST TR AC K 2:40 PM – 4:00 PM SESSION 8: Emerging Technologies Moderator: Chris Lawton (Bristol Heart Institute) 2:40 PM T1 and T2 Mapping Michael Gallagher, MD (William Beaumont Hospital) At the conclusion of this session, participants will be better able to: • Understand indications for T1 and T2 myocardial mapping • Understand technique of myocardial mapping • Understand interpretation of myocardial mapping 3:05 PM 4D Flow Michael Markl, PhD (Northwestern University At the conclusion of this session, participants will be better able to: • Explain basics and fundamental principles of 4D flow MRI data acquisition • Understand the use 4D flow data analysis tools for 3D blood flow visualization and quantification of cardiovascular hemodynamics • Identify emerging applications of 4D flow MRI for the comprehensive evaluation of cardiovascular disease 3:30 PM 3D Printing Laura Olivieri, MD (National Institutes of Health) At the conclusion of this session, participants will be better able to: • Introduce the basics of 3D printing • Understand the uses of 3D printing in cardiovascular applications. • Recognize the potential future for 3D printing and CMR. 3:55 PM Close Alison Fletcher, DCRR, PG Dip (Papworth Hospital) TECHNOLOGIST POSTERS T 4 An Unusual Cause of Right Heart Dilatation Yi-Hui Hung T 5 Asymptomatic Contained Left Ventricular Rupture Ceri Twigg (University Hospital Southampton) T 6 Increasing PACE of PACEMAKER Imaging! June Yamrozik, BS (Allegheny General Hospital) T 7 Gadolinium Contrast Agents: Over Exposure? Ronald Williams, BA,RT(R)(MR) (Allegheny General Hospital) T8 TWIST-MR-Angiography to aid central venous access in challenging patients. A single centre experience. Chris Lawton (Bristol Heart Institute) T 9 Myocardial T1 and ECV mapping: how we optimise technical aspects of acquisition Ricardo Wage (Royal Brompton Hospital) Location: California Showroom T 10 Essentials of Cardiac MRI in Clinical Practice Albert Piersson, MSc (Tamale Teaching Hospital) T 11 Streamlining Trigger Delay Estimation for T1 Mapping George Mathew, BA (Royal Brompton Hospital) T 12 A Model Argument for Accurate EF Geetha Rayarao, MS (Allegheny General Hospital) T 13 Virtual Reality Visualization of Patient Specific Heart Model Matthew Bramlet, MD (Children’s Hospital of Illinois, University of Illinois ) This activity will not be CME accredited.You are invited to meet the poster authors during the Welcome Reception on Thursday, January 28, 2016 from 6:00 PM – 7:00 PM. 44 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care POSTER S POSTER VIEWING SESSIONS This activity will not be CME accredited. You are invited to meet the poster authors during the following times: Thursday, January 28, 2016:6:00 PM – 7:00 PM Poster Session 1 (P001-P113) Categories being presented in Poster Session 1 are: • Basic Translational - Post Processing and Workflow • CAD/Ischemic Heart Disease • CAD-Other Friday, January 29, 2016: 12:30 PM – 1:30 PM Poster Session 2 (P114-P248) Categories being presented in Poster Session 2 are: • Clinical Outcome and Prognosis • Congenital Heart Disease • Cost-Effectiveness and Comparison to Other Modalities • EP and Interventional Applications • Early Career Award Saturday, January 30, 2016:12:00 PM – 1:00 PM Poster Session 3 (P249-P366) Categories being presented in Poster Session 3 are: • Inflammatory Heart Disease • Molecular Imaging; Contrast Agents • Multi-Center Trials • Non-Inflammatory Primary or Secondary CMP • Rapid, Efficient Imaging • Valvular Heart Disease • Vascular MRI P 001 Michael Markl P 002 Anish Bhuva, MRCP MA MBBS P 003 Liang Zhong, PhD P 004 Melanie Dufva, MS P 005 Kai Lin, MD P 006 Volker Rasche P 007 Yu Gao, BS P 008 Bashir Alaour, MD P 009 Kenneth Mangion P 010 Shuo Li P 011 Sofia Kvernby P 012 Mehdi Hedjazi Moghari, PhD P 013 Choukri Mekkaoui, PhD P 014 Jiun-Jie Wang, PhD P 015 Fei Han, MS P 016 Qi Yang, MD, PhD P 017 Eileen Hu-Wang P 018 Mitsue Miyazaki, PhD P 019 Maryam Nezafat P 020 Gilles Soulat, MD P 021 Takami Yoshida P 022 Vanessa Ferreira, MD, DPhil P 023 Yanchun Zhu, PhD LA Velocities and Stasis Assessed by 4D Flow MRI are Closely Associated with LAA Peak Velocities by Doppler TEE in Patients with Atrial Fibrillation Reproducibility of native T1 mapping using ShMOLLI and MOLLI – implications for sample size calculation. Lower-than-normal myocardial stress and excess hypertrophy from CMR are associated with worsening ventricular contractile performance in hypertrophic cardiomyopathy Left Ventricular Torsion Rates by CMR correlate with invasively-derived hemodynamic data in Pediatric Pulmonary Hypertension Displacement- versus velocity-encoding: Tracking regional myocardial motion using MR imaging High-quality reconstruction of arrhythmic cardiac cycles Improved Respiratory Motion Self-gating in Cardiaovascular MRI T1 Mapping Across the Ejection Fraction Spectrum Pixel-tracking derived strain using the GlasgowHeart Method. The accuracy and effectiveness of self-gating signals in free-breathing 3D cardiac cine MRI Myocardial mapping of T1 and T2 with 3D-QALAS – precision of independent and dependent scans in healthy subjects Prospective Heart Tracking for Respiratory Motion Compensation in Whole-heart Magnetic Resonance Angiography Characterization of the Myocardium in the 4-Chamber View Using Accelerated Free-Breathing Diffusion Tensor MRI Quantitative susceptibility map from the patients with chronic heart failure Image-Based 3D Non-Rigid Respiratory Motion Correction for Free-breathing Thoracic MR Angiography Early Detection and Quantification of Cerebral Venous Thrombosis by Magnetic Resonance Black Blood Thrombus Imaging (MRBTI) The Reproducibility of Heart Deformation Analysis for the Evaluation of Global Cardiac Function Non-Contrast Myocardium Blood Flow: Consideration of Technical Differences between 4D Time-SLIP using Tagging Aortic Root and FAIR Myocardial T1 mapping with spectrally-selective inversion pulse to reduce the influence of fat Comparison of brachial and central blood pressures using an oscillometric device with 2 or 6 metre tubing lengths for assessment of central pressure during mri exam. Morphology-Matching-Based R-Wave Detection For Noise-Robust ECG Gating Post-contrast T1-mapping Provides A Novel Approach To Optimal Myocardial Nulling For Late Gadolinium Enhancement Imaging: A Quantitative Prescription for the Correct TI Without the Guesswork Nonlinear Profile Order for 3D Hybrid Radial Acquisition Applied to Self-Gated Free-Breathing Cardiac CINE MRI www.scmr.org POSTERS BASIC TRANSLATIONAL - NEW TECHNIQUES READY FOR CLINICAL APPLICATION (POSTER SESSION 1) 45 From Innovation to Impact in Cardiovascular Care POSTER S P 024 Mohammed S. M. ElBaz P 026 Eric Aliotta, Bs. P 027 Emeline Lugand, MSc P 028 Kelvin Chow, PhD P 029 Ria Mazumder, Master of Science Apical inflow is associated with increased energy loss during left ventricular diastole in patients with a repaired atrioventricular septal defect: A 4D flow MRI study High-Resolution Spin-Echo Cardiac Diffusion-Weighted MRI with Motion Compensated Convex Optimized Diffusion Encoding (CODE) Breath-Held High-Resolution Cardiac T2 Mapping with SKRATCH Robust free-breathing SASHA T1 mapping using high-contrast image-based registration Quantification of Myocardial Stiffness in Heart Failure with Preserved Ejection Fraction Porcine Model Using Magnetic Resonance Elastography BASIC TRANSLATIONAL - POST-PROCESSING AND WORKFLOW P 030 Christopher Roy, MSc P 031 Mihir Sanghvi, MB BS, BSc P 032 Shuo Zhang, PhD P 033 Robert Jablonowski P 034 Hong Liu P 035 Elizabeth Tunnicliffe P 036 Pankaj Garg, MD P 037 Yuhua Chen P 038 Kai Lin, MD P 039 Vera-Christine Stahnke, MD P 040 Johannes Kowallick P 041 Filip Zemrak, MD, MRCP P 042 Georgios Kantasis P 043 Felicia Seemann, MSc in Engineering P 044 Christopher Roy, MSc P 045 Daniel Auger P 046 Prahlad Menon, PhD P 047 Haifa Almutairi, MSc P 048 Tazim Merchant P 049 Edvin Johansson P 050 Nivedita Naresh, PhD P 051 Steven Bellm, MD P 052 Kai Homer P 053 David Gross, MS P 054 Steven Bellm, MD P 055 Walter Witschey, PhD P 056 Davide Piccini P 057 Steven Bellm, MD P 058 Dominik Buckert P 059 Dominik Buckert P 060 El-Sayed Ibrahim P 061 Christian Stoeck, PhD P 062 Maxine Tang, MS Accelerated Phase Contrast Measurements of Fetal Blood Flow Using Compressed Sensing Automatic left ventricular analysis with Inline VF performs well compared to manual analysis: Results from Barts Cardiovascular Registry. Extracellular volume fraction mapping at 3T with non-rigid image co-registration MR photography of 3D-MR images Distribution pattern of left ventricular myocardial strain by feature-tracking CMR in Chinese normal subjects Intercentre reproducibility of second eigenvector orientation in cardiac diffusion tensor imaging Reliability and reproducibility of trans-valvular flow measurement by 4D flow magnetic resonance imaging in acute myocardial infarct patients: two centre study. Fully Automated Left Ventricle Function Analysis with Self-Gated 4D MRI Automated Assessment of Left Ventricular Function and Mass Using Heart Deformation Analysis: Initial Experience in 160 older adults Left ventricular strain during exercise stress: a CMR myocardial feature tracking study Quantitative Assessment of Left Ventricular Mechanical Dyssynchrony using Cine Cardiovascular Magnetic Resonance Imaging: Inter-study Reproducibility Can left ventricular endocardial surface roughness be measured by fractal dimension on fast gradient echo sequences? Accelerated Cloud and GPU-based Simulations for Quantification of Relaxation Times: An Example with MOLLI. Automated Time-Resolved Tracking Algorithm Of The Atrioventricular Plane Displacement In Cmr Images High Resolution Multislice Imaging of the Fetal Heart Using iGRASP and MOG Comparison of heart deformation analysis and cine DENSE in volunteers and heart failure patients Virtual Surgical Myectomy as a Planning Tool for Obstructive Hypertrophic Cardiomyopathy A comparison of cardiac motion analysis software packages: application to left ventricular deformation analysis in healthy subjects Physiologic Assessment of CMR Strain: Afterload and Contractility Rat heart T2-mapping with full coverage of the left ventricle myocardium High Temporal-Resolution Phase-Contrast MRI Demonstrates Impaired Left-ventricular Diastolic Relaxation in Mice Fed a High-Fat High-Sucrose Diet Reproducibility of Slice-Interleaved T1 (STONE) Mapping Sequence Use of Left Ventricle Blood Pool Oxygenation-Sensitive Signal Intensity as a Measure of Arterial Hemoglobin Saturation In Vivo and Post-Mortem Measurements of Radio Frequency Induced Heating during MRI of Pigs Implanted with Vascular Stents Reproducibility of Slice-Interleaved Myocardial T2 Mapping Sequences Alterations in ectopic myocardial contraction assessed using real-time MRI Respiratory Self Navigated Whole-Heart Angiography with Ultra-small Super-paramagnetic Iron Oxide Particles: A Feasibility Study Blood T1 Measurements using Slice-Interleaved T1 Mapping (STONE) Sequence Reproducibility of Regional- and Global Left-Ventricular Strain Analyzes Using Tagging and Feature Tracking Techniques A Cardiac Magnetic Resonance Imaging Study in Healthy Volunteers Physiological Changes in Regional and Global Left-Ventricular Strain During Exercise – A Cardiac Magnetic Resonance Imaging Study Using Tagging and Feature Tracking in Healthy Volunteers HARP Versus SinMod for Measuring Regional Heart Function from Tagged CMR Images Second order motion compensated spin echo cardiac diffusion tensor imaging on clinical MR systems Left Atrial Wall Imaging Using a Novel Black-Blood Late Gadolinium Enhancement Sequence CAD/ISCHEMIC HEART DISEASE P 063 Sotirios Tsaftaris P 064 Tomas Lapinskas, MD P 065 Wei Chen, PhD Student 46 Towards pixel-wise area-at-risk characterization with cardiac BOLD MRI at rest Evaluation of left atrial myocardial deformation in patients with acute MR after STEMI using CMR feature tracking Characterazation of Myocardial Edema in Rats with Acute Reperfused Myocardial Infarction at Multiple Time Points by 7 T MR 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care P 066 Alessandro Satriano, PhD P 067 Elisabeth Paiman, MD, MSc P 068 John Lisko, MD, MPH P 069 Robert Edelman, MD P 070 Yoshitaka Goto P 071 Tom Gyllenhammar P 072 Manish Ramlall P 073 Ian Paterson, MD P 074 Tobias Rutz, MD P 075 John Greenwood, MD, PhD P 076 Sebastian Kelle, MD, PhD, FESC P 077 Leah Iles, FRACP, PhD P 078 Daniel Lee, MD P 079 Peter Shaw, MD P 080 Lorenzo Monti, MD P 081 Michael Jesinger, MD P 082 Ahmed AlBadri, MD P 083 Anna Schmidt, MD-PhD Candidate P 084 Ryo Ogawa P 085 Kalyan Kancherla, MD P 086 Joy Shome, MBBS MRCP P 087 Akimasa Yamada P 088 Joyce Wong, MRCP, PhD P 089 Francesco Secchi, MD P 090 Antonia Camporeale, MD P 091 Joseph Soltys, PhD P 092 Enver Tahir, MD P 093 Nadine Abanador-Kamper P 094 David Nordlund P 095 Paras Parikh, MS P 096 Nicola Galea, MD PhD P 097 Gerald Pohost P 098 Terrence Jao, BS P 099 Vishal Mehra, MD, PhD P 100 Terrence Jao, BS P 101 Paras Parikh, MS P 102 Steven Bellm, MD Segmental Strain Analysis by Deformation of a Mesh Model: Comparison of Segmental Strain Metrics and Late Gadolinium Enhancement Quantification in Myocardial Infarction. MRI-derived cardiac mechanical dispersion for risk stratification in patients with ischemic cardiomyopathy: a preliminary study Assessment of Transient Ischemic Dilation With Cardiac MRI Breath-Hold Imaging Of The Coronary Arteries Using Quiescent-Interval Slice-Selective (Qiss) Magnetic Resonance Angiography - Pilot Study At 1.5 Tesla And 3 Tesla Native T1 mapping allows for the accurate detection of the segments with chronic myocardial infarction in patients with known or suspected coronary artery disease. Myocardial perfusion using cardiac magnetic resonance: Evidence of decreased global myocardial perfusion in patients with systemic sclerosis with possible gender differences High-sensitivity Troponin-T levels in reperfused STEMI patients: A comparison with CMR Right Ventricular Remodeling and Dysfunction Among the Spectrum of Heart Failure Phenotypes Border sharpness of scar tissue after myocardial infarction as determined by self-navigated free-breathing isotropic 3D whole-heart inversion recovery magnetic resonance Rationale and design of the Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease 2 trial (CEMARC 2): A prospective, multi-centre, randomized controlled trial of diagnostic strategies for suspected coronary heart disease Prognostic value of cardiovascular magnetic resonance stress perfusion imaging in patients with atrial fibrillation. Biomarker validation of cardiac magnetic resonance analysis of regional myocardial fibrosis in ischaemic heart disease Electrocardiographic Markers of Myocardial Infarction Size, Transmural Extent, and Extent of Nonviable Myocardium Comparison to CMR Quantitative CMR perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease. Role of adenosine Stress CMR before Chronic Total Occlusion reopening LV wall motion assessment during regadenoson vasodilator stress CMR Interscan Reproducibility of Cardiovascular Magnetic Resonance Myocardial Perfusion Reserve Index in Women with Suspected Coronary Microvascular Dysfunction and No Obstructive Coronary Artery Disease Intra-Thoracic Fat Volume is Associated with Impaired Myocardial Function and Adverse Left Ventricular Remodeling in Patients with Known or Suspected Coronary Artery Disease Quantitative Circumferential Strain Analysis Using 3-Tesla Feature-Tracking Cardiovascular Magnetic Resonance in Patients with Old Myocardial Infarction. Effect of Myocardial Scar detected by cardiac Magnetic Resonance on perfusion time and short term outcomes after Coronary Artery Bypass Graft Surgery Validation of perfusion dyssynchrony indices as a novel non-invasive diagnostic tool in the detection of hemodynamically significant coronary artery disease in the setting of three dimensional (3D) myocardial perfusion CMR. Fermi function constrained deconvolution underestimates myocardial blood flow and myocardial perfusion reserve regardless of saturation correction of arterial input curve. DE-CMR and MPS for assessment of myocardial viability: to what extent do the two techniques agree? Epicardial Adipose Tissue Evaluated with Cardiac Magnetic Resonance in Normal Subject and in patients with Ischemic and Dilated Cardiomyopathies Lack of right ventricular remodelling after surgical ventricular restoration Initial Description of Changes in Wall Motion Parameters in Normal Subjects Undergoing Rest/Regadenoson Stress Using A Tagged MRI Sequence Reproducibility of native and contrast-enhanced CMR techniques to measure lesion size following acute myocardial infarction Impact of coronary flow on the risk of microvascular obstruction in acute myocardial infarction The Evolution of Myocardium at Risk by T2-STIR MR imaging the first Week after Acute Myocardial Ischemia Extracellular Volume Fractions Are Not Consistent in Gray Zones Determined by Late Gadolinium Enhancement Imaging of Myocardial Infarction. Application of native T1 map in characterization of acute myocardial infarction: can T1 distinguish between infarct area and area-at-risk? Impact of Ranolazine on Myocardial Metabolic Ischemia Detected by Phosphorus-31 Magnetic Resonance Spectroscopy Demonstration of Velocity Selective Myocardial Arterial Spin Labeling Perfusion CMR The Relationship of Gray Zone and Infarct Core in the Iceland MI Study Myocardial ASL-CMR Perfusion Imaging with Improved Sensitivity using GRAPPA A Novel Calibration Technique to Obtain High Resolution 3D T1 Maps for Infarct Characterization The Native T1 in Remote Myocardium of Patients with Prior Chronic Infarction is Not Normal www.scmr.org POSTERS POSTER S 47 From Innovation to Impact in Cardiovascular Care POSTER S CAD – OTHER P 103 Susann Beier, BSME, ME P 104 Sung A Chang, MD, PhD P 105 Felix Range, MD P 106 Enver Tahir, MD P 107 Akhil Narang, MD P 108 Tendoh Timoh, MD P 109 Ryo Ogawa P 110 Sarah Nasser, Masters P 111 Darius Dabir, MD P 112 Mita Patel, MD P 113 Abbas Nasiraei-Moghaddam, PhD A new method to quantify coronary flow conditions using dynamically scaled in vitro phase contrast magnetic resonance imaging Safety of Adenosine Stress Perfusion Cardiac MRI in Patients undergoing Lung Transplantation Evaluation Acute regadenoson stress prefusion testing using cardiac MRI is a valuable test of high predictive value for risk stratification of COPD-patients with NSTEM Effects on blood pressure, cardiac mass and function after renal denervation in patients with resistant hypertension. Vasodilator stress cardiovascular magnetic resonance imaging in post-orthotopic heart transplant recipients: evaluation of safety, hemodynamics, and myocardial perfusion How well do individual first pass perfusion images correlate with fully quantitative myocardial blood flow pixel maps? T1 Mapping Using a Saturation Recovery Single-Shot Acquisition at 3 Tesla MRI in Differentiation of Normal Myocardium from Hypertrophic Cardiomyopathy Quantitative tissue characterization of cardiac myxomas by CMR-Mapping techniques validated by histology. Association between early diastolic dysfunction and increased peri-/epicardial fat: A CMR based study Novel 3-Dimensional K-Space Segmented Acquisition Scheme (CENTRA-PLUS) for Enhanced Coronary Imaging A software tool for segmentation of the myocardium in CMR exams using level-set algorithm CLINICAL OUTCOME AND PROGNOSIS P 114 Francesco Secchi, MD P 115 Sameer Raina, MD P 116 Amir Rahsepar, MD P 117 Raymond Chan, MD P 118 Amardeep Ghosh Dastidar, MBBS, MRCP P 119 Moon Young Kim, Doctor P 120 George Cater, MD P 121 Eric Yang, MD P 122 Simon Lee, MD P 123 Andrew Cheng, MD P 124 Eks Pollock, MD P 125 Xuefei Duan P 126 Michael Nelson, PhD P 127 Julius Weinrich, MD P 128 Lei Zhao P 129 Kenneth Mangion P 130 Michael Chuang, MD P 131 Sabha Bhatti, MD P 132 Yoshiaki Ohyama, MD P 133 Ian Chang, MD P 134 Mohammed Khanji, MB BCh P 135 Satish Chacko, MD P 136 Huma Samar, MD P 137 Antonella Meloni, P 138 Robert Biederman, MD, FACC, FAHA P 139 Ke Wan 48 Prognostic Value of Late Enhancement in Cardiac Magnetic Resonance in Patients with Dilated Cardiomyopathy: A Meta-analysis Prognostic utility of Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Cardiac Amyloidosis: A Meta-analysis. MR Tissue Phase Mapping Reveals Reduced Left Ventricular Velocities in Patients with Myocardial Scar. Prognostic Value of Late Gadolinium Enhancement Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy: A Meta-analysis Impact of cardiovascular magnetic resonance on management and clinical decision-making in patients presenting with chest pain, elevated troponin and unobstructed coronary artery Myocardial T1 mapping in asymptomatic subjects: variations according to left ventricular segments and correlation with cardiovascular risk factors Pulmonary Artery Pressure is Associated with Extracellular Volume Fraction in Patients with Normal Left Ventricular Function Prognostic implications of myocardial fibrosis and troponin levels measured by a highly sensitive assay in non-ischemic cardiomyopathy Simplifying the Diagnosis of Left Ventricular Hypertrophy: Is Left Ventricular Mass to Volume Ratio Constant in Children Throughout Growth? Comparison of MOLLI and ShMOLLI at 1.5 and 3 Tesla for Detection of Early Cardiac Iron Deposition in Patients with Transfusional Siderosis Withdrawn Extracellualr volume(ECV) quantified by T1 mapping could reflect effect of long term blood pressure control status in patients with essential hypertension Changes in left ventricular function and coronary blood flow velocity during isocapnic hypoxia: A cardiac magnetic resonance imaging study Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM) Myocardial T1 mapping at 3 T in healthy adults: reference values and influencing factors The Cardiac Toxicity CMR Study in Patients with Lung Cancer Treated with Chemo-radiotherapy: The CART study- a semi quantitative analysis of the myocardial perfusion index. Impact of Sex and Advancing Age on Left Atrial Volume and Shape: The Framingham Heart Study Clinical characteristics and predictors of mortality in patients with normal wall thickness cardiac amyloidosis Age-Related Association of Aortic Arch Pulse Wave Velocity Assessed by MRI with Incident Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Impact of Cardiovascular Imaging on the Management of Patients with Cardiac Masses The applicability of current global cardiovascular risk scores and cardiovascular surrogates in chronic obstructive pulmonary disease Longitudinal fiber dysfunction assessed during cine-cardiac magnetic resonance imaging is an independent predictor of adverse cardiac events Pacemakers and AICDs in the Magnet; have we turned the corner? Significant improvement of survival by T2* CMR in thalassemia major Physiologic Left Ventricular Ejection Efficiency Assessed at the Level of the Aorta The Right Ventricular End-systolic Volume Index Predicts Mortality in Patients with Cardiac Amyloidosis 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care POSTER S P 140 Katia Menacho Medina P 141 Antonella Meloni P 142 Vikram Brahmanandam, MD P 143 Michael Chuang, MD P 144 Thomas Hauser, MD, MPH, MMSc P 145 Sahadev Reddy, MD P 146 Angela Koh, MBBS, MPH P 147 Geeshath Jayasekera P 148 Ryan Avery, MD P 149 Robert White P 150 El-Sayed Ibrahim The Right ventricle and cardiac surgery -- more resilient than thought: multiparametric quantification shows altered rather than reduced function Withdrawn Improved Prediction of Adverse Events in Hypertrophic Cardiomyopathy with Quantitative Late Gadolinium Enhancement and Myocardial Strain Aortic Arch Width by CMR Is Highly Reproducible Between Readers and Across Imaging Sequences CMR Measures of Left and Right Ventricular Systolic Performance and Mortality: A Factor Analysis Cardio-Hepatic Risk Assessment by CMR in Liver Transplant Candidates; Advancing Beyond a Proof of Concept. Subclinical Cardiac Abnormalities and Physical Function in Asymptomatic Elderly Right Ventricular free wall myocardial tissue characterisation by systolic Cardiac Magnetic Resonance T1 mapping in pulmonary hypertension. Multiparameter Use of Cardiac Magnetic Resonance as a Predictor of Pulmonary Artery Hypertension Atrial Fibrosis Progression in Patients with Atrial Fibrillation CMR for Evaluation of Cardiac Function in Type-1 Diabetes P 151 Theo Kingdom P 152 Michael Morcos, MD P 153 Gilles Soulat, MD P 154 Avan Suinesiaputra P 155 Jonathan Levine, MD Candidate P 156 Prashob Porayette, MBBS, MSc P 157 Mun Cheang P 158 Kevin Gralewski, MSE P 159 Dan Yang P 160 Hari Narayan, MD P 161 Bram Ruijsink P 162 Bernadette Elders P 163 Ramkumar Krishnamurthy, PhD P 164 Sara Swanson, MD, PhD P 165 Tamadhir Gazzaz, MBBS P 166 Jimmy Lu, MD P 167 Cory Noel, MD P 168 Emmanuel Ogele, BS Biology P 169 James Enos, MD P 170 Michael Rose, BSc P 171 Joyce Woo P 172 Jason Christensen, MD P 173 Laura Olivieri P 174 Sujatha Buddhe, MD P 175 Puneet Bhatla P 176 Margaret Samyn, MD P 177 David Lloyd P 178 Nathaniel Barber, MBBS P 179 Mahesh Kappanayil, MD P 180 David Lloyd The absolute and relative sizes of the brains and bodies of fetuses with different forms of congenital heart disease and intrauterine growth restriction. Comparison of Systemic Right Ventricular Function in Transposition of the Great Arteries after Atrial Switch and Congenitally Corrected Transposition of the Great Arteries Accuracy and Inter observer variability of blood flow quantification on 4D flow MRI in adult with transposition of the great arteries corrected by arterial switch Application of Atlas-Based Global Shape and Local Contraction Analysis to Single-Ventricle Congenital Heart Disease Segmental late gadolinium enhancement and Gadolinium extracellular volume in hypertrophic cardiomyopathy Serial Prenatal And Post-Natal Brain Mri Demonstrates Impact Of Congenital Heart Disease And Cardiac Surgery On Brain Growth And Maturity Comprehensive Cardiovascular Assessment of Children with Chronic Kidney Disease using Exercise Cardiac Magnetic Resonance Imaging Continuity equation-derived valve area using CMR phase-contrast provides flow-independent assessment of valve stenosis LV geometric and substrate remodeling in patient with Ebstein anomaly - A Deep insight from MRI T1 mapping fibrosis imaging Reliable Aortic Arch Measurements Using a Novel Cardiac Magnetic Resonance Sequence: Navigated 3D SPACE Right ventricular function and adaption after hemi-Fontan completion in children with hypoplastic left heart syndrome. Ascending aortic wall shear stress and distensibility are different in patients with corrected atrioventricular septal defect compared to healthy controls: a comprehensive CMR and 4D flow MRI evaluation Ventricular Coupling in Single Ventricle Patients: A MRI Study of Cardiac Biomechanics in Left ventricular extracellular volume measurements in repaired tetralogy of Fallot patients Validation of a Semi-automatic Threshold-based Approach for Right Ventricular Endocardial Border Detection for Volumetry Predictors of Change in Functional Health Status in Adults with Repaired Tetralogy of Fallot Myocardial T1 Mapping as a Diagnostic Tool in Pediatric Patients with a Concern for Cardiac Disease The Use of Cardiac Magnetic Resonance Imaging in Diagnosing and Characterizing Hypertrophic Cardiomyopathy A Comparison of Right Ventricular Volumes in Children and Adults with Repaired Tetralogy of Fallot - Including and Excluding Right Ventricular Trabeculations Evaluating the Disease Progression of Pediatric Bicuspid Aortic Valve Patients Using 4D Flow MRI Data Can 2-Dimensional Echocardiography Accurately Classify Patients with Repaired Tetralogy of Fallot in Possible Need of Pulmonic Valve Replacement? Relation of increased BMI to left atrial volume in repaired tetralogy of Fallot patients Coronary Flow Reserve in Adults with Systemic Right or Single Ventricles Myocarditis Masquerading as Acute Coronary Syndrome: Diagnostic Role of Cardiac MRI Utility of rapid prototyping in Complex DORV: Does it alter management decisions? Utility of Speckle Tracking Echocardiography in Measuring Systemic Right Ventricular Systolic Function for Patients with d-Transposition of the Great Arteries Status post Atrial Switch Procedure: A Comparison with Cardiac Magnetic Resonance Imaging Early experience of multi-sequence fetal cardiac magnetic resonance imaging within a clinical fetal cardiology service MR-Augmented Cardio Pulmonary Exercise Testing: an integrated approach to assessment of children with Pulmonary Hypertension. From establishing a CHD-CMR unit to 3D printing in a developing country pediatric cardiac unit. Prenatal MRI visualisation of the aortic arch and fetal vasculature using motion-corrected slice-to-volume reconstruction www.scmr.org POSTERS CONGENITAL HEART DISEASE 49 From Innovation to Impact in Cardiovascular Care POSTER S P 181 Nao Sasaki, MD P 182 Amita Singh, MD P 183 Erin Paul, MD P 184 Pia Sjöberg, MD P 185 Nicole Wake, MS P 186 AK Ortiz, BA P 187 Sihong Huang, MD P 188 Arni Nutting, MD P 189 Tim Slesnick, MD P 190 Nicholas Byrne Calculation of differential pulmonary blood flow in patients with congenital heart disease using pulmonary artery flow versus pulmonary vein flow. Alterations in Regional Right Ventricular Shape in Patients Following Tetralogy of Fallot Repair Involving a Transannular Patch Nonlinear Self-Calibrated Phase Contrast Correction in Pediatric and Congenital Cardiovascular Magnetic Resonance Imaging Patients with Tetralogy of Fallot have lower systolic KE in the left ventricle and higher diastolic KE in the right ventricle. Whole Heart Self-Navigated 3D Radial MRI for the Creation of Virtual 3D Models in Congenital Heart Disease Left Ventricular Shape Variation in Patients with Aortic Coarctation Pre- and Post-Stent Implantation Prevalence of myocardial scarring in congenital heart disease – comparison between left ventricular pressure and volume overload using a novel black-blood delayed enhancement imaging technique Single center experience with a prototype self-navigated 3D SSFP whole heart sequence in assessing coronary artery origin Quantification and Origin of Differential Pulmonary Blood Flow in Patients with a Fontan Circulation Steps towards automated image segmentation as part of a 3D printing pipeline in congenital heart disease COST-EFFECTIVENESS AND COMPARISON TO OTHER MODALITIES P 191 Gayathri Kumarasinghe, MBBS FRACP P 192 Mohan Mallikarjuna Rao Edupuganti, MD, FRACP P 193 Mohan Mallikarjuna Rao Edupuganti, MD, FRACP P 194 Mariam Narous P 195 Daniel Morgenstern Cardiovascular Magnetic Resonance Imaging Produces Highly Reproducible Rodent Cardiac Volumetric and Functional Data Using a 1.5 Tesla Scanner Exploring difference in atrioventricular valve opening times to predict elevated left atrial pressure – a novel approach to left atrial pressure quantification on cardiovascular MRI. Comparison of regional and global Cardiac MRI diastolic strain rates with echo grading of diastolic dysfunction. Do Whole Body Impedance Cardiography Estimates of Left Ventricular Structure, Volumes and Function Correlate with the Gold Standard of Cardiac Magnetic Resonance Imaging? Cardiac MRI Stress Testing in the Reduction of Radiation Exposure for Patients Undergoing Ischemic Evaluation EP AND INTERVENTIONAL APPLICATIONS P 196 Eugene Kholmovski, PhD P 197 Stephanie Clement-Guinaudeau P 198 Hubert Cochet, MD PhD P 199 Maurits van der Graaf, MD P 200 Erik Bieging, MD P 201 Hubert Cochet, MD PhD P 202 Christian Mahnkopf, MD P 203 Joseph Soltys, PhD P 204 Amir Durrani, MD P 205 Adrienne Campbell-Washburn, PhD P 206 Philippa Krahn, BSc P 207 Dana Peters P 208 Ozgur Kocaturk, PhD P 209 Dana Peters P 210 Zhen Qian P 211 Peter Kellman, PhD P 212 Mikayel Dabaghyan, PhD P 213 Michael Guttman, MS P 214 Thomas Gregory, MS P 215 Daniel Auger P 216 Adrienne Campbell-Washburn, PhD Visibility of RF Ablation Lesions in Native T1-weighted MRI Reduces with Time after Ablation Characterization of ARVC substrate on MRI and electrophysiological mapping Post-Infarction Ventricular Fibrillation Mechanisms: Insights From Combined Body Surface Potential Mapping And Late Gadolinium-Enhanced Cmr Use and Safety of Magnetic Resonance Imaging in Patients With an Implanted MRI-Conditional Pacing Device Regional left atrial wall fibrosis and recurrence after atrial fibrillation ablation Atrial Scar On Late Gadolinium-Enhanced Imaging To Predict Electrical Reconnection After Pulmonary Vein Isolation For Atrial Fibrillation Assessment of left atrial structural remodeling in patients with cryptogenic stroke - Lessons Learned from LGE-MRI Post Ablation Timing to Best Visualize Left-Atrial Lesions: A Feasibility Study The Cumulative Effects and Clinical Safety of Repeat Magnetic Resonance Imaging on an MRI-conditional Pacemaker System at 1 .5 Tesla Real-time inversion recovery for infarct visualization during MR-guided interventions Intrinsic MRI visualizes RF lesions within minutes after MR-guided ablation Lower Left Atrial Strain in the Presence of Regional Atrial Fibrosis: An MRI Study of Patients with Atrial Fibrillation Lithography Based Resonant Marker Design For Mri Catheter Visualization Atrial fibrosis segmentation thresholds: a theoretical and empirical study Comparison of Noninvasive Three Dimensional Delayed Enhancement MRI of Left Atrial Scar with Invasive Voltage Map by Using Robust 4D Point-to-Point Registration in Patients with Atrial Fibrillation Dark Blood Late Gadolinium Enhancement Improves Conspicuity of Ablation Lesions 3T Cardiac Imaging With On-Line 12-Lead Ecg Monitoring Towards MRI-guided cardiac ablation procedures with no contrast agent: safety and efficacy considerations Intra-MRI Extraction of Diagnostic Electrocardiograms using Dynamic Feedback from Carotidal Magnetohydrodynamic Voltages Cine DENSE MRI of Mechanical Activation in Heart Failure Patients Referred for Cardiac Resynchronization Therapy Spiral imaging with off-resonance reconstruction for MRI-guided cardiovascular catheterizations using commercial off-the-shelf nitinol guidewires EARLY CAREER AWARD P 217 Joseph Cheng, PhD P 218 Zixin Deng 50 Feasibility of Ultra-High-Dimensional Flow Imaging for Rapid Pediatric Cardiopulmonary MRI Pressure Gradient Measurement in the Coronary Artery Using Phase Contrast (PC)-MRI: Initial Patient Results Towards Noninvasive Quantification of Fractional Flow Reserve 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care POSTER S Remote myocardium is also affected in acute myocardial infarction: evidence from advanced CMR relaxometry Skeletal Muscle Assessment to Understand Cardiometabolic Interactions New automatic algorithm for segmentation of myocardial scar in both inversion recovery and phase sensitive inversion recovery late gadolinium enhancement: validation against TTC and in multi-center, multi-vendor patient data Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT Inter-study repeatability of self-gated CMR perfusion: A comparison of Fermi and compartment models Cardiac and hepatic phenotype of diabetes in the presence and the absence of obesity - mechanistic role of ectopic/ visceral adiposity Accuracy of Non-contrast-enhanced Quiescent Interval Single-Shot (QISS) Lower Extremity MRA for the Diagnosis of Peripheral Artery Disease: Comparison with CTA and Digital Subtraction Angiography Myocardial Extracellular Matrix Volume has independent prognostic value in patients with non-ischemic cardiomyopathy. In the presence of a patent foramen ovale paroxysmal embolism risk increases with non-vortical right atrial blood flow Comprehensive intra/extracellular myocardial structural and functional characterization of hypertensive heart disease phenotypes Quantification of the myocardial partition coefficient for intravenous iron (ferric carboxymaltose) using T1 mapping cardiovascular magnetic resonance Chronic iron deposit and left ventricular remodeling in reperfused STEMI patients Myocardial haemorrhage after acute reperfused ST-elevation myocardial infarction evolves progressively and contributes to the early bimodal pattern in T2-relaxation time: advanced imaging and clinical significance. Improved assessment of aortic 3D blood flow with combined k-t accelerated 3D CINE bSSFP & 4D flow MRI 4D Strain Analysis within Non-Infarcted Myocardium of Patients with Ischemic Cardiomyopathy: Potential Marker for the Prediction of Adverse Cardiac Events. Refining the Characterization of Residual Function in Hypertrophic Cardiomyopathy through Remote Segment 4D Strain Analysis. A simple clinical model to predict presence of myocardial fibrosis in patients with aortic stenosis. Withdrawn Measurement of the intracellular lifetime of water to estimate myocardial cell size is not feasible in humans using clinical contrast agent doses at 1.5T Diffuse Myocardial Fibrosis detected by Multi-slice T1 Mapping using Slice Interleaved T1 (STONE) Sequence in Patients with Hypertrophic Cardiomyopathy Role of 12 lead ECG Q-waves as a marker of myocardial infarction in the era of cardiac magnetic resonance Patients with Cardiac syndrome X have decreased global myocardial perfusion compared to gender matched controls; insights from CMR coronary sinus flow measurements Non-contrast cardiac MRI for tissue characterization in patients with end stage renal disease Free-breathing respiratory self-gated Golden angle RAdial Three-dimensional whole-heart isotropic cine imaging for left ventricular volumetric Evaluation (GRATE) – comparison with conventional 2D breath-hold cine imaging Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy Papillary Muscle Native T1 Time is Associated with Severity of Functional Mitral Regurgitation in Patients with Non-ischemic Dilated Cardiomyopathy Best precision in measuring Qp/Qs is achieved with quadratic, not linear, stationary tissue background correction in phase contrast velocity encoded CMR In Patients with Acute Myocarditis, the Difference in Apparent Extracellular Volume Fraction between Affected and Healthy Myocardium does not differ between Early and Late Post-Contrast Imaging Debt-Free Cardiac Health Extrapolating echocardiographic determinants of elevated Left Atrial Pressure (LAP) to Cardiac Magnetic Resonance Imaging (CMR) to determine the best CMR correlate of elevated LAP. POSTERS P 219 Amardeep Ghosh Dastidar MBBS, MRCP P 220 Vidhya Kumar P 221 Jane Tufvesson, MSC P 222 Jane Tufvesson, MSC P 223 Devavrat Likhite P 224 Eylem Levelt P 225 Akos Varga-Szemes, MD, PhD P 226 Tomas Vita P 227 Victoria Stoll P 228 Jonathan Rodrigues, BSc(Hons), MBChB(Hons), MRCP, FRCR P 229 Goran Abdula, MD P 230 Heerajnarain Bulluck, MBBS P 231 David Carrick, BScMedSci, MBChB, MRCP P 232 Kelly Jarvis, MS P 233 Alessandro Satriano, PhD P 234 Alessandro Satriano, PhD P 235 Vassilis Vassiliou, MA, MBBS, MRCP P 236 Johannes Kowallick P 237 Magnus Lundin, MSc, MD P 238 Shingo Kato P 239 Amardeep Ghosh Dastidar, MBBS, MRCP P 240 Tom Gyllenhammar P 241 Tori Stromp P 242 Karen Holst P 243 James Starc, MD P 244 Shingo Kato P 245 Jannike Nickander P 246 Magnus Lundin, MSc. Engg P 247 Victor Farah, MD P 248 Mohan Mallikarjuna Rao Edupuganti, MD, FRACP INFLAMMATORY HEART DISEASE P 249 Yoko Mikami, MD, PhD P 250 Patrizia Pedrotti, Medical Doctor P 251 Ahmed Kharabish, Master P 252 Theodore Murphy, MD P 253 Reina Tonegawa Inter-center variability in the application of the Lake Louise Criteria to the diagnosis of myocarditis Fulminant versus non fulminant acute myocarditis: evolution of functional parameters evaluated with cardiac magnetic resonance CMRI morphological and functional changes of the heart in myocarditis and dilated cardiomyopathy in acute pediatric heart failure Incidence of Cardiac Sarcoidosis in those with Extra-cardiac Disease without known Cardiac Involvement – a CMR Study Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and T2-weighted short tau inversion recovery black-blood images of cardiac magnetic resonance in cardiac sarcoidosis www.scmr.org 51 From Innovation to Impact in Cardiovascular Care POSTER S P 254 Alban Redheuil P 255 Darius Dabir, MD P 256 Johannes Schüler, Student P 257 Julius Traber Detection of Subclinical Cardiac Involvement in Inflammatory Myopathy by CMR T1 Relaxometry Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T Combined parametric mapping allows discrimination of disease activity in myocarditis Assessment of acute radiation therapy-related cardiotoxicity by cardiovascular magnetic resonance MOLECULAR IMAGING; CONTRAST AGENTS P 258 Jessica Bastiaansen, PhD Flow imaging in vivo using off resonance spin labeling induced by extraneous contrast agent P 259 Kim-Lien Nguyen, MD Ferumoxytol across the Age Spectrum: a Single Center Experience of Safety P 260 Naveen Rajpurohit, MD Global and Regional Extracellular Volume and Myocardial Circumferential Strain Correlate Significantly in a Heterogeneous Patient Population P 261 Lindsay Urbinelli, MD T1 Mapping in Becker Muscular Dystrophy Patients Detects Diffuse Microfibrosis Prior to Evidence of Late Gadolinium Enhancement or Cardiac Dysfunction P 262 Dara Kraitchman, VMD, PhD Cardiac CEST-MRI For Tracking Stem Cell Survival and Determining the Role of CXCL2 MULTI-CENTER TRIALS P 263 Amol Pednekar, PhD Two-Center Clinical Validation of Free Breathing Respiratory Triggered Retrospectively Cardiac Gated Steady-State Free Precession (RT-SSFP) Cine Imaging in Adults NON-INFLAMMATORY PRIMARY OR SECONDARY CMP P 264 Jonathan Rodrigues, BSc(Hons), MBChB(Hons), MRCP, FRCR P 265 Shawn Pun, MD P 266 Maria Espinoza Barillas, Resident P 268 Olga Toro-Salazar, MD P 269 Amardeep Ghosh Dastidar, MBBS, MRCP P 270 Antonella Meloni P 271 Chiara Valentina Lario P 272 Yong Luo P 273 Sabha Bhatti, MD P 274 Julien Frandon, MD P 275 Karolina Zareba, MD P 276 Rami Homsi P 277 Minjie Lu, MD, PhD P 278 Xiaohai Ma, MD, PhD P 279 Jonathan Soslow, MD P 280 Lilia Sierra-Galan, MD, FACC, FSCCT P 281 Upasana Tayal P 282 Minjie Lu, MD, PhD P 283 Upasana Tayal P 284 Anna Schmidt, MD-PhD Candidate P 285 Flavia Junqueira, PhD P 286 Leena RV, MD P 287 Yoko Mikami, MD, PhD 52 Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric CMR predictors beyond end-diastolic wall thickness ≥15mm Tissue Characteristics and Anatomic Distribution of Cardiac Metastases among Patients with Advanced Systemic Cancer Assessed by Cardiac Magnetic Resonance (CMR) Cardiovascular Magnetic Resonance in Familial Amyloidosis. Cardiac Magnetic Resonance Characteristics of Acute Anthracycline-Induced Cardiotoxicity Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM) Changes of cardiac iron and function during pregnancy in trasfusion-dependent thalassemia patients Early markers of heart damage in systemic sclerosis: role of cardiac magnetic resonance with late gadolinium enhancement Mitral valve leaflet length as an important factor to differentiate hypertrophic cardiomyopathy from other causes of left ventricular hypertrophy Determination of strain pattern in patients with cardiac amyloidosis secondary to Multiple Myeloma: A Feature Tracking Study Evaluation of trabeculated mass in patient with non compaction: do we need criteria reappraisal? Wide QRS-T angle and low T wave amplitude are associated with the presence of myocardial expansion as measured by extracellular volume fraction with cardiac MRI Pulmonary arterial hypertension is associated with increased T1 relaxation times and decreased left ventricular performance in spite of preserved left ventricular function CMR Assessment of the Left Ventricle Apical Morphology in Subjects with Giant T-wave Inversions and Without Apical Wall Thickness>15mm Systolic MOLLI T1 mapping with heart rate depends pulse sequence sampling scheme is feasible in patients with atrial fibrillation Myocardial T1 and T2 Mapping in Duchenne Muscular Dystrophy: Characterization of Late Gadolinium Enhancement Presence Of Late Gadolinium Enhancement In “Healthy Subjects”: Correlation With Chronic Exposure To Moderately High Altitudes. Evaluation of CMR predictors of Right Ventricular Remodelling in Dilated Cardiomyopathy Myocardial Extracellular Volume Fraction Quantified by Cardiovascular Magnetic Resonance is Increased in Hypertension and Associated with Left Ventricular Remodeling Evaluating the Significance of Left Ventricular Midwall Fibrosis Detected by Late Gadolinium Enhancement Imaging on Left Ventricular Functional Remodelling in Dilated Cardiomyopathy Cardiovascular Magnetic Resonance Imaging of Cardiac Remodeling and Strain Analysis in Adolescent Obesity Fat Content Effect in the Measurement of T2* for Iron Quantification in the Liver in Patients With Suspected Myocardial Iron Overload Retrospective analysis of MR imaging characteristics and demographic characteristics of Tropical Endomyocardial fibrosis in a tertiary care centre in South India Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care POSTER S P 288 Hong-Mi Choi P 289 Noha Behairy P 290 Vassilis Vassiliou, MA, MBBS, MRCP P 291 Elena Pena, MD P 292 Rebecca Thornhill, PhD P 293 Minjie Lu, MD, PhD P 294 Yu-pin Chang, MD P 295 Antonella Meloni, PhD P 296 Shadi Akhtari, MD P 297 Sharif Sabe P 298 Ganesh Kumar Gnanappa M.B.B.S, MD P 299 Min Liu, MD P 300 Tom Gyllenhammar Left atrial remodeling and mechanical dysfunction in hypertrophic cardiomyopathy Delayed myocardial enhancement in pediatric hypertrophic cardiomyopathy: correlation with LV functional and demographic parameters Left atrial dilation in patients with heart failure and preserved ejection fraction: Value of CMR Simpson method. Relationship between expansion of the myocardial interstitial space and ventricular performance in patients with pulmonary hypertension Relationship between MRI First pass Perfusion Parameters and Biventricular Performance in Pulmonary Hypertension The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype Assessment of Fabry variant (IVS4+919G>A) Cardiomyopathy in Taiwanese: Emphasis on T1 mapping Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients Left and Right Ventricular Volumes and Global Systolic Function in Isolated Left Bundle Branch Block: A Cardiac Magnetic Resonance Imaging Study Predictors of Right Ventricular Ejection Fraction in Patients with Nonischemic Cardiomyopathy Pediatrics, Fellowship in Paediatric cardiology Presence of Left Ventricular Non Compaction in Hypertrophic Pediatrics Is Associated With Arrhythmia Longitudinal strain correlated with haemodynamics in patients with chronic thromboembolic pulmonary hypertension Right atrial volume measured by cardiac magnetic resonance correlates with NT-ProBNP and invasive right atrial pressure in pulmonary hypertension, with and without systemic sclerosis P 267 Aurelien Bustin P 301 Peter Speier P 302 Claudio Santelli P 303 LI ZHANG, MaSc. P 304 Iain Pierce, PhD P 305 Xin Liu, MD, PhD P 306 Marcos Ferreira Botelho, MD P 307 Raluca Saru, MD P 308 Raluca Saru, MD P 309 Sanket Shah, MD MHS P 310 Konstantinos Bratis P 311 Dipan Shah, MD P 312 Britt-Marie Ahlander, MRI tech, MSc P 313 Juliano Fernandes, MD, PhD, MBA P 314 Daniel Kuetting P 315 Abbas Nasiraei-Moghaddam, PhD P 316 Lu Lin P 317 Karima Addetia, MD P 319 Xiaoying Cai, Bachelor P 320 Ying Liu P 321 Keigo Kawaji, PhD P 322 Wolfgang Rehwald, PhD P 323 Gastao Lima da Cruz P 324 Gergely Szantho, MD P 325 Yang Yang, MS P 326 R Reeve Ingle, PhD P 327 Abbas Nasiraei-Moghaddam, PhD P 328 Thomas Gregory, MS P 329 Francisco Contijoch P 330 Bram Ruijsink A fully automated binning method for improved SHARP reconstruction of free-breathing cardiac images CAIPIRINHA-accelerated 2D bSSFP imaging with improved banding behavior using Gradient-Controlled Local Larmor Frequency (GC-LOLA) L1 k-t ESPIRiT: Accelerating Dynamic MRI Using Efficient Auto-Calibrated Parallel Imaging and Compressed Sensing Reconstruction High-Resolution MR Characterization of Myocardial Infarction using Compressed Sensing with Edge Preservation Late Gadolinium Enhancemnet imaging of the Left Ventricle in a sinlge breath-hold using multi-slice spiral PSIR imaging at 3T Accelerated 3D self-gated cardiac cine imaging at 3T using a tiny golden angle and compressed sensing Dark Blood Imaging of the Heart using Dual-Inversion, Balanced Steady-State Free-Precession Remote CMR 4D Flow Quantification of Pulmonary Flow Global left ventricular function quantification with CMR 4D Flow Improving Patient Throughput in a Busy Pediatric Mri Imaging Program Through a Nursing Coordinator Clinical Evaluation of 3D High Resolution Late Enhancement using Image-Based Navigation CMR Clinical Practice Patterns Across Four U.S. Medical Centers from 2010-2014 Development and validation of a questionnaire evaluating patient anxiety during Magnetic Resonance Imaging: the Magnetic Resonance Imaging-Anxiety Questionnaire (MRI-AQ). A Comprehensive Free-Breathing Protocol for Cardiovascular Magnetic Resonance Imaging of Ischemia and Cardiomyopathies: a Feasibility Study Quantitative assessment of systolic and diastolic function in patients with systemic amyloidosis Real time circular tagging is possible through radial acquisition. 3.0T Cardiac Magnetic Resonance Quantification of Myocardial Extracellular Volume using different delay time of postcontrast T1 mapping for the Diagnosis of Cardiac Amyloidosis Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents Free-breathing 2D Cine DENSE with Localized Excitation, Self-navigation and Motion Correction T1 mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy Operator-guided Navigator Gating for Real-Time Interactive Coronary Cardiovascular Magnetic Resonance Fully Automatic Rapid inversion time (TI) Adjustment for Late Gadolinium Enhancement (LGE) Imaging Using a Pencil Beam Excitation Pulse for Single-Line T1 (SLT1) Mapping of Myocardium Motion Corrected 3D Whole-Heart Vessel Wall Imaging Aortic flow changes during free breathing exercise, measured with real time MRI Reduced field-of-view stack-of-spirals enables high spatiotemporal resolution 3D perfusion imaging Rapid left ventricular function MRI with an accelerated real-time-based spiral acquisition Circumferenial Compression Encoding (CIRCOME) using Polar K-space ECG Electrode Placements for Magnetohydrodynamic Voltage Suppression and improving Cardiac Gating in high-field MRI Impact of Respiration on LV Volume and Function Using rt-MRI Routine 3D Ssfp Cine Imaging For Improved Analysis Of Myocardial Volumetry And Deformation. www.scmr.org POSTERS RAPID, EFFICIENT IMAGING 53 From Innovation to Impact in Cardiovascular Care POSTER S P 331 Samuel Ting P 332 Abbas Nasiraei-Moghaddam, PhD P 333 Amol Pednekar, PhD Patch-based, Iteratively-Reweighted Compressive Recovery for Reconstruction of Highly Accelerated Exercise Stress Cardiac Cine Rotational Motion of Left Ventricle by Harmonic Phase on Radial Tagging Quantitative Assessment of Temporal Stability of the Myocardial Signal and Relative Blood to Myocardial Contrast in Free Breathing Respiratory Triggered Retrospectively Cardiac Gated Cine Steady-State Free Precession (RT-SSFP) Imaging. VALVULAR HEART DISEASE P 334 Yang Lin P 335 Juliana Serafim da Silveira, MD P 336 Florian von Knobelsdorff- Brenkenhoff, MD P 337 John Greenwood, MD, PhD P 338 J. Paul Finn, MD P 339 Willis Lam, MD P 340 Henrique Trad, MD P 341 Malenka Bissell, MD P 342 Hae Jin Kim, Doctor P 343 Diego Medvedofsky, Fellow P 344 Noha Behairy P 345 Katherine McGee P 346 Eric Keller, M.A. P 347 Stephanie Marchesseau Comparison of Two Methods for Correcting Baseline Offset Error in Phase-Contrast MR Imaging Peak velocity estimation in aortic stenosis patients using a fast three-directional two-dimensional phase contrast technique in a single breath-hold: comparison to unidirectional phase contrast MRI and transthoracic echocardiography. Abnormal regional myocardial morphology in patients with left ventricular pressure overload and preserved ejection fraction detected by multiparametric MR tissue mapping Post-procedural myocardial infarction following surgical and trans-catheter aortic valve replacement – mechanistic insights from cardiovascular magnetic resonance imaging Ferumoxytol MR Angiography for Pre-TAVR Assessment Severe Aortic Stenosis with High Valvulo-arterial Impedance (Zva) Has More Adverse Cardiac Changes on Cardiovascular Magnetic Resonance. Aortic Regurgitation Quantification using Cardiac Magnetic Resonance. Is there a best imaging plane for flow quantification? A single center clinical trial. Inherited aortopathy assessment in bicuspid aortic valve disease relative Aortic valve planimetry by high-resolution 3-dimensional MR image acquisition with a breath-hold: comparison with conventional cine MR imaging and echocardiography to assess the severity of aortic valve stenosis Quantification of the Severity of Tricuspid Regurgitation from Cardiac Magnetic Resonance Cine Images Congenital biscuspid aortic valve in pediatric and early adulthood: Is there a relationship between the valvular leaflet fusion pattern and other functional parameters Impact of Beta-blocker, ACE Inhibitor, and ARB therapy on thoracic aorta wall shear stress in bicuspid aortic valve patients Restoration of Physiologic Hemodynamics in the Ascending Aorta Following Aortic Valve Replacement: a 4D Flow MR Study Ejection and Filling rates assessed from Cardiac Magnetic Resonance Imaging: possible indices of Degenerative Mitral Valve Regurgitation VASCULAR MRI P 348 Xiangzhi Zhou, Ph.D P 349 Stig F. Samnøy P 350 Zhaoyang Fan, PhD P 351 M. R. Avendi, PHD P 352 Jorge Gonzalez, MD P 353 Yoshiaki Ohyama, MD P 354 Karunakaravel Karuppasamy P 355 Wenchuan Wang P 356 Jorge Gonzalez, MD P 357 Emilie Bollache, PhD P 358 Marcos Ferreira Botelho, MD P 359 Tomoki Fujii, MS,RT P 360 Ria Mazumder, Master of Science P 361 Yi He P 362 Leonard Bergau, MD P 363 Ziwu Zhou P 364 Da Wang, MS P 365 Rouzbeh Ahmadian, MD, MS P 366 Robert Edelman, MD 54 Fresh Blood Imaging using Variable TR and Variable Refocusing Flip Angle for Non-Contrast Peripheral MR Angiography at 3T: A 7-Minute Iliac to Calf Station Run-Offs Scan Visualization and Quantification of Regional Ventricular Wall and Blood Velocities by 3T 4D PC-MRI Development of a clinically practical whole-brain intracranial vessel wall MRI technique at 3 Tesla Fully automatic segmentation of heart chambers in cardiac MRI using deep learning. Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD Relationship between Tissue Factor Pathway Inhibitor and Aortic Stiffness assessed by MRI: The Multi-Ethnic Study of Atherosclerosis (MESA) Diagnostic accuracy of non-contrast magnetic resonance angiogram of infra-popliteal arteries prior to fibular-free flap harvest Withdrawn Determinants of Exercise Calf Muscle Perfusion in Peripheral Arterial Disease (PAD) 4D Flow and 2D PC MRI: Impact of Volumetric Coverage and Three-Directional Velocity Encoding on Quantification of Aortic Hemodynamics Comprehensive non-contrast MR assessment of the iliofemoral arteries with visualization of vascular calcifications in TAVR candidates – initial experience Reproducibility of cuff-induced hyperemic popliteal artery flow analysis using phase-contrast MRI: Patients With Intermittent Claudication Injected With ALDH Bright Cells (PACE) trial Quantification and comparison of 4D Flow MRI derived wall shear stress and MRE derived wall shear stiffness of abdominal aorta. Evaluation of the Diagnostic Performance of Self-Navigated Whole-Heart Contrast-Enhanced Coronary MRA at 3T Serial assessment of left atrial deformation in patients undergoing pulmonary vein isolation: a cardiovascular magnetic resonance feasibility study Ferumoxytol-Enhanced 4D MR Angiography with Retrospectively Defined Temporal Resolution Hybrid One- and Two-sided Flow-Encodings Only (HOTFEO) to Accelerate 4D Flow MRI Comprehesnive Evaluation of Aortic Disease by In-vivo 4D Flow MRI and 3D Printing of Patient-Specific Models: A Feasibility Study Rapid Imaging Of Peripheral Vascular Calcifications Using In-Phase, Two-Dimensional Radial Flash At 3 Tesla 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Abbasi, Siddique Abd-Elmoniem, Khaled Abdel-Gadir, Amna P 093 P 226, O 130 O 005 O 038, O 039, O 040, O 042, O 086, P 002, P 230, Q 48, Q 67 Ammirati, Enrico P 250 An, Jing P 278, P 282, P 316, P 361 Anderson, Allen O 034 Anderson, Kevan P 206 Anderson, Todd P 083, P 284 Abdula, Goran P 229 Andres, Kristin O 010, O 083, P 241 Abdullah, Shuaib O 130 Andrews, Melissa O 085, O 093, P 333 Abidin, Nik Abouelnour, Amr Acevedo-Bolton, Gabriel Q 43 O 136 Q 54 Androulakis, Alexander Angel, Nathan P 067 O 128, P 196 Anita, Sri Q 52, T 11 Acikel, Volkan O 121 Annex, Brian Ackermann, Mary O 034 Antoniades, Charalambos P 224 Anwar, Mohammed O 059 Adam, Gerhard Addetia, Karima Addy, Nii Adhyapak, Srilakshmi Adluru, Ganesh Afilalo, Jonathan Agarwal, Prachi Agati, Luciano Ahlander, Britt-Marie Ahmad, Rizwan O 099, P 092, P 106, P 127 P 317, P 343 P 326, Q 30, W 31 P 046 O 111, P 223 O 075 P 356 Aoki, Ryosuke Q 40 Apitz, Christian O 116 Appelbaum, Evan O 130, P 144 Arai, Andrew O 008, O 061, O 087, P 099, P 108, P 173, P 279, Q 14, Q 17, W 08, W 12 Arasaratnam, Punitha Q 21 P 096 Araszkiewicz, Aleksander W 20 P 312 Arcopinto, Michele P 164, P 166 P 331, P 335, W 22, W 29 O 075 Arena, Claudio O 093, P 333 Ahmadian, Rouzbeh P 365 Arestedt, Kristofer Ahmed, Nadeem P 231 Argento, Crocetta P 141 Ahmed, Nauman O 127 Argulian, Edgar O 134 O 056 Arheden, Håkan Akcakaya, Mehmet Akhtari, Shadi Akintuerk, Hakan Ako, Emmanuel Aksoy, Olcay Al hadad, Sudad Al-Mashat, Mariam P 244, P 296, Q 47 O 116 O 039, O 069 P 338, Q 59 O 032 Q 23 P 312 O 023, O 072, P 033, P 043, P 071, P 094, P 184, P 221, P 222, P 240, P 300, Q 23, Q 61 Ariga, Rina Armstrong, Lynne Arnhold, Kristin O 035, P 035 T8 Q 64 Arnold, John O 132 Arnold, Madeline P 284 O 025 Arora, Garima P 130 Alaour, Bashir P 008 Arvidsson, Per O 023, Q 61 AlBadri, Ahmed P 082 Arya, Nikesh O 118 Albers, Erin P 174 Asfour, Ahmed O 033 Albert, Christine P 078 Ashworth, Michael O 040 P 049 Asimakopoulos, George Alehagen, Urban O 091 Aspelund, Thor Aletras, Anthony P 033, P 042, P 094, P 221, P 222, W 28 Al-Wakeel, Nadya Albery, Tamsin Ali, Aamir Aliotta, Eric Allen, Bradley Allsop, Joanna Almutairi, Haifa Alon, Lina Alpendurada, Francisco P 281, P 283, Q 52 P 026 P 170, Q 16, W 18 Assimopoulos, Stephania Atar, Dan Q 56 O 061 Q 05 P 094, P 221, P 222 Atkinson, David P 323 Attili, Anil O 123 P 177 Auger, Daniel P 047 Auger, Dominique P 290, Q 52 P 262 Augustine, Daniel O 127 P 290, Q 52, Q 56, T 11 Aupart, Michel Alway, Thomas P 088 Avanesov, Maxim Alì, Marco P 114 Avants, Brian O 126, P 045, P 215 O 047 P 092, P 106, P 127 P 055 P 228, P 269 Avery, Ryan P 148 Amano, Yasuo P 318 Awan, Hira O 134 Ambach, Stephanie P 273 Axel, Leon W 24 O 065, O 077, O 133, P 132, P 353, P 359 Ayad, Ihab O 113, P 259 Amadu, Antonio Matteo Ambale Venkatesh, Bharath Azarine, Arshid www.scmr.org AUTHOR INXEX Abanador-Kamper, Nadine P 153 55 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Azevedo, Clerio Q 31 Bernard, Stephen Babaee, Nafiseh P 332 Bernhardt, Peter O 026 Berry, Colin Babu-Narayan, Sonya Baessler, Bettina W 09, W 21 Bai, Wenjia Bairey Merz, C Noel P 209 Q 63 Berul, Charles P 211 O 003, O 012, O 043, P 082, P 126, W 25 Betts, Timothy O 035 O 124 Beuf, Olivier Balawon, Armida P 134 Bevilacqua, Marco P 271 Bhagirath, Pranav Balfour, Pelbreton O 036, P 009, P 075, P 129, P 231 Bertelsen, Litten Bakhos, Lara Balbo Mussetto, Annalisa P 077 O 058, P 006, P 058, P 059, P 249, Q 01 P 352, P 079 O 041 P 063, W 27 P 199 Bhat, Himanshu O 052, P 013 Ball, Stephen O 060 Bhatla, Puneet Ballantyne, Christie P 121 Bhatti, Sabha P 080 Bhuva, Anish O 037, O 042, O 086, P 002, P 230, Q 67 O 135, Q 35, Q 38, Q 39 Bi, Xiaoming O 018, P 016, P 218, P 350, Q 58, Q 62, W 02, W 15 Balzarini, Luca Banerjee, Rajarshi P 175, P 185 P 115, P 131, P 248, P 273 Biasiolli, Luca P 341, W 10 Barber, Nathaniel O 069, P 157, P 178 Barfuss, Spencer O 034 Bidhult, Sebastian W 28 O 062, O 127, P 118, P 219, P 239, P 269 Biederman, Robert O 136, P 136, P 138, P 145, P 247, T 12, T 6, T 7 Baritussio, Anna Barker, Alex P 170, P 232, P 345, P 346, P 357, P 365, Q 57 Bieging, Erik O 111, P 200 Barker, Piers P 187 Biglino, Giovanni Barnes, Neil P 134 Bigvava, Tamar P 076, P 110 Bijsterveld, Petra O 060, P 075 Barry, Jennifer P 206, P 303, Q 05 Bartone, Cheryl O 132 Baruah, Dhiraj Q 45 Basar, Burcu P 216 Bilal, Hasan Bilchick, Kenneth Birney, Ewan O 118, Q 02 Q 52 O 126, P 045, P 215 Q 63 O 056, P 019, P 051, P 054, P 062, P 238, P 244, Q 41 Bissell, Malenka P 227, P 341 Bashir, Yaver O 035 Biswas, Labonny P 206 Bassett, Paul Q 37 Blackman, Daniel P 337 Basha, Tamer Bastiaansen, Jessica P 258 Blaes, Anne P 133 Bateman, Timothy P 091 Blaisdell, Julie O 034 Battle, Bennett P 192 Blankenberg, Stefan O 099 Bauer, Juergen Baumbach, Andreas Bauml, Michael O 116 Blankstein, Ron O 130, P 226 P 118, P 239 Blaszczyk, Edyta Q 57 Q 20 Blazek, Stephan Baysoy, Engin P 208 Behairy, Noha Blom, Nico Q 66 P 162 P 289, P 344 Bluemke, David O 065, O 077, O 133, P 132, P 353 Behnke-Hall, Kachina O 116 Boccalini, Sara P 307, P 308 Beier, Susann P 103 Bogachkov, Abraham Belhajer, Zahra P 153 Bogun, Frank Bellm, Steven P 051, P 054, P 057, P 102, P 238, Q 41 Bellsham-Revell, Hannah Benefield, Brandon Benni, Monica P 161 P 095, P 101, W 38 P 270 Bohnen, Sebastian Bolger, Ann W 18, W 30 O 123 O 099 O 089, O 091 Bollache, Emilie P 345, P 357 Bonanno, Gabriele O 105, O 106 Bonetti, Federico P 137 Benveniste, Olivier P 254 Boniface, Karen O 040 Benza, Raymond O 136 Boniface, Nicholas Berendsen, Floris O 084 Bonnet, Christopher P 136 Berg, Sophie O 056, P 051, P 054, P 057, P 062, P 102, P 238, P 244, P 296 Bonnet, Damien P 153 Bergau, Leonard P 362 Bonvin, Debora P 258 Berger, Alexander P 076 Borgna-Pignatti, Caterina P 137 Borgquist, Rasmus O 023 Benovoy, Mitchel Berger, Felix Berisha, Sebastian Berman, Daniel Bernard, Monique 56 O 087, Q 17 O 025, Q 18 P 329 O 003, O 012, O 022, O 043, P 082, P 218, W 15, W 25 P 274, Q 34 Botnar, Rene Bou Ayache, Jad Boubertakh, Redha O 100, Q 27 P 019, P 191, P 310, P 323, P 330, Q 11 W 18 P 031, P 047, P 134 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Boudriot, Enno O 098 Campbell-Washburn, Adrienne Boulet, Lindsey P 126 Camporeale, Antonia Bourque, Jamieson P 079 Cannao, Paola Maria Boutouyrie, Pierre P 020 Cao, Jian Bowman, Alex O 048 Cao, Jie T3 Capelli, Claudio Boyce, Steven P 085 Captur, Gabriella Boyd, Austin P 365 Caravan, Peter Brachmann, Johannes P 202 Carberry, Jaclyn Bradley, Chris O 017 Carbone, Iacopo P 090 P 089, P 090, P 114, P 225 P 316 O 017, O 061, O 079 Q 02 O 065, O 077, P 041, Q 37, W 14 O 016 P 231 O 046, P 096 Braggion-Santos, Maria Fernanda P 340, Q 55 Carlhall, Carl Johan Brahmanandam, Vikram P 142, Q 12 Bramlet, Matthew O 114, T 13 Carlsson, Marcus O 023, O 072, P 033, P 043, P 071, P 094, P 184, P 221, P 222, P 240, P 300, Q 61 Bratis, Konstantinos Brau, Anja Bravetti, Marine P 310 O 054, O 110, P 267 P 254 Bray, Janet P 077 Brener, Sorin O 033 Bricq, Stéphanie P 274, Q 34 Broder, Marike O 119 Brout, Dustin P 133 Brown, Julia Bruehl, Ruediger O 060, P 075 W 14 Brunengraber, Daniel O 113 Brunereau, Laurent O 047 Brunner, Fabian P 106 Brunner, Gerd P 121 Bruse, Jan Bryant, Jennifer Q 02 P 008, T 5 Bucciarelli-Ducci, ChiaraO 062, O 127, P 118, P 219, P 228, P 239, P 269, T 1 Bucius, Paulius Buckert, Dominik Budde, Ricardo Buddhe, Sujatha Bull, Sacha Bulluck, Heerajnarain Bulte, Jeff Bunck, Alexander Burchell, Amy Bustin, Aurelien Butcher, Charles Butler, Javed Butler, John P 064 O 058, P 058, P 059 P 307, P 308 P 174 Q 35 O 037, O 038, O 042, O 086, P 002, P 072, P 140, P 230, Q 48, Q 67 P 262 W 09, W 21 P 228, P 264, Q 26 Caroline, Ita P 209 Carpenter, Alexander P 239 Carr, James O 034, O 090, P 001, P 005, P 017, P 038, P 116, P 155, P 168, P 232, P 345, P 346, P 357, P 358, P 365, Q 13, Q 16, W 18, W 30, W 32 Carr, Maria Carrick, David Carroll, Timothy Carter, Martha P 231 P 095, P 101, W 38 P 309 Q 65 Casadei, Barbara O 035 Casale, Maddalena P 295 Case, James P 091 Castelletti, Silvia O 037 Castelvecchio, Serenella Catalano, Carlo Cater, George Cater, John Cates, Joshua Cazeneuve, Nicolas Cecelja, Marina P 090 O 046, P 096 P 120 P 103 P 149, P 200 O 047 Q 36 Celermajer, David P 298 Chabi, Marie Laure P 254 Chacko, Satish P 135, Q 20 Chai, Joshua W 10 Chai, Jyh-wen P 294 Chakravarti, Sujata Chamera, Elzbieta P 175 O 065, P 359 Chan, Angel P 265 P 088 Chan, Raymond P 117 O 079 Chang, Henry O 110, P 267 O 019, W 02 Chang, Hyuk-Jae O 135 Chang, Ian Byrne, Nicholas P 190 Chang, James Bönner, Florian P 105 Chang, Michael Chang, Sung A Calkoen, Emmeline O 090, Q 16, W 18 Caruso, Damiano Byrne, James Cai, Xiaoying O 068, O 089, O 091, P 011 P 319 P 024, P 162 Calvieri, Camilla P 090 Cameron, Peter P 077 Camici, Paolo P 250 Campbell, Michael P 187 Chang, Yu-pin P 220 O 022, P 218, W 15 P 133 Q 47 P 191 P 104, Q 08 P 294 Chaptinel, Jérôme P 027, P 074, W 16 Charnigo, Richard O 032 Charoensri, Nisarat P 297 Chatterjee, Neil Chattranukulchai, Pairoj www.scmr.org AUTHOR INXEX Bowman, Katherine P 205, P 216, Q 68, Q 69 W 38 O 044 57 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Chaturvedi, Rajiv Q 24 Church, Colin P 147 Ciolina, Federica O 046 Chazot, Alban O 045, W 16 Cheang, Mun O 038, P 157 Cirillo, Stefano P 271 Chelikani, Sudhakar P 207, P 209 Clarke, Kieran O 104, P 224 Chelliah, Anjali P 183 Clarke, William Chemaly, Elie O 073 Clement-Guinaudeau, Stephanie P 224 Chen, Albert O 015 Clemons, Alexander T 13 Chen, Clayton Chi-Chang P 294 Clerfond, Guillaume P 231 P 197, P 198, P 201 O 044, O 055, P 187, P 322, Q 06, Q 08, Q 10 Cluzel, Philippe P 254 Chen, Hanwei P 305, Q 49, Q 58 Clymer, Bradley P 029 Chen, Howard O 016 Cochet, Hubert P 197, P 198, P 201 Chen, John O 016 Coelho-Filho, Otavio Chen, Enn-Ling Chen, Liyong O 111, Q 60 Coenen, Adriaan W 07 P 308 Chen, On O 033 Cohen, Scott P 176 Chen, Stuart O 101 Colan, Steven O 030 P 065 Collins, Jeremy Chen, Wei Chen, Xiao O 126, P 215, P 319, P 325 O 034, P 005, P 017, P 038, P 116, P 155, P 168, P 232, P 346, P 358, P 365, Q 13, Q 16, W 18, W 30, W 32 Chen, Y Iris O 016 Comyns, Julie T3 Chen, Yong W 01 Conn, Hannah O 087, Q 17 Chen, Yucheng O 031, P 034, P 125, P 139, P 159, P 272 Connelly, Kim Contijoch, Francisco O 015 P 055, P 329, W 13 Chen, Yuhua O 070, O 107, P 037 Chen, Yushu P 065 Contreras, Laurn P 123 Cook, Judy Cheng, Joseph P 217 Cook, Stuart Cheng, Wei P 159 Cook-Wiens, Galen P 082 O 073 Cooper, Annette P 056 Cooper, Leslie P 249 Cheng, Andrew Cheng, Ya-Jian Cheong, Benjamin Chetrit, Michael Chin, Calvin Chiodi, Elisabetta Chiribiri, Amedeo Cho, Goo-Young Cho, Soo Jin O 085, O 093, P 263, P 333 P 097 P 262 P 032, P 146, P 281, P 283, Q 63 O 075 Coppo, Simone O 105, O 106, P 074 P 032, P 235 Cordeiro, Marco P 104 P 137 Coristine, Andrew P 258 P 040, P 086, P 236, Q 15, W 14 Corneloup, Olivier P 197, P 198, P 201 P 288 Cornfeld, Daniel P 119 Cornhill, Aidan P 207 O 078, P 287 Corrado, Domenico O 062 Cortez, Angel P 262 P 288 Cossor, Waseem P 171 O 079 Costello, Benedict P 077 Choudhary, Preeti P 298 Couderc, Jean-Philippe P 275 Choudhury, Lubna P 155, P 168 Coulden, Richard O 011 Choudhury, Robin W 10 Cowan, Brett P 103 Choe, Yeon Hyeon Choi, Byoung Wook Choi, Hong-Mi Choudhary, Naila Chow, Kelvin Chowdhary, Varun P 119, P 342 O 022, P 218, W 15 O 049, P 028, P 073, P 079, P 325, Q 03 O 034, P 005 Cowan, Karen P 194 Cox, Andrew O 038 P 188 Cozzi, Andrea Chrispin, Jonathan O 065 Craft, Jason Christensen, Jason P 172 Croisille, Pierre O 114 Cross, Russell Chowdhury, Shahryar Christodoulou, Anthony Chua, Serene Chuang, Michael Chubb, Henry Chugh, Atul P 146 O 075, P 130, P 143, P 296 Q 28 P 132, P 353 Crowley, Anna Lisa Crum, Kimberly Cui, Sophia Culotta, Veronica P 089 O 132, Q 12 O 041, O 045, W 16 P 169 O 001, O 131, P 104, P 311, Q 33 P 279 P 215, W 03 O 038, O 042, O 086 Chung, Jaehoon P 135 Cummins, Ciara O 014 Chung, Yiu-Cho P 334 Cunningham, Chuck O 015 Chungsomprasong, Paweena P 165 Cupps, Brian 58 W 11 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X O 112 da Silva, Cynthia W 07 Dabaghyan, Mikayel P 212, W 04 Dabir, Darius O 004, O 102, P 111, P 255, P 314, Q 04 Didier, Juliette O 041 Dieringer, Matthias P 256, P 336, W 36 DiMaria, Joseph P 352, P 356 Dinjus, Dirk P 105 Damon, Bruce P 279 Dipchand, Anne Q 24 Damon, Stephen P 279 Dishart, Michael P 145 Darty, Stephen P 187, Q 10 Do, Hung O 007, P 100 T1 Dobson, Laura P 036, P 337, Q 11 Davies, Ceri P 031 Doltra, Adelina P 076, P 110 Davies, John P 072 Donekal, Sirisha Davis, Anne P 022 Dong, Wei Dastidar, Amardeep Dawes, Timothy Q 63 Dawkins, James O 070, Q 62 Dawson, Dana de Bourguignon, Charles De Cecco, Carlo O 133 O 002 Dorfman, Adam P 164, P 166 Dori, Yoav P 160 O 036 Dorrell, Lucy O 104 O 041 Dournes, Gael P 225, Q 65 Doyle, Mark P 197 O 136, P 136, P 138, P 145, P 247, T 12, T 6, T 7 Duan, Xuefei P 125 de Koning, Patrick P 024 Dufva, Melanie P 004 De Luca, Laura P 096 Duncan, James P 207 Duncanson, Lynette O 079 De Garate, Estefania O 062, P 118, P 219, P 269 de Marvao, Antonio Q 63, T 2 de Roos, Albert P 162 de Souza, Anthony Q 56 de Waha, Suzanne O 098, Q 19 Deering, Thomas P 210 Durrani, Amir P 204 Duvernoy, Claire P 060, P 150 Dweck, Marc P 235 Dwivedi, Girish P 291, P 292 Dyck, Jason O 009, O 049, P 073 Q 44 Dyckmanns, Nils O 058, P 058, P 059 Del Vecchio, Giovanni Carlo P 137 Dyverfeldt, Petter Dell’ Omodarme, Matteo P 310 Ebbers, Tino Dellegrottaglie, Santo O 063 Eckhaus, Michael Delling, Francesca P 244 Edelman, Robert P 166 Edupuganti, Mohan Mallikarjuna Rao Dees, Debra O 085, O 093, P 333 deFreitas, Roger DeLong, Amanda Deng, Jie O 074, Q 44 Deng, Wei Q 58 Deng, Zixin P 126, P 218, P 350, W 15 Dennie, Carole P 291, P 292 O 068, O 091 O 068, O 089, O 091, P 011 Q 68 P 069, P 306, P 358, P 366 P 192, P 193, P 248, Q 46 Eichhorn, Christian O 035 Eiriksdottir, Gudny O 061 Eitel, Charlotte Eitel, Ingo Q 19 O 098, Q 19 DeSa, Travis W 32 Ejsmont, Marta P 064 Desai, Ankit P 148 El Mozy, Wesam P 289 Q 19 EL Saiedi, Sonia P 289 Desch, Steffen Detterich, Jon O 120 El-Rewaidy, Hossam Deux, Jean-Francois P 222 Elagha, Abdalla P 085 ElBaz, Mohammed S. M. P 024 Elders, Bernadette P 162 Ellims, Andris P 077 P 354 Dey, Damini O 019, W 02 Dhakshinamurthy, Vijay Anand Dharmakumar, Rohan O 036 O 012, O 019, P 063, P 126, W 02, W 27, W 34 Di Giovine, Gabriella P 080 Elliott, Charles Di Leo, Giovanni P 114 Elliott, Perry Di Mario, Carlo P 290 Emmanuel, Sam Q 22 Endozo, Raymond Diamond, Tamara DiBella, Edward O 111, P 223, Q 60 Engblom, Henrik Engvall, Jan DiCarli, Marcelo P 226 Dick, Alexander P 291, P 292 Ennis, Daniel W 09, W 21 Enos, James Dick, Anastasia Dickerson, Jennifer Dickinson, Catherine O 132, P 335, W 22 O 060 Epstein, Frederick www.scmr.org W 26 AUTHOR INXEX D’Errico, Luigia Q 37 O 104 O 082 P 033, P 071, P 094, P 221, P 222, P 240 P 011, P 312 O 109, O 121, P 026, P 364 P 169 O 050, O 073, O 103, O 126, P 045, P 050, P 079, P 215, P 319, P 325, P 352, P 356, W 03 59 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Er, Alicia T4 Erdei, Tamas P 324, Q 26 Erhayiem, Bara P 036, P 337, Q 11 Ericsson, Elisabeth P 312 Eriksson, Jonatan O 068, O 089, O 091 Finn, J. Paul O 051, O 113, O 121, P 007, P 015, P 259, P 338, P 363, Q 59 Fioravante, Luciana Firmin, David P 313, Q 53 O 048, O 050, P 035, P 304, Q 31, Q 56, Q 60, W 17, W 19 Fischer, André O 110 Fischer, Kady P 052 Fischer, Thomas Erixon, Hanna O 089 Erlinge, David P 094, P 221, P 222 Flamm, Scott Espinoza Barillas, Maria P 362 P 263, P 297 O 037, O 097, P 266 Flett, Andrew P 008 Eteiba, Hany P 231 Flögel, Ulrich O 057 Evans, Betsy P 337 Fogel, Mark Everett, Colin O 060, P 075 Exner, Derek O 006, P 066, P 194, P 233 Ezekowitz, Justin O 049, P 073 Faber, Ingrid W 07 Foley, James Fontana, Marianna Foote, Lucy Ford, Ian O 076, P 160 Q 11 O 037, O 038, O 040, P 230, Q 67 O 014 P 231 Facchetti, Rita O 063 Forman, Christoph O 112, P 313, Q 50 Fahmy, Ahmed W 06, W 26 Fornwalt, Brandon O 010, O 032, O 076, O 083, P 241 Q 60 Forsythe, Rachael P 056 P 126 Fair, Merlin Fairbairn, Timothy P 337 Foster, Glen Falk, Volkmar P 110 Foster, John P 129 Foucar, Charles O 090 Fan, Zhanming O 002, O 070, P 128, P 278, P 355, P 361 Fan, Zhaoyang O 018, O 022, P 016, P 126, P 218, P 305, P 350, P 355, Q 49, Q 58, W 15 Farah, Victor P 138, P 247, T 12 Faranesh, Anthony P 205, P 208, P 216, Q 68, Q 69 Fox, Matthew P 177 Francis, Jane O 066, O 135, P 022, P 224, Q 38, Q 39 Franco, Veronica P 124 Francois, Christopher O 110 Farhad, Hoshang P 226 Francone, Marco Farrar, Christian O 016 Frandon, Julien Farrar, Genevieve P 154, P 186 Frank, Luba Farzad, Zohreh P 281, P 283 França Júnior, Marcondes Farzaneh-Far, Afshin Fasshauer, Martin O 001, O 131, P 135, P 311, Q 20, Q 33 O 080, O 129 Freed, Benjamin Freeman, Alexandra Fedaravicius, Augustinas P 064 French, Brent Fedson, Savitri P 107 Frieberg, Petter Feinberg, Loryn P 144 Friedrich, Matthias O 076 Frigerio, Maria Feindt, Jared Feliciano, Hélène P 027, P 258, W 23 Feng, Jiazuo O 130 Feng, Li O 105, P 185, W 24 Fenwick, Kate O 006, P 066, P 083, P 233, P 284 O 046, P 096 P 274, Q 34 O 123 W 07 Q 16, W 30 O 005 O 073, W 03 O 072 P 052, P 083, P 249, P 284 O 063, P 250 Frontera, Antonio O 127 Fu, Yun-ching P 294 Fuernau, Georg Q 19 Fuisz, Anthon P 085 Ferguson, Mark P 174 Fujii, Shinya P 253 Fernandes, Joao Filipe O 095 Fujii, Tomoki P 359 Fernandes, Juliano O 039, P 285, P 313, Q 31, Q 53 Fujiwara, Kensuke P 253 Ferranti, Joanna P 268 Fuller, Stephen P 225, Q 65 Ferrari, Victor P 280 Fung, Kenneth O 059 Ferraris, Federica P 271 Funk, Stephanie Ferreira, Pedro O 050, P 035, W 17, W 19 Ferreira, Vanessa O 035, O 066, O 104, P 022, Q 35 Ferreira Botelho, Marcos Feuchter, Patricia P 069, P 306, P 358, P 366 P 031, P 041 Field, Suzanne P 172 Figueroa, C. Alberto Q 36, Q 42 Filosa, Aldo P 295 Fine, Nowell O 006, O 078, P 066, P 083, P 194, P 233, P 234, P 284 Fink, Sarah 60 P 213 Furiasse, Nicholas Gale, Eric Galea, Nicola Gali, Ana Marta Gamberini, Maria Rita Q 64 P 001 O 016 O 046, P 096 P 340, Q 55 P 137, P 270 Gan, Li-ming O 103 Ganeshan, Balaji O 082 Gao, Fabao P 065 Gao, Hao P 009 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Gao, Song P 010 Goodarzian, Fariba Gao, Yi O 034 Gorbonosov, Michelle Gao, Yu P 007, P 363 Gorman, Joseph P 329, W 13 Garcia, Anne T3 Gorman, Robert P 329, W 13 Garcia, Julio O 096, P 360 Gorre, Donovan P 112 Garg, Pankaj P 036, P 337, Q 11 Goswami, Robi Gasparini, Gabriele Gatehouse, Peter Goto, Yoshitaka P 080 Gottbrecht, Matthew O 103 Goubergrits, Leonid O 095 Goyal, Amita P 116 Gatzoulis, Michael O 026 Goyal, Sandeep Gaur, Lasya P 169 Grabau, Jonathan P 165 Gebker, Rolf P 260 O 117 O 026, O 048, O 088, Q 17, Q 52, Q 56, Q 60, T 11, T 9, W 14 Gazzaz, Tamadhir O 033 P 076, P 110 P 070, P 087 P 210 O 010, O 083 Gralewski, Kevin P 158 Grant, Elena P 211 P 270 Gelder, David P 008 Grassedonio, Emanuele Gelfand, Eli P 144 Graves, Martin Gerbay, Antoine O 045 Greenway, Steven Q 24 Gergelé, Laurent O 041 Greenwood, John O 036, O 060, P 036, P 075, P 337, Q 11 O 013, O 053 Gregory, Thomas P 214, P 328 Gerstenblith, Gary Geva, Tal O 029, O 030, O 032, P 012 Ghadimi Mahani, Maryam P 164, P 166 Gharib, Ahmed O 005 Ghelani, Sunil Ghosh Dastidar, Amardeep Ghugre, Nilesh Giannattasio, Cristina Greiser, Andreas P 190 O 048, P 045, P 256, P 278, P 313, P 320, P 336, Q 52, Q 53, Q 56 O 029, O 030 Grenier, Justin O 011 Greve, Anders O 061 Greve, Gottfried P 349 O 007, Q 05 Grieve, Stuart P 298 Grigoratos, Chrysanthos P 310 O 063, P 250 O 046 Gibbs, J. Simon Q 22, T 2 Gilad, Assaf Greil, Gerald O 062, O 127, P 118, P 219, P 228, P 239, P 264, P 269, Q 26 Giannetta, Elisa Gieseke, Juergen W 14 O 004, P 111, Q 04 P 262 Griswold, Mark W 01 Grizzard, John O 131 Gross, David P 053 Gilbert, Kathleen P 154 Grosse-Wortmann, Lars Gilbertson, Janet O 040 Grotenhuis, Heynric Gilkeson, Robert O 132 Grothoff, Matthias O 098 Gillmore, Julian O 040 Groves, Ashley O 082 P 356 Grunseich, Karl P 207 Gucuk Ipek, Esra O 084 Gudnason, Vilmundur O 061 Guensch, Dominik P 052 Gina, Petroni Ginami, Giulia O 106, P 074, W 35 O 027, O 028, O 071, P 151, P 156, P 165, Q 24, Q 25 Q 24 Ginks, Matthew O 035 Giri, Shivraman P 069, P 225, P 232, P 366 Giuliano, Pietro P 141 Guo, xiaojuan P 299 Giunta, Nicola P 141 Gupta, Dipti P 265 GIvertz, Michael P 226 Gupta, Sanjaya P 203 Glegg, Martin P 129 Gurajala, Ram P 354 Gleva, Marye P 204 Guron, Nita P 234 Gliganic, Kathleen P 048 Gustafsson, Ronny P 184 Gloer, Karen O 120 Gutberlet, Matthias Gnanappa, Ganesh Kumar P 298 Guttman, Michael Go, Yunyun T4 Gyllenhammar, Tom O 098, Q 66 O 122, P 213 P 071, P 240, P 300 Goddu, Beth O 056, P 051, P 054, P 057, P 062, P 102, P 238, P 244, P 296 Götte, Marco P 199 Godsave, Cattleya P 228 Haaf, Philip P 036 Goldberger, Jeffrey O 090, P 001, P 078, P 095, P 101 Haage, Patrick P 093 P 315, P 327, P 332 Haberkorn, Sebastian O 057, P 105 Gona, Philimon P 130 Habibi, Mohammadali O 065 Gonzalez, Jorge O 103, O 126, P 079, P 215, P 325, P 352, P 356 Hachmann, Pauline O 116 Golshani, Shokoufeh www.scmr.org AUTHOR INXEX Gasparetto, Taisa O 120 61 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Hadamitzky, Martin O 064 Haggerty, Christopher O 032, O 076, O 083, O 115 O 001, O 033, O 131, P 311, Q 33 Helbing, Willem P 152 P 097 Haig, Caroline P 009, P 231 Helfenstein, Jeffrey Hajnal, Joseph P 177, P 180 Hembree, Elliot Hakeem, Abdul P 115, P 131, P 273 Hendrich, Eva O 064 P 281, P 283 Heng, Ee Ling O 026, Q 56, T 11 Halliday, Brian Halpenny, Darragh P 265 Halperin, Henry O 122, P 213 Hamarneh, Ashraf P 072, P 230, Q 67 Hamilton, Craig O 081 Hamilton, Jesse W 01 Hamilton, Mark P 228, P 264, P 324, Q 26 Hamlet, Sean Han, Eric Han, Fei Hengstenberg, Christian Hennemuth, Anja Hennig, Pierre Henningsson, Markus Hernandez, Gabriela Herrey, Anna T3 O 064 W 24 P 336 P 310, P 323, Q 11 O 120 O 037, O 042, O 086, O 125, P 031, P 230, Q 67 Herzka, Daniel P 213 O 095 Herzog, Bernhard O 060 O 051 Heslinga, Friso O 010, O 083 Hammel, James O 051, O 108, O 109, O 113, P 007, P 015, P 363, Q 59 Hess, Aaron Hesselstrand, Roger W 14 O 068, P 227 P 071, P 300 Han, Yiying P 032, P 146, T 4 Han, Yuchi P 055, P 280, P 329, W 13, W 37 Heydari, Bobak O 006, O 078, P 066, P 233, P 234 W 10 Heydari, Bobby O 130, P 083, P 284, Q 21 Handa, Ashok Hansen, Michael O 008, P 205, P 211, P 216, P 313, Q 14, W 08, W 12 Harden, Stephen P 008, T 5 Harrild, David O 029, O 030 Hickey, Kelsey O 032 Higgins, Angela O 101 Higgins, David O 014 Harris, Matthew P 160 Hill, Peter P 085 Harris, Tamara O 061 Hinojar, Rocio O 014 Harris, William O 130 Hirohata, Makoto P 021 Hirsch, Alan P 359 Hlavacek, Anthony P 188 Harrison, James Q 28 Hart, Emma P 228, P 264, Q 26 Hartz, Jacob P 169 Ho, Jamie P 347 Harvey, Hayley P 227 Ho, Jean O 033 Hasenfuss, Gerd O 119, P 040, P 236, P 362 Hoffmann, Pavel P 094, P 221 Hoffmann, Udo O 130 Hashimoto, Hidenobu P 318 Hofman, Mark O 088 Hassell, Mariella P 036 Hofmann, Heinrich P 258 Hausenloy, Derek P 032, P 072, P 230, Q 67 Hogrefe, Kai O 036 Hashemi, Sassan O 094, O 115, P 189 Hauser, Jakob O 092 Hauser, Thomas O 101, P 144 Holdsworth, David Holland, Steven Q 35 O 005 Hawkins, Philip O 040 Holloway, Cameron Haydock, Paul P 008 Holmes, Jeffrey P 050 Hayes, Brenda P 187 Holst, Karen P 242 Haykowsky, Mark Hays, Allison O 067, O 104, P 191, Q 35 O 009, O 049, P 073 Hombach, Vinzens Q 01 O 013, O 053 Hombach, Vinzenz P 006 Hayward, Carl P 290 Homer, Kai Hayward, Christopher O 067 Homsi, Rami O 004, O 102, P 111, P 255, P 276, P 314, Q 04 Hayward, Martin O 040 Hood, Stuart P 231 Hoogeveen, Ron P 121 He, Xueping Q 58 He, Yang P 117 He, Yi O 002, P 361 P 052 Hor, Kan P 268 Horwood, Laura O 123 He, Zhuonan Q 58 Hoshino, Tsutomu P 018 Heather, Lisa O 024 Hothi, Daljit P 157 Hedjazi Moghari, Mehdi P 012 Howard, Luke Hegde, Sanjeet Heiberg, Einar 62 Heitner, John P 154, P 186 O 023, O 072, P 033, P 043, P 094, P 184, P 221, P 222, P 245, Q 61, W 28 Howarth, Andrew Hsia, Tain-Yen Q 22 O 006, O 078, P 066, P 233, P 234, P 249, P 284, P 287, Q 21 Q 02 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X P 307, P 308 Hsu, Chi Jen P 298 Hsu, Li-Yueh O 087, P 099, P 108, P 173, Q 17 Hu, Bob P 326, Q 30, W 31 Jao, Terrence O 007, P 098, P 100 Jariwala, Nikhil O 124, P 135 Jarvis, Kelly P 170, P 232 Jasmin, Nur Hayati T9 Hu, Peng O 051, O 108, O 109, O 113, O 121, P 007, P 015, P 025, P 259, P 363, P 364, Q 59 Jayasekera, Geeshath Hu-Wang, Eileen P 017 Jenista, Elizabeth Huang, Feiqiong P 146 Jensen, Christoph Huang, Justyn O 067 Jerosch-Herold, Michael Huang, Pei-Ching P 014 Jesinger, Michael Huang, Sihong P 187 Jeuthe, Sarah Q 18 W 23 Jezzard, Peter W 10 Hullin, Roger Hundley, Gregory Hung, Yi-Hui Hussain, Tarique O 077, O 081, O 133, P 132, P 353 T4 P 190, P 330, Q 36, Q 42 Jefferies, John Jiang, Ke Jiang, Yun Jin, Ning Husser, Oliver O 064 Jing, Linyuan Hutt, David O 040 Jogiya, Roy Iantorno, Micaela O 013, O 053 P 243, P 261 O 044, O 055, P 187, P 322, Q 06, Q 08, Q 10 O 055 O 130, P 226, W 07 P 081 P 334 W 01 P 220, P 331, P 335, Q 31, W 22, W 29 O 032, O 083, P 241 P 040, P 086 Johansson, Edvin P 049 John, Anitha P 173 P 134 Ibrahim, El-Sayed O 123, P 060, P 150, W 06, W 26 Ichihara, Takashi P 087 John, Leonette P 070, P 087 Johnson, Kara Ichikawa, Yasutaka P 147 P 149 Iffrig, Elizabeth O 021 Johnson, Kenneth Iles, Leah P 077 Johnson, Kevin O 110 Illapani, Venkata Sita Priyanka P 360 Johnson, Martin P 147 Imran, Muhammad O 067 Johnston, Peter Ingle, R Reeve P 326, Q 30, W 31 P 262 P 326, Q 30, W 31 Jolly, Marie-Pierre O 081, P 045, Q 16 Iqbal, Mohammed O 059 Jones, Alexander O 092 Isaaz, Karl O 045 Jones, Daniel O 059 Iserin, Laurence P 153 Jordan, Jennifer O 081 Ishida, Masaki P 070, P 087 Jovanovic, Ana Ishimori, Mariko W 25 Ishimura, Rieko P 018 Judd, Robert Ito, Masaaki P 070 Jung, Denna Ittermann, Bernd W 14 Ivanov, Alexander O 001, O 033, P 311, Q 07 Jabbour, Andrew O 067, P 191, Q 56 Juan, Yu-Hsiang Junqueira, Flavia Jögi, Jonas Q 43 P 014 O 001, O 044, O 131, P 311, Q 06, Q 33 O 120 O 117, P 285 Q 23 Kabra, Ashish P 260 Jablonowski, Robert P 033, P 221 Kabus, Sven P 032 Jackowski, Marcel O 052, P 013 Kachenoura, Nadjia P 254 Jacobs, Matthew O 087, Q 17 Kadish, Alan P 078 Jacoby, Christoph O 057 Kadiyala, Madhavi P 048 Jacot, Jeffrey P 163 Kaine, Joshua P 241 Kainz, Bernhard P 180 Jacquier, Alexis Jaeggi, Edgar Jafarkhani, Hamid Jagarlamudi, Ashadevi P 221, P 274, Q 34 O 071, P 151, P 156 Kallianos, Kimberly P 351 Kamper, Lars Q 54 P 093 O 134 Kanagala, Prathap Q 09 Jaijee, Shareen Q 22, T 2 Kancharla, Krishna P 085 James, Nielsen P 122 Kancherla, Kalyan P 085 James, Stephanie P 252 Kandolf, Reinhard O 098 James, Wai-Yee P 134 Kannan, Rajesh P 179 Janardhanan, Rajesh P 148 Kansal, Preeti P 345 Jang, Jihye Janich, Martin Jankauskas, Antanas P 019, P 057, P 238, P 244, Q 41 O 054, P 267 P 064 Kanski, Mikael Kantasis, Georgios Kanter, Kirk www.scmr.org AUTHOR INXEX Hsiao, Albert P 071, Q 23, Q 61 P 042, W 28 O 115 63 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Kantor, Paul Q 24 Kappanayil, Mahesh Kar, Julia P 179 W 11 Karamani, Vasiliki P 093 Karamitsos, Theodoros Karim, Rashid Karlsson, Lars Kim, Han O 001, O 044, O 055, O 131, P 104, P 187, P 311, P 322, Q 06, Q 08, Q 10, Q 33 Kim, Heewon O 074 Q 28 Kim, Jung-Sun O 022 O 089 Kim, Kyung-Jin P 288 Q 69 Kim, Moon Young Karunaharamoorthy, Achudhan Q 57 Kim, Raymond Kashem, Abyaad P 354 Q 41 Kato, Atsuko O 028 Kato, Shingo P 102, P 238, P 244, Q 41, Q 47 Kato, Sojuro P 021 Katz, Marc O 033 Kaur, Gagandeep P 149 Kawaji, Keigo P 112, P 317, P 321 Kawakami, Taketo P 021 Kawel-Boehm, Nadine O 077 Kay, Jennifer P 352, P 356 Kaye, David P 077 Keegan, Jennifer P 304 Keeley, Ellen O 103 Keenan, Ellen O 029 Keenan, Katy W 14 Keith, Matthew P 204 Kelle, Sebastian P 076, P 110 Keller, Eric P 346, Q 16 Keller, Marc Kellman, Peter P 132, P 353 Kim, Jooho O 104, P 224 Karmarkar, Parag Karuppasamy, Karunakaravel P 097 Kim, Jang-Young P 160 O 008, O 026, O 039, O 042, O 061, P 120, P 211, P 230, P 237, P 246, P 256, P 277, P 282, P 293, P 313, Q 14, Q 17, Q 67, W 08, W 12, W 14 P 119, P 342 O 001, O 044, O 055, O 131, P 104, P 187, P 311, P 322, Q 06, Q 08, Q 10, Q 33 Kim, Steven Q 68 Kim, Sung Mok P 119, P 342 Kim, Young Jin O 022 King, Jordan P 149 Kingdom, John P 151 Kingdom, Theo P 151 Kinney, Aaron P 176 Kirby, Kevin O 048 Kissinger, Kraig O 056, P 051, P 054, P 057, P 062, P 102, P 144, P 238, P 244, P 296 Kitagawa, Kakuya P 070, P 087 Kitzman, Dalane O 009 Klein, Christoph P 076 Klem, Igor O 001, O 131, P 104, P 311, P 322, Q 33 Klingel, Karin O 098 Kluenker, Folke O 102, P 255 Klug, Gert P 094 Knowlton, Joshua P 309 Kobashigawa, Jon O 018 Kober, Frank P 221 Kocaturk, Ozgur P 208, P 216, Q 69 Koenigkam Santos, Marcel Kelly, Catherine P 224 Koerner, Danielle Kelly, Damian O 036 Koh, Angela Kelm, Malte P 105 Koh, Woon Puay Kenny, Cliona P 252 Koktzoglou, Ioannis Keogh, Anne O 067 Kolandaivelu, Aravindan Kolipaka, Arunark P 340, Q 55 W 11 P 146 P 146 P 069, P 306, P 358, P 366 P 213 P 029, P 360 Kesavadas, Thenkurussi T 13 Kestenbaum, Samantha P 239 Komori, Yoshiaki Keymel, Stefanie P 105 Konecny, Filip O 095 Khalique, Zohya W 19 Kong, Lingyan P 316 Q 09 Konkle, Justin P 326 Khan, Jamal Q 50 Khanji, Mohammed P 047, P 134 Koops, Andreas P 106 Kharabish, Ahmed P 251, P 344 Kotlyar, Eugene O 067 Kheradvar, Arash Khettab, Hakim Kheyfets, Vitaly Kholmovski, Eugene Khoo, Jeffrey Kido, Teruhito Kido, Tomoyuki Kilner, Philip Kim, Daniel Kim, Hae Jin 64 P 351 Koul, Sasha P 020 Kovács, Sándor P 004 Kowalik, Grzegorz O 128, P 196 Kowallick, Johannes P 094, P 222 O 023 O 069, P 157 O 080, O 119, P 039, P 040, P 236, P 362 Kozerke, Sebastian P 061, P 086, P 302, Q 18 P 084, P 109 Kozor, Rebecca O 037, O 082, P 140, Q 48 P 084, P 109, Q 50 Krahn, Philippa P 206 O 088, P 152, W 19 Kraitchman, Dara P 262 O 036 O 111 P 119, P 342 Kramer, Christopher Krempien, Robert O 103, O 126, P 079, P 215, P 325, P 352, P 356 P 257 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X P 262 Lawton, Chris O 127, P 219, P 269, P 324, T 1, T 8 Krishnamurthy, Rajesh P 163, P 167 Le, Thu Thao P 032, P 146 Krishnamurthy, Ramkumar P 163, P 167 Le Goff, Caroline O 041 Krolikowski, Mary P 176 Lebel, Julie Krupinski, Elizabeth P 148 Lederman, Robert Kruse, Jane P 346 Ledoux, Jean-Baptiste Krüwel, Thomas O 129 Lee, Daniel Kubota, Takeyukii P 253 Lee, Jongmin Kudielka, Guido P 267 Lee, Sang Eun P 218, W 15 Kuehl, Karen P 173 Lee, Sang-Chol P 119 O 025, O 095, Q 18 Lee, Seung-Pyo P 288 Kuehne, Titus Kuetting, Daniel Kuhara, Shigehide Kulshrestha, Kevin O 004, O 102, P 111, P 255, P 314, Q 04 P 021 W 11 P 052 P 205, P 208, P 216, Q 68, Q 69 P 258 O 090, P 001, P 078, P 095, P 101, Q 13, W 38 P 277 Lee, Simon P 122 Lelieveldt, Boudewijn P. P 024 Lensing, Shelly P 115, P 192, P 193, P 248, Q 46 Kumar, Vidhya P 220 Leon Jimenez, Javier Kumarasinghe, Gayathri P 191 Leong, Bao Ru Kumita, Shinichiro P 318 Lepor, Norman Kuruvilla, Sujith O 103 Leung, Steve P 081, P 241 O 095, O 119, P 040, P 171, P 182, P 236 Levelt, Eylem O 035, P 224 Kutty, Shelby Kvernby, Sofia Kwon, Deborah Kwong, Raymond Kydd, Anna Labedi, Mohamed Labib, Dina Ladouceur, Magalie LaFountain, Richard P 011 Levine, Jonathan P 297 Lewis, Andrew O 130, P 212, P 226, W 04 O 125 P 149 O 131, Q 08, Q 33 P 153 W 39 Lai, Wyman P 183 Lakhman, Yuliya P 265 Lalande, Alain P 274, Q 34 Lam, Adrian O 020 Lam, Willis P 339 Lamata, Pablo Lamb, Hildo Lamba, Nathan O 119, P 040 P 067 Q 31 Landes, Sofy P 082 Lang, Chim O 036 Lang, Roberto P 107, P 112, P 171, P 182, P 317, P 321, P 343 Langman, Craig P 017 Lantin-Hermoso, Regina P 163 Lapinskas, Tomas P 064 Lario, Chiara Valentina Larsen, Terje P 271 P 094, P 349 Larson, Peder Q 30 Lathra Mathew, George Q 31 Latson, Larry P 175, P 185 Latus, Heiner O 116 Latuscynski, Konrad Launer, Lenore Laurent, François Laurent, Stéphane Q 66 O 061 P 197, P 198, P 201 P 020 Lavalle, Steven T 13 Lawless, Claire P 129 P 097 P 155 O 024, Q 32 Li, Christine Li, Debiao P 343 P 032, T 4 O 033 O 003, O 012, O 018, O 019, O 022, O 043, O 070, O 107, P 016, P 037, P 082, P 126, P 218, P 350, P 355, P 361, Q 58, Q 62, W 02, W 15, W 25 Li, Linqing Li, Rongmao W 10 P 023 Li, Shuo P 010, P 023 Li, Wei P 069, P 306 Li, Xiaohu Li, Yan P 226 P 352, P 356 Liang, Jianke Q 58 Liao, Ronglih O 016 Liao, Ying-xiang P 294 Likhite, Devavrat P 223 Lim, Jessie Mei Lim, Ruth Lim, Tiong Keng Lima, Joao Lima da Cruz, Gastao Lin, Gigin Lin, Kai P 151, P 156 O 105 T4 O 065, O 077, O 133, P 132, P 353, P 359 P 323 P 014 P 005, P 017, P 038, Q 16, W 30, W 32 Lin, Linda P 298 Lin, Lu P 316 Lin, Yang P 334 Lindsay, Mitchell P 231 Ling, Lieng P 347 Lisicki, Craig P 354 Lisko, John O 100, P 068, Q 27 Litt, Harold P 152, W 37 Litwin, Sheldon Liu, Alexander Liu, Chia-Ying Liu, Hong www.scmr.org AUTHOR INXEX Krimins, Rebecca P 225, Q 65 O 035, O 066, P 022 O 077, P 132, P 353, O 133 O 031, P 034, P 139, P 159, P 272 65 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Liu, Jennifer P 265 Mahapatra, Srijoy Q 68 Liu, Jiayi P 355 Mahmod, Masliza P 224, Q 35 P 299 Mahnkopf, Christian Liu, Min Liu, Shizhen P 210, P 260 Liu, Xin P 305, Q 49, Q 58 Liu, Ying P 320 Liu, Yingmin W 22 Mahrous, Ahmed P 202 P 231 Maintz, David W 09, W 21 Malaisrie, S P 346, P 365 Malamateniou, Christina P 177, P 180 Liu, Yuan-Chang O 133 Malkin, Christopher Liuba, Petru O 072 Malley, Tamir Lloyd, David P 177, P 180 Mandawat, Aditya O 001 Lloyd, Michael O 020 Mandawat, Anant O 001 Lo, Wei-Ching W 01 Mandry, Damien Lof, John O 095 Manghat, Nathan Loggetto, Sandra P 285 Mangion, Kenneth Lohezic, Maelene P 180 Mangold, Stefanie P 225, Q 65 P 089, P 090, P 114 O 037, O 042, O 082, O 086, O 125, P 002, P 031, P 041, P 140, P 230, Q 37, Q 48, Q 67 Longmore, Ryan P 203 Manisty, Charlotte Looft, Yana O 099 Manlhiot, Cedric Lopes, Luis Q 37 Lopes-Cendes, Iscia W 07 Lombardi, Massimo Lopez, David P 356 Lotz, Joachim O 080, O 119, O 129, P 039, P 040, P 236, P 362 Loudon, Margaret P 227, P 341 Lowery, Ray P 166 Lu, Jimmy P 164, P 166 Lu, Minjie P 277, P 282, P 293 Luecke, Christian O 098, Q 66 P 347 O 060 Maret, Eva P 312 Marieb, Mark P 207 Marini, Claudia P 022 Markenroth Bloch, Karin O 088 Markham, Larry P 279 P 027 Luining, Wietske Q 25 Lumish, Heidi O 130 Maron, Martin Lund, Gunnar O 099, P 092, P 106, P 127 Lydell, Carmen O 034, O 090, O 096, P 001, P 005, P 017, P 038, P 095, P 101, P 116, P 155, P 170, P 232, P 345, P 346, P 357, P 360, P 365, Q 13, Q 44, Q 57, W 30, W 32 Marrouche, Nassir P 238 O 128, P 149, P 196, P 200 P 229, P 237, P 246 Martinez, Alberto W 07 P 009 Martinoff, Stefan O 064 O 031, P 034, P 139, P 159, P 272 O 098, Q 66 O 006, O 078, P 066, P 233, P 234, P 249, P 287, Q 21 Marx, Christian W 35 Masterson, Conor P 176 P 290 Masuoka, Keiko Lysaker, Kirsti P 349 Matasar, Matthew Lüthje, Lars P 362 Mathew, George W 01 O 004, O 102, P 111, P 255, Q 04 Masci, Pier Giorgio Lyon, Alexander Ma, Dan O 070, Q 62 Maredia, Neil Lugand, Emeline Lurz, Philipp Q 25 Marbán, Eduardo Markl, Michael Luo, Yong P 009, P 129 Marchesseau, Stephanie O 102, P 111, P 255, P 276, O 004, P 314, Q 04 Luo, Xiaoyu O 130 P 228, P 264, Q 26, T 8 Manning, Warren O 056, O 075, O 101, P 051, P 054, P 057, P 062, P 102, P 130, P 143, P 144, P 238, P 244, P 296, Q 41, Q 47 Luetkens, Julian Lundin, Magnus P 337 O 048, P 235, Q 52 Q 40 P 265 Q 52, T 11 Mathew, Jacob P 261 Ma, Xiaohai P 128, P 278 Mathur, Anthony O 059 Macdonald, Peter O 067, P 191 Mathur, Sujeev Macera, Annalisa P 271 Macgowan, Christopher O 071, P 030, P 044, P 151, P 156 Maciel, Benedito P 340, Q 55 Madathil, Sujana P 156 Madden, Marie Madyoon, Hooman Maestrini, Viviana Maffessanti, Francesco Q 42 Matich, Susanne O 120 Mattesi, Giulia O 062 Matthews, Julianne Q 27 Mavrogeni, Sophie P 249 W 13 Mayosi, Bongani Q 29 P 097 Mazal, Jonathan P 205, Q 68, Q 69 O 038, O 042, O 086 Mazhari, Nona O 116 P 182 Mazo, Paulo Magier, Adam P 273 Mazumder, Ria P 029, P 360 Magrath, Patrick O 121 Mazur, Wojciech O 132, P 273 66 P 313, Q 53 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X O 132 McAlindon, Elisa O 127, P 219 McCallum, Chloe O 024 McCann, Gerry McCarthy, Beth McCarthy, Patrick O 036, P 075, Q 09 Mikolich, J. Ronald Milazzo, Angela O 100, P 068, P 195, Q 27 O 063, P 250 Millasseau, Sandrine Miller, Christopher P 020 P 099, Q 43 P 220, Q 12 Miller, Jack O 024 P 346, P 365 Miller, Owen P 177 McClelland, Robyn O 077 Miller, Steven P 156 McConnell, Joseph O 130 Millet, Grégoire O 041 McCrindle, Brian Q 25 Min, James O 132 McCrohon, Jane O 067, P 191 Mionic, Marijana P 258 McCulloch, Andrew P 154, P 186 Miquel, Marc P 047 McDiarmid, Adam P 337, Q 11 Miquerol, Lucile Q 34 Q 37 McEntegart, Margaret P 231 Mirabel, Mariana McGann, Christopher P 223 Mirza, Omer McGee, Katherine P 345 Mita, Mitsuyoshi P 253 McGill, Laura-Ann P 035, W 19 Mitchell, Kevin P 204 Q 20 McGraw, Sloane Q 20 Mitlacher, Marcel P 202 McIntyre, Bethannie Q 26 Miyagawa, Masao P 084, P 109 P 356 Miyamoto, Takashi McKenzie, Robyn McLeod, Kristin O 118, Q 02 Miyazaki, Mitsue McMahon, Michael P 262 Mochizuki, Teruhito McManus, David P 130 Moffat, Kirsten McNeal, Gary McQuaker, Jacqueline P 160, P 189 Q 21 O 067, P 191 O 033 Mohammed, Nazia P 129 P 298 Mohammed, Shahid Mediratta, Anuj P 182 Mohiddin, Saidi Medrano-Gracia, Pau P 103 Moir, Stuart Medvedofsky, Diego P 343 Mojsejenko, Dimitri Mehra, Vishal P 099 Mongeon, François-Pierre Mehta, Bhairav W 01 Mekkaoui, Choukri Meloni, Antonella Menacho Medina, Katia Menicanti, Lorenzo Menini, Anne Menon, Prahlad Merchant, Naeem O 003, O 043, P 082, P 126 Metzler, Bernhard P 354 P 140 P 090 O 110, P 267 P 046 O 006, O 078, P 234, P 287, Q 21 O 038, O 042, O 086 W 05 O 025, P 110, Q 18 W 23 P 094, P 221 P 079, P 319, P 325, P 352, P 356 Meyer, David O 102 Michelakis, Evangelos Michels, Guido Mielniczuk, Lisa Q 63 O 049, P 073 W 09, W 21 P 291, P 292 Mikami, Yoko O 006, O 078, P 066, P 194, P 233, P 234, P 249, P 287, Q 21 Mikolich, Brandon P 080 O 026, O 038, O 039, O 042, O 065, O 077, O 086, O 125, P 031, P 140, P 230, Q 43, Q 67, O 037, O 040, O 082, P 002, P 041, P 072, Q 37, Q 48, W 14 Meyer, Craig Meyer, Hannah Monti, Lorenzo P 226 P 197, P 198, P 201 Moon, James P 077 Metrich, Mélanie Montaudon, Michel P 137, P 141, P 270, P 295 P 048 Messroghli, Daniel Q 51 O 032, O 076, O 083 Moon, Eunice Meredith, Ian Messner, Nadja W 13 O 065, P 031, P 041 O 052, P 013 Merchant, Tazim Merghani, Ahmed P 084, P 109, Q 50 Mohamed, Ambreen Medi, Caroline Mehta, Puja P 253 P 018, P 348 O 100, P 068, P 195, Q 27 Moore, Richard O 013, O 053 Moore, Ryan P 243, P 261 Moosa, Sulaiman Mor-Avi, Victor Morcos, Michael Mordi, Ify Morgenstern, Daniel Moriarty, John Moroni, Francesco Morris, Alan Morton, Geraint Mosca, Ralph Motwani, Manish Q 29 P 107, P 182, P 317, P 343 P 152 P 231 O 100, P 068, P 195 P 338 P 250 P 149, P 200 P 040 P 175, P 185 O 003, O 060, P 082 Moulin, Kévin O 041, W 16 Mousseaux, Elie P 020, P 153 Muehlberg, Fabian Q 64 Mueller, Anna-Katharina P 336 Mueller, Edgar P 301 www.scmr.org AUTHOR INXEX Mazzaferri, Ernest 67 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X O 099, P 092 Nazir, Sheraz Q 09 Mukai, Kanae Q 54 Nehme, Ziad P 077 Mukhopadhyay, Anirban W 27 Neilan, Tomas P 226, W 07 T3 Neiman, David P 037 Muellerleile, Kai Mumford, Amy Muniz, Juan Carlos P 181 Neizel-Wittke, Mirja Murakami, Akimichi P 253 Nelson, Michael O 003, O 043, P 082, P 126 O 136 Neri, Maria Giovanna P 137, P 141, P 270, P 295 Murali, Srinivas Murphy, Ian P 358, W 18 Nerlerkar, Nitesh Q 51 Murphy, Theodore P 252 Nethononda, Richard Murtagh, Gillian P 155 Neubauer, Stefan Murthy, Venkatesh Musa, Tarique Muscogiuri, Giuseppe Muthupillai, Raja Muthurangu, Vivek O 135 P 036, P 337, Q 11 P 225, Q 65 O 085, O 093, P 263, P 333 Nezafat, Maryam O 069, O 092, P 157, P 178 Nezafat, Reza P 208 Muto, Makoto Q 40 Mutoh, Makoto P 253 Myerson, Saul O 068, P 227, P 341, Q 35 Månsson, Sven P 049 Müllerleile, Kai P 127 Münch, Frédéric O 025 Münch, Julia P 127 Nabi, Faisal O 001, O 131, P 121, P 311, Q 33 Nadar, Mariappan P 313 Nadjiri, Jonathan O 064 Naehle, Claas Nagata, Motonori Nagel, Eike Nairooz, Ramez Nakajima, Takatomo Nakamori, Shiro Nakamura, Masashi Nakano, Yosuke Nambi, Vijay Napan, Sirikarn P 276 P 070, P 087 O 014, P 040, P 310 P 115 P 253, Q 40 P 070 P 084, P 109, Q 50 P 253, Q 40 P 121 T7 Narang, Akhil P 107 Narayan, Hari P 160 Narayan, Srinivas P 190 Nardi, Barbara P 080 Naresh, Nivedita P 050 Narous, Mariam P 194 Narula, Dhiraj P 078 Nash, Martyn O 017 Nasiraei-Moghaddam, Abbas Nasis, Arthur Nasser, Sarah P 113, P 315, P 327, P 332 O 082 P 076, P 110 Natsuaki, Yutaka P 322 Natsume, Takahiro P 087 Nauffal, Victor P 359 Nayak, Krishna Nazarian, Saman Nazemoroaya, Azadeh 68 O 007, O 108, P 098, P 100 O 065, O 084 P 113 Q 35 O 024, O 035, O 066, O 068, O 104, O 135, P 022, P 035, P 224, P 227, P 341, Q 32, Q 35, Q 38, Q 39 Newby, David Newsome, Simon Mutlu, Senol P 105 P 056 P 235, P 281, P 283 P 019, Q 11 O 056, P 051, P 054, P 057, P 062, P 102, P 238, P 244, Q 41, W 14 Ng, Jason O 090, P 001, P 095, P 101 Ng, Justin P 095, P 101 Ngamkasem, Hataichanok Ngo, Long Nguyen, Christopher Nguyen, Kim-Lien Nickander, Jannike Nicoloff, Nicola O 039 P 051, P 054, P 057, P 102 O 018, O 022, O 070, P 037, P 218, Q 62, W 15 O 113, P 025, P 259 P 245 P 068, P 195 Nielles-Vallespin, Sonia O 008, O 050, P 035, Q 14, W 08, W 12, W 17, W 19 Nieman, Koen Nightingale, Angus Nijveldt, Robin P 307, P 308 P 118, P 228, P 239, P 264, Q 26 O 088, P 036 Nitatori, Toshiaki P 018 Nixon, Jane O 060 Noda, Chikara Noel, Cory Nordin, Sabrina P 132, P 353, P 359 P 163, P 167 O 039, P 002, Q 48 Nordlund, David P 094 Nordmeyer, Sarah O 025 Norris, Stuart P 103 Nowicki, Stefan P 129 Nozohoor, Shahab P 184 Ntsekhe, Mpiko Ntsinjana, Hopewell Ntusi, Ntobeko Nutting, Arni Nyktari, Evangelia Nyns, Emile Nystrom, Michelle O h-Ici, Darach O’Brien, Kendall O’Donnell, Christopher Q 29 Q 02 O 104, Q 29, Q 35 P 188 Q 56 Q 24 P 326, W 31 Q 18 P 211 P 130, P 143 O’Dwyer, Eoin O 104 O’Halloran, T. P 144 O’Hanlon, Rory P 252 O’Neill, Mark O’Regan, Declan Q 28 T 2, Q 22, Q 63 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X O’Rourke, Noelle P 129 Parker, Scott Obara, Makoto P 318 Parks, W. James O 094, O 115 P 172, P 279 Q 66 Parra, David Obianyo, Chinwe Q 37 Pasque, Michael Odille, Freddy P 267 Patel, Amit P 084, P 109 Patel, Hitesh Ogele, Emmanuel P 168 Patel, Mehul Ogimoto, Akiyoshi P 084, P 109 Ohyama, Yoshiaki O 133, P 132, P 353 Ogawa, Ryo Okene, Erica Oksuz, Ilkay Patel, Mita Patel, Vimal W 11 P 107, P 112, P 171, P 182, P 317, P 321, P 343 P 290 P 277 P 107, P 112, P 321 Q 37 O 020 Paterson, Ian O 009, O 049, P 073, Q 03 W 27, W 34 Paton, Julian P 228, P 264, Q 26 Oldman, James O 125 Patten, Monica P 127 Oldroyd, Keith P 231 Paul, Erin P 183 Oliva, Jose P 145 Paul, James Olivieri, Laura P 169, P 173, P 211 Omens, Jeff P 154, P 186 Oral, Hakan O 123 Paul, Jan Paul, Thomas O 119 Pauly, John P 217 P 224 Ordovas, Karen Q 54 Pavlides, Michael Ormerod, Oliver P 227 Peacock, Andrew Ormiston, John P 103 Pednekar, Amol P 186 Pedretti, Stefano Ortiz, AK Oshinski, John O 020, O 021, P 214, P 328 P 129 P 006, Q 01 Pedrizzetti, Gianni P 147 O 085, O 093, P 263, P 333 O 063 Q 61 W 06 Pedrotti, Patrizia O 063, P 250 Ostenfeld, Ellen P 043, P 300 Peebles, Charles P 008, T 5 Oswal, Abhishek P 341 Osman, Nael Pellegrini, Costanza Pellerito, Raffaele Otazo, Ricardo O 105, W 24 Otton, James O 067, P 191 Pena, Elena Oudit, Gavin O 049, P 073 Pennec, Xavier Ouyang, Cheng P 015 Overall, William P 326, Q 30, W 31 Ozsoy, Cagla Pacaud, Daniele Pacchia, Christina Pagano, Joseph Pahlm, Ulrika Paiman, Elisabeth Palazzuoli, Alberto Palkowski, Gregori Pennell, Dudley P 284 Pepper, John P 149 Perazzolo Marra, Martina O 062 Perera, Divaka P 086 P 043 Perin, Emerson P 359 P 067 Peritore, Angelica P 250 P 239 Pernow, John P 222 Q 29 Perry, James P 154, P 186 O 009, O 049, P 073, Q 03 Peters, Brigitte Palumbo, Pierpaolo P 096 Peters, Dana Pan, Wei P 163 Petersen, Steffen P 115, P 131, P 192, P 193, P 248, Q 46 Pang, Jianing O 002, O 018, O 022, O 107, P 037, P 361 Pang, Wenjie W 14 Parekh, Keyur Parikh, Paras Q 02 O 048, P 035, P 235, P 281, P 283, P 290, Q 31, Q 52, Q 56, T 11, T 9, W 17, W 19 Pepe, Alessia P 049 Pantaleon, Clemence P 271 P 291, P 292 P 208 Palmér, Malin Pandey, Tarun O 064 O 047 Q 44 P 095, P 101 Petrie, Mark Petrini, Marcello Petrose, Lia Piccini, Davide Piechnik, Stefan Pierce, Iain P 137, P 141, P 270, P 295 Q 56 O 116 P 207, P 209 O 065, O 077, P 031, P 041, P 047, P 134 P 231 P 089, P 114 O 053 O 105, O 106, P 056, P 074, P 185, P 188, W 23 O 039, O 066, O 104, P 022 O 048, P 304 Park, Hyo Eun P 288 Piersson, Albert T 10 Park, Jin Joo P 288 Pieske, Burkert P 076, P 110 Park, Jun-Bean P 288 Pilla, James P 342 Pinto, Gustavo P 285 Pitcher, Alex P 227 Pitrolo, Lorella P 295 Park, Sung-Ji Parker, Michele O 044, O 055, P 104, P 187, P 311, P 322, Q 06, Q 08, Q 10, Q 33 www.scmr.org AUTHOR INXEX Oberueck, Christian O 121 P 055, W 13 69 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Pizarro, Carmen P 276 Plein, Sven O 060, P 036, P 075, P 086, P 337, Q 11, Q 15 P 009, P 129, P 147, P 231 Radunski, Ulf O 099, P 092 Plodkowski, Andrew P 265 Rafiq, Isma Q 36, Q 42 Plotnik, Adam P 338 Ragin, Ann O 034 Pofi, Riccardo O 046 Rahsepar, Amir P 116 Pohost, Gerald P 097 Raina, Sameer P 115 Pollock, Eks P 124 Rajagopalan, Archa Pollock, Sam P 158 Rajappan, Kim Polsani, Venkateshwar Pontana, Francois Pontnau, Florence P 121, P 210, P 260 Rajpurohit, Naveen P 153 Ramadan, Ahmed P 206, P 303 Ramamurthy, Senthil Pop-Busui, Rodica P 060, P 150 Raman, Subha V. P 297 Porayette, Prashob Porter, John Positano, Vincenzo Q 21 O 035 Rajewska-Tabor, Justyna P 339 Pop, Mihaela Popovic, Zoran W 20 P 210, P 260 P 344 O 094, P 189 O 132, P 124, P 142, P 220, P 275, P 335, Q 12, Q 31, T 3, W 22 P 151, P 156 Ramanan, Venkat O 039, O 069 Ramirez de Arellano, Ignacio Rodríguez P 137, P 141, P 270, P 295 Ramlall, Manish O 007, P 206, Q 05 W 33 P 072, P 230, Q 67 Post, Wendy O 133 Ramos, Nadine Pothineni, Naga Venkata K P 115 Rangarajan, Vibhav Pottala, James O 130 Range, Felix P 105 W 22, W 29 Ranjan, Ravi O 128, P 196 Potter, Lee Powell, Alexander L. Powell, Andrew Prasad, Sanjay P 357 O 029, O 030, O 032, P 012 O 005 P 135, Q 20 Rao, Parachuri P 046 Rapacchi, Stanislas O 113 O 010, O 083 Raphael, Claire O 048, Q 52, Q 56 O 048, O 067, P 235, P 281, P 283, P 290, P 339, Q 52, Q 56, T 11, O 050 Rasche, Volker P 006, Q 01 Powell, David Prato, Frank O 019, W 02 Rashid, Shams P 025 Rastin, Sanaz O 025 Prieto, Claudia P 323 Ratcliffe, Laura Printz, Beth P 186 Rathod, Rahul Prothmann, Marcel P 256, P 336, Q 64, W 14, W 36 Ratnayaka, Kanishka P 228, P 264, Q 26 O 029, O 030 P 211, P 216, Q 68, Q 69 Pucheux, Julien O 047 Rattan, Mantosh Pulini, Stefano P 141 Rauhalammi, Samuli P 231 Pun, Shawn P 265 Rave-Fränk, Margret O 129 Puntmann, Valentina O 014, O 067 Rayarao, Geetha Puranik, Raj P 298 Rayner, Jennifer Purini, Maria Cristina P 285 Razavi, Reza Pursnani, Amit P 069, P 366 Reant, Patricia P 161, P 177, P 180 P 261 P 138, P 247, T 12, T 6, T 7 O 135, Q 35, Q 38, Q 39 P 161, P 177, P 180, Q 15, Q 28 O 037, P 230, Q 37, Q 67 Recht, Hannah Q 13 W 20 Reddy, Sahadev P 145 Qazi, Saadia P 143 Redheuil, Alban P 132, P 254, P 353 Qi, Shun P 320 Redwood, Simon Pushparajah, Kuberan Pyda, Magorzata Qi, Xiuling Qian, Zhen Qiu, Bensheng Quarta, Antonella Quarto, Cesare Quattrocchi, Giuseppina Quellhorst, Laura Quinlan, Marina Q 05 Reed, Galen P 210, P 260 Reemtsen, Brian P 305, Q 49 Reese, Timothy P 086 P 326, Q 30, W 31 P 259 O 052, P 013 P 270 Rehwald, Wolfgang O 001, O 044, O 055, P 322, Q 06, Q 08, Q 10, Q 65 Q 56 Reichek, Nathaniel O 079, P 048 P 250 W 21 Q 22, T 2 Reid, Anna Reinstadler, Sebastian Renne, Stefania Q 43 Q 19 P 295 Quinn, Rachel P 169 Resta, Maria Chiara P 270 R. Avendi, M. P 351 Restrepo, Maria O 115 O 124 Revstedt, Johan O 072 Rabbat, Mark Radermacher, Michael 70 Radjenovic, Aleksandra P 006, Q 01 Rich, Adam W 22 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X O 024, O 135, P 224, P 227, Q 32, Q 35, Q 38, Q 39 Riesenkampff, Eugenie O 027, O 028, Q 25 Righetti, Irene W 07 Rigolet, Aude P 254 Rigsby, Cynthia O 074, O 096, P 170, Q 44 Rimoldi, Ornella O 063 Ripley, David P 036, P 075, P 337, Q 11 Ritter, Christian O 129 Robinson, Joshua O 074, O 096, P 170 Robson, Matthew O 066, P 035, Q 62, W 10 Rochitte, Carlos P 335, W 22 Saini, Brahmdeep Sallee, Denver O 094, O 115 P 130 Salusky, Isidro P 259 Salvatori, Cristina P 141, P 270 Samar, Huma P 136, T 6 Samineni, Swetha O 088 P 224 Samnøy, Stig F. Rogers, Toby O 103, O 126, P 028, P 050, P 079, P 319, P 325, P 352, P 356, W 14 Salton, Carol Rodgers, Chris Roest, Arno P 197, P 198, P 201 Salerno, Michael Rodenburg, Manouk O 062, O 127, P 118, P 219, P 228, P 239, P 264, P 269, Q 26, T 1, T 8 P 070, P 087 Salel, Marjorie Sammut, Eva Rodrigues, Jonathan P 151, P 156 Sakuma, Hajime P 085 P 086, Q 15 P 349 Samuels, Petronella Q 29 Samyn, Margaret P 176 P 024, P 162 Sancaktar, Orhan Q 45 P 205, P 216, Q 68, Q 69 Sandberg, Sarah P 204 O 063, P 250 Sandhu, Vaneet W 25 Rohan, Stephen P 264 Sandri, Marcus O 098, Q 66 Romano, Simone P 135 Sanghvi, Mihir P 031 Romeo, Maria Antonietta P 137 Sankaralingham, Marimuthu P 129 Roghi, Alberto Rommel, Karl-Philipp Q 66 Santelli, Claudio Roos-Hesselink, Jolien P 307, P 308 Santos, Juan Rose, Michael O 096, P 170 Sardanelli, Francesco Rosen, Stuart P 290 Rosmini, Stefania O 038, O 040, O 042, O 086, P 002, P 230, Q 67 Sarikouch, Samir Saru, Raluca P 302 P 326, Q 30, W 31 P 089, P 114 O 116 P 307, P 308 Ross, Joanne O 067 Sasaki, Jun Ross, Patrick O 120 Sasaki, Nao P 181 W 23 Satou, Gary O 113, P 259 Rotman, Samuel Rottbauer, Wolfgang O 058, P 006, P 058, P 059, Q 01 Satriano, Alessandro Roubille, François P 052 Sattar, Naveed Roujol, Sébastien P 019, P 238, P 244, Q 41 Saudek, David Roux, Charles Rowin, Ethan Roy, Christopher Rubenstein, Jason Ruden, Emily Rudolph, André Rueckert, Daniel Ruijsink, Bram Ruiz-Cabello Osuna, Jesús María P 254 Scandling, Debbie P 226 Scardino, Claudia P 030, P 044 Q 45 P 142 P 256, Q 64 Q 63 P 161, P 330, Q 36 W 33 Scatteia, Alessandra Schaarschmidt, Frank Schad, Lothar Schaechter, Andi Schapira, Jay Scheiderer, Kelly Schelbert, Erik P 181 O 006, O 078, P 066, P 083, P 233, P 234, P 284 P 129, P 231 P 176 O 132, P 335, Q 12, W 22, W 39 P 080 O 062, P 118, P 219, P 269 W 09, W 21 W 05 P 078 W 25 T3 P 120, O 061, O 132, P 133 Rutherford, Mary P 177, P 180 Schenke, William Q 68, Q 69 Rutz, Tobias O 106, P 074 Schievano, Silvia O 118, Q 02 RV, Leena P 286 Schild, Hans Rådegran, Göran P 300 Schmacht, Luisa Sabe, Marwa P 297 Schmidt, Andre Sabe, Sharif P 297 Schmidt, Anna P 073, P 083, P 284 Sabharwal, Nikant P 224 Schmidt, Ehud O 122, P 212, P 214, P 328, W 04 Sabzevari, Kian O 125 Schmidt, Michaela Sado, Daniel Saeed, Ibrahim Q 37 Schmitt, Matthias P 091, P 203 Schmitt, Vanessa Sagi, Janaki P 166 Schnackenburg, Bernhard Sahn, David P 152 Schneider, Jurgen www.scmr.org AUTHOR INXEX Rider, Oliver P 314, O 004, O 102, P 111, P 255, P 276, Q 04 P 256, P 336 P 340, Q 55 O 112, P 313, Q 50, W 18 Q 43 Q 01 O 099, P 076, P 110, W 09 P 224 71 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Schnell, Susanne O 096, P 170, P 232 O 103, P 079, P 325, P 352, P 356 P 152 O 048, O 082 Shemin, Richard P 338 Schranz, Dietmar O 116 Sherzai, Ayesha P 350 Schroeder, Marie O 015 Sherzai, Dean P 350 Schroeder, Samuel P 029 Shetye, Abhishek P 225, Q 65 Schofield, Rebecca Schuler, Gerhard Schulz-Menger, Jeanette Shi, Wenzhe Q 63 P 249, P 256, P 257, P 336, Q 57, Q 64, W 36 Shie, Nancy P 052 Shirasaki, Keisuke Schwid, Madeline Shome, Joy Q 13 O 105, O 106, P 074, W 23 Schär, Michael O 013, O 053, P 262 Schüler, Johannes Scott, Andrew Shufelt, Chrisandra Sierra-Galan, Lilia O 050, P 035, W 17, W 19 Sigurdsson, Sigurdur O 061 Sculpher, Mark P 075 Simon, Marc Seed, Mike O 027, O 028, O 071, P 030, P 044, P 151, P 156, P 165, Q 25 Simonetti, Orlando P. Seehase, Matthias O 119 Simpson, John Seemann, Felicia P 043 Simpson, Scott P 089, P 090, P 114 Seguro, Florent Q 54 Sindhura, Alapati Sehmi, Joban Q 52 Singh, Amita O 074, W 01 Singh, Anil O 059, P 031 Singh, Anvesha O 049 Singh, Sheldon Sellwood, Joanne P 224 Singhal, Priyanka Semaan, Edouard P 346 Sinn, Martin Semple, Scott P 056 Sinusas, Albert Semsarian, Chris P 298 Sirker, Alex Senel, Mirac O 099 Sjöberg, Pia Sekowski, Viktor Serafim da Silveira, Juliana Sermesant, Maxime P 280 P 229, P 237, P 242, P 245, P 246, Q 70 Sikdar, Khokan Sekhri, Neha O 003 Sigfridsson, Andreas P 365 Seiberlich, Nicole P 253 P 086, Q 15 P 249, P 256 Scotti, Alessandro Secchi, Francesco Q 09 O 098, Q 66 Schuster, Andreas O 080, O 095, O 119, O 129, P 039, P 040, P 236, P 362 Schwitter, Juerg P 335, Q 12, Q 31, W 22, W 39 Q 02 Q 21 P 120 O 132, P 053, P 331, P 335, Q 12, Q 31, W 22, W 29, W 39 P 177, P 180 P 172 P 193, Q 46 P 182, P 317 P 145 O 036, Q 09 P 206 P 118, P 269 P 092 P 207 P 230, Q 67 O 072, P 184 Skondros, Evangelos P 088 Skowasch, Dirk P 276 P 093 Slavin, Glenn P 268 Shah, Amee P 183 Sleeper, Lynn O 029 Shah, Dipan O 001, O 131, P 121, P 311, Q 33 Slesnick, Tim O 094, O 115, P 189 Seyfarth, Melchior Shah, Moneal Shah, Ravi O 136, P 136, P 138, P 145, P 247, T 12, T 6, T 7 O 130, Q 41, O 135, P 102, W 07 Slicker, Julie Slomka, Piotr P 176 O 019, W 02 Shah, Sanket P 309 Smacchia, Maria Paola P 295 Shahid, Mohammed P 055 Smart, Suzanne P 220 Shahir, Kaushik Shahzad, Rahil Shambrook, James Q 45 Smink, Jouke P 321 O 084 Smith, Gillian P 290, Q 52, T 11 P 008, T 5 Smith, Karen P 077 O 061 Smith, Peter Shandas, Robin P 004 Smyke, Matthew Shang, Quanliang O 095 Socolow, Joshua P 210 Sodickson, Daniel Shanbhag, Sujata Shannon, Wooden Shao, Jiaxin Sharif, Behzad P 025, P 364 O 003, O 012, O 019, O 043, P 082, W 02, W 25 Sohns, Jan Solana, Ana Beatriz Soleimanifard, Sahar Q 16 W 22, P 335 O 033 O 105, P 175, P 185 O 080, O 119, O 129, P 039 P 183 O 013, O 053 Sharland, Gurleen P 177 Sharma, Aditya P 356 Solomon, Joseph Sharma, Ravi O 133 Soltys, Joseph Sharma, Sanjay O 038 Soma, Siva O 136 Song, Shlee P 350 Shaw, Jaime 72 Shaw, Peter Sheehan, Florence Schoepf, U. Joseph O 003, O 043, O 075, W 25 P 055 P 091, P 203 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Q 68 Suinesiaputra, Avan Sonnex, Emer O 011 Suksaranjit, Promporn Soriano, Brian P 174 Sun, Jiayu Sorrell, Vincent O 010, P 081, P 241 Soslow, Jonathan P 172, P 279 Sosnovik, David O 016, O 052, P 013 Soto-Lopez, Maria-Elena P 280 Soulat, Gilles P 020, P 153 Speidel, Nathaniel Christopher Speier, Peter Spottiswoode, Bruce Sprigings, David Sprinkart, Alois Martin Spruijt, Onno Srivastava, Shubhika Staab, Wieland Steeds, Richard Steele, Russell Stehning, Christian Steigner, Michael Steingart, Richard Steinman, Theodore Swart, Laurens P 307 O 036 Swoboda, Peter P 036, P 337, Q 11 O 004, P 111, Q 04 Sydow, Karsten P 106 O 088 Syed, Mushabbar O 124 P 122 Sykes, Jane O 032 Steding-Ehrenborg, Katarina Steeden, Jennifer O 048, P 316, Q 16, Q 52, Q 56 Q 22 Stearns, Evan Sörensson, Peder Ta, Allison Tachi, Masaki Tahir, Enver P 127 P 222, P 229, P 237, P 245, P 246, Q 70 P 108 P 318 P 092, P 106, P 127 P 253 P 021 O 036, Q 43 O 075 O 067, O 099, W 09 O 130, P 226 P 265 Q 47 P 212, W 04 Q 66 Stoll, Victoria Säring, Dennis Q 37 P 228, P 324 Takeshima, Hidenori Stiermaier, Thomas Stojanovska, Jadranka Szantho, Gergely Takahashi, Hirotake Stevenson, William Stoeck, Christian Syrris, Petros O 019, W 02 O 048, Q 52, T 11 P 043, P 300, Q 61 O 080, O 119, O 129, P 039 Stochitoiu, Ioana Symmonds, Karen O 069, O 092, P 157 Steinmetz, Michael Stobo, Jon P 253 P 164 P 243, P 261 Statton, Benjamin O 114 Suzuki, Teruhiko P 060, P 150 O 112 Starc, James O 039 Sutton, Brad Swanson, Scott O 080, O 129, P 039 Stalder, Aurelien O 062 Sutcharitchan, Pranee O 018, P 301, P 313 P 301, P 313 Stahnke, Vera-Christine P 225, Q 65 Susana, Angela Swanson, Sara P 064 Staeb, Daniel P 223 O 031, P 159, P 272 T 13 O 080, O 119, O 129, P 362 Stabinskaite, Agnieta Suranyi, Pal P 031, P 154, P 186 Talmud, Phillippa Tan, Ru San Q 37 P 003, P 032, P 146 Tanami, Yutaka P 132 Tang, Haw Chiaw P 003 Tang, Maxine P 062 Tang, W.H. Wilson Tao, Qian Tautz, Lennart Tavolaro, Sébastian P 297 O 084, P 067 W 24 P 020 Tayal, Upasana O 050, P 281, P 283, Q 52 O 071, P 151 Taylor, Andrew O 092, O 118, P 077, Q 02 P 129 P 061 Taylor, Michael P 243, P 261 O 123, P 060, P 150 Taylor, William O 021 O 068, P 227 Teixeira, Tiago P 249 Stone, Ian P 134 Teixido-Tura, Gisela Strange, Julian O 062 Teo, Soo Kng P 003 Thai, Ngoc P 145 Strauss, Bradley Strecker, Ralph Q 05 P 313, Q 53 Thalén, Simon Stroer, Sebastian P 020 Thavendiranathan, Paaladinesh Stromp, Tori P 241 Thiele, Holger Stub, Dion P 077 Thomas, Daniel Stuber, Matthias Stump, Claire Su, Shi Su, Yi Subramanian, Sharath Suever, Jonathan Suh, William P 132, P 353 Q 70 O 132 O 098, Q 19 O 004, O 102, P 111, P 255, P 314, Q 04 O 041, O 105, O 106, P 027, P 074, P 258, W 35 Thomas, Sheena P 224 P 045 Thompson, Diane O 136, P 138, P 247, T 12, T 6 P 305, Q 49 P 003 Q 12, Q 31 O 010, O 032, O 076, O 083 P 338, Q 59 Thompson, Richard Thomson, Louise Thorgeirsson, Gudmundur Thornhill, Rebecca Thul, Josef www.scmr.org AUTHOR INXEX Sonmez, Merdim O 003, O 009, O 011, O 049, P 073, Q 03 O 003, O 043, P 082, W 25 O 061 P 291, P 292 O 116 73 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Tian, Yikui O 073 Van Assche, Lowie Tichelbaecker, Tobias P 362 van den Boogaard, Pieter Timmis, Adam O 059 van der Geest, Rob Timoh, Tendoh P 108 van der Graaf, Maurits Ting, Samuel P 331 van Heeswijk, Ruud Todoran, Thomas P 225 van Ooij, Pim Tokarczuk, Pawel Q 22, T 2 Tom, Kusum P 145 Tomlinson, George Q 24 Tonegawa, Reina P 253, Q 40 Vannan, Mani Varga-Szemes, Akos P 257 Varghese, Juliet Trauzeddel, Ralf Q 57 Treibel, Thomas O 037, O 038, O 040, O 042, O 086, P 002, P 140, P 230, Q 48, Q 67 Treutlein, Melanie W 09 P 262 O 010, O 083, P 241 Q 09 P 210, P 260 P 188, P 225, Q 65 W 29, W 39 Vasanawala, Shreyas Vassiliou, Vassilis P 217, P 307, P 308 O 048, O 067, P 235, P 290, P 339, Q 52, Q 56, T 11 Velasco Forte, Mari-Nieves P 190, P 330 Venancio, Thiago W 07 Venuti, Giuseppe P 269 Truong, Uyen P 004 Vermes, Emmanuelle Trusty, Phillip O 115 Viallon, Magalie O 041, O 045, W 16 O 019, P 063, W 02, W 27, W 34 Vieira, Miguel S. P 236, P 330, Q 11, Q 36, Q 42 O 056 Vigneron, Daniel Tsaftaris, Sotirios Tsao, Connie Tse, Zion P 212, P 214, P 328, W 04 Vijayakumar, Sathya Tsuge, Shinsuke P 087 Villa, Adriana Tudisca, Chiara P 141 Villa, Chet Tufvesson, Jane P 033, P 221, P 222 Vincenti, Gabriella O 047 Q 30 P 196 P 086, Q 15 P 243 O 106, P 074 Tullus, Kjell P 157 Vita, Tomas P 226 Tumkosit, Monravee O 039 Vittori, Claudia O 063 Tunnicliffe, Elizabeth P 035, Q 62 Vittorio, Timothy O 079 T5 Vogel, Mika P 307 Tyler, Damian O 024 Voges, Inga Tymchak, Wayne O 049 Volpe, Gustavo Töger, Johannes O 023, Q 61 Uddin, Akhlaque P 337 Ugander, Martin P 229, P 237, P 242, P 245, P 246, Q 70 Twigg, Ceri Underwood, Richard P 088 Unnikrishnan, Nishad T 11 Uno, Mio P 070, P 087 Unterberg-Buchwald, Christina O 080, O 119, O 129, P 039, P 362 von Deuster, Constantin von Knobelsdorff-Brenkenhoff, Florian von Loesch, Eckhart Thassilo von Morze, Cornelius von Roeder, Maximilian O 116 P 340, Q 55 P 061 P 256, P 257, P 336, Q 57, Q 64 O 080 Q 30 Q 66 Vorasettakarnkij, Yongkasem O 039 Vorobiof, Gabriel P 097 Uppu, Santosh P 122 Wada, Akira P 275 Urbinelli, Lindsay P 261 Wage, Ricardo Urbonaite, Laura P 064 Wake, Nicole P 175, P 185 Uretsky, Seth O 134 Walker, John Malcolm O 039, O 069 Vaid, Haris O 006, P 066, P 233 Walker, Simon P 281, P 283, P 290, P 304, Q 60, T 9 P 075 Valadkhani, Arman P 229 Wallace, Daniel Valente, Anne Marie O 032 Wan, Ke Valeri, Gianluca P 270 Wanambiro, Kevin P 307, P 308 Valeti, Uma P 133 Wang, Chao-Hung P 014 Vallone, Antonino P 295 Wang, Da P 364 Wang, Harris P 073 Vallurupalli, Srikanth P 131, P 248, P 273 Valsangiacomo-Buechel, Emanuela Valverde, Israel van Amerom, Joshua 74 O 088 Vanezis, Andrew P 347 P 340, Q 55 P 346, P 357 Vandsburger, Moriel P 268 Trad, Henrique P 199 O 041, P 027, W 23 van Zijl, Peter Totman, John P 162 O 084, P 024, P 036, P 067 van Rossum, Albert Toro-Salazar, Olga Traber, Julius O 055 O 088, P 152 Wang, Hui P 190 Wang, Jing P 177, P 180 Wang, Jiun-Jie W 25 O 031, P 034, P 139, P 159, P 272 P 112, P 263, P 321 W 37 P 014 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Wang, Kuocheng P 294 T 13 White, James O 006, O 078, P 066, P 073, P 083, P 194, P 233, P 234, P 284, P 287, Q 21 O 067 White, Richard O 017 White, Robert P 149 Wang, Wei O 122 White, Steven O 037, O 040, P 072, P 230, Q 67 Wang, Wenchuan P 355 Whitehead, Kevin P 158, P 160 Wang, Yi O 109 Whitman, Teresa O 006, O 078 Wang, Yining P 316 Wichmann, Julian P 225, Q 65 Wang, Zhankui P 320 Wielopolski, Piotr P 308 Wang, Zhe O 109 Wien, Joshua O 017 Wijesurendra, Rohan Wang, Louis Wang, Vicky Wang, Zhinuo Jenny Ward, Jay P 212, W 04 Will, Albrecht P 029, P 360 P 092 O 035, O 066 O 064 Warntjes, Marcel P 011 Williams, Ronald Washburn, Adrienne P 208 Wilmink, Lena O 099 P 017 Wilson, Brent O 111, P 223 Wasse, Haimanot Wassilew, Katharina Watanabe, Eri Watanabe, Kouki Waterhouse, Deirdre P 138, P 145, T 12, O 136, P 136, P 247, T 6, T 7 O 048, P 110, Q 56 Wilson, Catherine P 239 P 226 Winterfield, Jeffrey O 124 Wintersperger, Bernd O 112 Q 50 P 252 Wisotzkey, Bethany Witschey, Walter P 174 P 055, P 158, P 329, W 13, W 37 Waters, Dexter O 006, P 066, P 233 Watkins, Hugh P 341, Q 35 Wolff, Steven O 054, O 134 O 122, P 212, W 04 Wong, Jia ing P 146 Watkins, Ronald P 231 Wong, Joyce Watts, Evan P 131 Wong, Timothy Weale, Peter P 056 Woo, Joyce P 171 Webster, Mark P 103 Wood, John O 120, P 123 Wechalekar, Ashutosh O 040 Woodard, Pamela Weeks, Richard P 046 Woolfson, Peter Weerackody, Roshan P 031 Wragg, Andrew Watkins, Stuart Wehner, Gregory Wei, Janet Wei, Zijun O 010, O 076, O 083 O 003, O 043, P 082, P 126 P 305, Q 49 Wright, Graham Wright, Matthew Wu, Bailing W 05 Wu, Can Weinrich, Julius P 127 Wu, Colin Weinsaft, Jonathan P 265 Wu, Edwin W 25 Wu, Holden Weingärtner, Sebastian Weisman, Michael Weiss, Robert Weissman, Gaby O 013, O 053 P 085 Well, Lennart P 106, P 127 Weller, Daniel P 319 Welsh, Aimee Welsh, Paul Weltman, Arthur Wu, Kevin P 088 O 132, P 120 P 204 Q 43 O 059 O 007, P 206, P 303, Q 05 Q 28 P 277, P 293 O 096, P 232 O 133, P 132, P 353 P 078 O 121, P 026 P 214 Wu, Yi-Ying P 294 Wu, Ziyue O 108 Wundrak, Stefan P 006, Q 01 Wuttge, Dirk P 071 P 231 Xanthis, Christos P 042 P 352 Xia, Xiaojuan Q 45 Wendell, Dave O 044, Q 06 Wendell, David O 055, P 187, P 322, Q 08, Q 10 Xie, Guoxi Xie, Yaoqin P 275 P 305, Q 49, Q 58 P 010, P 023 Weng, Zhen P 117 Xie, Yibin Werner, Beat O 088 Xu, Lingyu P 073 P 206 O 117 Xu, Robert Westenberg, Jos O 088, P 024, P 036, P 162 Xu, Ziqian Westwood, Mark O 039, P 031, P 041 Werner, Heron Wetzl, Jens Whelan, Carol Whitaker, John Xue, Hui O 112 Yadav, Nirbhay O 040 Yak, Nicolas Q 28 Yamada, Akimasa www.scmr.org AUTHOR INXEX Wang, John O 018, O 022, O 070, P 037 P 065 O 008, P 216, P 313, Q 14, W 08, W 12 P 262 P 206 P 070, P 087 75 From Innovation to Impact in Cardiovascular Care AUTH O R I N D E X Yamada, Fumi P 318 Yamrozik, June O 136, P 136, P 138, P 145, P 247, T 12, T 6, T 7 Yan, Fei P 305, Q 49 Yancy, Clyde O 034 O 091 Zaliunas, Remigijus P 064 Zambelli, Daniel Zapf, Antonia Zareba, Karolina Yang, Dan O 031, P 034, P 139, P 159, P 272 Yang, Eric P 121, P 311 Zemrak, Filip Yang, Hsin-Jung O 019, W 02 Zeng, Mu Yang, Jie P 010, P 023 Zenge, Michael Yang, Qi Yang, Yang O 022, P 016, P 218, P 350, Q 58, W 15 O 103, P 028, P 050, P 079, P 319, P 325, P 352, P 356 P 067 P 299 Zhang, Jiming Zhang, Li Yao, Jialu P 117 Zhang, Ruzhi O 005 Zhang, Shelley Zhang, Shuo Yazdanparast, Ehsan W 33 Zhang, Tao Ye, Yufeng Q 58 Yee, Eric P 194 Zhang, Tianjing Yee, Raymond O 078 Zhang, Xiaoyong Yellon, Derek P 072 Zhang, Yan Yerly, Jérôme O 105, P 027, W 35 Zhang, Zhicheng Yildirim, Dursun P 208 Zhao, Lei Yilmaz, Sevim O 025 Zhao, Li Yim, Deane Yin, Hong Yoganathan, Ajit Yokoyama, Kenichi Yoo, Shi-Joon O 027, O 028 O 070 P 313, W 18 O 075 O 120 Yazdani, Saami P 275 O 065, O 077, P 031, P 041 Zhan, Yang Yanofsky, Samuel P 291, P 292 P 089 O 080, O 129, P 039 Zeppenfeld, Katja Yang, Yuanhua Yassin Kassab, Lin Zhao, Shihua O 093, P 333 P 303 P 065 P 212, W 04 P 032 P 217 O 031, P 034, P 125, P 128, P 159, P 272, P 278, P 299, P 316, P 320, P 361 P 305, Q 49 P 277, P 282, P 293 P 023 P 128, P 278 P 325 P 277, P 282, P 293 P 320 Zhao, Xiaodan P 003 O 115 Zheng, Jianmin P 320 P 018 Zheng, Jie P 065 O 027, O 028, O 071, P 151, P 156, P 165, Q 24, Q 25 Zhong, Liang P 003 Yoon, Yeonyee P 288 Zhong, Xiaodong O 050, P 210 Yoshida, Takami P 021 Zhou, Xiangzhi P 018, P 348 Yoshida, Takegawa Young, Alistair P 259, P 338, P 363, Q 59 O 017, O 079, P 031, P 048, P 103, P 154, P 186 Youssof, Emile O 045 Yu, Chung-Yao O 067, P 191 Yu, Shaode Yu, Sunkyung 76 Zajac, Jakub P 023 P 164, P 166 Zhou, Xiao Zhou, Yafeng Zhou, Zhengwei Zhou, Ziwu Zhu, Meng Yuan Zhu, Yanchun P 210 P 117 O 070, P 037 O 051, P 007, P 015, P 363, Q 59 O 071, P 151, P 156 P 010, P 023, P 305, Q 49 Yuanchang, Ou P 046 Zidere, Vita P 177 Yuecel, Seyrani O 004 Zoellner, Frank Yushkevich, Paul P 055 Zorzi, Alessandro O 062 Zabel, Markus P 362 Zviman, Menekhm O 122 W 05 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care E X H I BITO R DI R EC TO RY 13703 W. Colfax Ave., Suite 300 European Association of Booth #22 Cardiovascular Imaging (EACVI) Golden, CO 80401 USA 2035, route des colles Phone (303) 273-5344 Sophia Antipolis 06903 FRANCE [email protected] Phone +33 6 8987 2038 Webwww.3dsystems.com/healthcare Fax +33 6 9296 8646 3D Systems offers healthcare-centric 3D printing and 3D visualization technology. The company’s surgical tools include accurate 3D printed anatomical models, advanced virtual reality simulators, direct metal printing for implants and instrumentation, virtual surgical planning (VSP*) and personalized 3D printed surgical guides. 3DS is developing true patient-specific healthcare solutions, one by one or at scale, designed to change the future of personalized medicine. [email protected] 3D Systems Bracco Diagnostics Booth # 11 Booth # 7 259 Prospect Plains Rd Webwww.escardio.org The EACVI is the leading international network in Cardiovascular Imaging worldwide. Its mission is “to promote excellence in clinical diagnosis, research, technical development and education in Cardiovascular Imaging in Europe”. It is a unified platform of experts and a knowledge provider in CMR, Echo-cardiography Nuclear Cardiology and Cardiac CT: live events and distance learning – certification - Journal membership – Grants - EuroCMR congress - recommendations. Learn more at www. escardio.org/EACVI. Monroe Township, NJ 08831 USA GE Healthcare Phone (609) 514-2343 Fax (609) 514-2514 Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities: X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catherization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), Nuclear Medicine through radioactive tracers, and Gastrointenstinal Endoscopy. The diagnostic imaging portfolio is completed by a range of medical devices and advanced administration systems for contrast imaging products. Cardiovascular Imaging Solutions LTD Booth #3 9900 Innovation Drive Booth # 8 Incurator, Bessemer Building, Imperial College London SW7 2AZ United Kingdom Phone (44) 0 7885 906770 Wauwatosa, WI 53226 USA Phone (414) 721-2620 Fax (414) 918-8138 [email protected] Webwww.gehealthcare.com For over 10 years, Heart Imaging Technologies has offered worldwide access to diagnostic-quality DICOM images using nothing but a web browser. Now your web browser is also your CMR workstation (volumes, VENC, T1/T2, etc.), your structured reporting system (382 data elements), and your admission ticket to a searchable database, real-time collaboration, and multi-center trial organization tools. Share your de-identified images, and reports, with your colleagues across the country and around the world! Webwww.cmrtools.com Booth #2 Heart Imaging Technologies, LLC Booth #4 5003 Southpark Drive #250 815 8th Ave SW Durham, NC 27713 USA Calgary, AB T2P 3P2 Canada Phone (919) 323-3001 Phone (403) 453-2061 Fax (866) 457-3694 Fax (403) 338-1895 [email protected] [email protected] Webwww.heartit.com Webwww.circlecvi.com For over 10 years, Heart Imaging Technologies has offered worldwide access to diagnostic-quality DICOM images using nothing but a web browser. Now your web browser is also your CMR workstation (volumes, VENC, T1/T2, etc.), your structured reporting system (382 data elements), and your admission ticket to a searchable database, real-time collaboration, and multi-center trial organization tools. Share your de-identified images, and reports, with your colleagues across the country and around the world! Circle Cardiovascular Imaging Inc. develops and markets cardiac post-processing software that allows for the evaluation and analysis of MR and CT images. Available for clinical and research use, the stand-alone software provides full DICOM and PACS connectivity. Circle operates worldwide and its products (cvi42, cmr42, ct42, and report 42) have been approved for the Canadian, American, Australian, Korean and European markets. Circle’s goal is to contribute to quality in cardiovascular imaging and research. www.scmr.org EXHIBITOR DIRECTORY Circle Cardiovascular Imaging Inc. 77 From Innovation to Impact in Cardiovascular Care E X H I BITO R DI R EC TO RY HeartVista, Inc. Booth #16 4984 El Camino Real, Suite 102 Medis Medical Imaging Systems, Inc. Booth #19 9360 Falls of Neuse Road, Suite 103 Los Alto, CA 94022 USA Raleigh, NC 27615 USA Phone (650) 800-7937 Phone (919) 278-7889 [email protected] Fax (919) 847-8817 Webwww.heartvista.com Webwww.medis.nl HeartVista develops high-end acquisition solutions with modern user interfaces to perform quick, comprehensive cardiac MRI examinations. Its real-time and advanced acquisition and reconstruction methods significantly reduce overall exam time and enable imaging difficult patients. Many of these imaging methods do not require breath-holds or cardiac gating. The included real-time sequences have high temporal and spatial resolution and can be used to visualize the motion of anatomy or blood flow. Since 1989 Medis medical imaging systems has been a leading provider of analytical software for the quantification of cardiovascular images. Imricor Booth #10 At this year’s SCMR we will demonstrate our new workflow-centric imaging platform Medis Suite, a multimodality, single reporting patient analysis platform, from which our well-known and high-quality analysis solutions (Apps) can be launched. These include the further extended QMass and QFlow, as well as solutions for myocardial characterization, strain imaging, CT-volumetric plaque analysis, image-based physiologic assessment of coronary lesions, etc. Please visit booth #19 & #20. 400 Gateway Blvd. Burnsville, MN 55337 USA NeoSoft/NeoCoil, LLC Phone (952) 818-8417 N27 W23910 A Paul Rd Fax (952) 818-8401 Pewaukee, WI 53072 USA [email protected] Phone (262) 522-6142 Webwww.imricor.com Fax (262) 347-1251 Imricor specializes in developing medical devices that are compatible with magnetic resonance imaging. Our MR-enabled™ products are designed to provide doctors the ability to perform interventional procedures under real-time MRI guidance. While we are applying our patented technology to an array of applications, our first MR-enabled solutions are for use in MRI-guided cardiac ablation procedures. We are also collaborating with medical imaging companies to establish interventional MRI suites in medical centers around the world. [email protected] Journal of Cardiovascular Booth# 24 Magnetic Resonance (JCMR) Web www.neosoftllc.com / www.neocoil.com NeoSoft’s suiteHEART software is a fast, comprehensive, and intuitive analysis tool for structured reporting of cardiac MRI examinations including function, flow, tissue characterization, and T2*. Learn from cardiac MRI Industry leaders via mini fellowship training, onsite training, or remote support. Since 2004, NeoCoil and NeoSoft have led the industry with many first to market products: 16 element flexible coils, MR conditional android tablet, and wireless MRI hearing protection – entertainment system. Please visit www.neosoftllc.com Cardiovascular MR Unit Philips Healthcare Royal Brompton Hospital Building QR-0119 Sydney Street Veenpluis 4-6, 5684 PC Best, The Netherlands London, SW3 6NP Phone +31 40 27 64061 United Kingdom Email [email protected] Tel +44 207 351 8825 Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and wellbeing company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www. philips.com/newscenter. Fax +44 207 351 8816 Email [email protected] Web www.jcmr-online.com JCMR, the official journal of the Society for Cardiovascular MR, is an open access, online journal that publishes articles on all aspects of basic and clinical research on the design, development, manufacture, and evaluation of magnetic resonance methods applied to the cardiovascular system. The only journal devoted exclusively to cardiovascular MR, JCMR aims to provide an international forum for communicating the latest findings and reviews on the burgeoning field of cardiovascular MR imaging and spectroscopy. 78 Booth #17 Booth #13 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care E X H I BITO R DI R EC TO RY Philipsweg 1 Society for Cardiovascular Magnetic Resonance (SCMR) Maastricht 6227AJ, The Netherlands 19 Mantua Road Phone043-3281328 Mt. Royal, NJ 08061 USA Fax043-3281329 Phone (856) 423-8955 [email protected] Fax (856) 423-3420 Webwww.piemedicalimaging.com [email protected] Pie Medical Imaging, a company with over 25 years of experience in quantitative analysis software for medical images, offers a wide range of software packages for cardiovascular analysis of MR images. With our CAAS MRV software Functional analysis of the left and right ventricles, Viability, Edema and First Pass Perfusion analysis can be performed. CAAS MR (4D) Flow software allows for quantification of blood flow, velocities, wall shear stress and detailed visualization of hemodynamics. Webwww.scmr.org Precision Image Analysis Booth #15 The Society for Cardiovascular Magnetic Resonance (SCMR) is a professional association whose vision is to be the recognized representative and advocate for physicians, scientists, and technologists who work in the field of cardiovascular magnetic resonance. It endeavors to be the principal international, independent organization committed to the further development of cardiovascular magnetic resonance through education, quality control, research, and training. Booth #12 303 Parkplace Center, Suite G-131 Springer Kirkland, WA 98033 USA 233 Spring Street Phone (425) 822-8199 New York, NY 10013 USA Fax (425) 519-9971 Phone (212) 460-1500 [email protected] Fax (212) 460-1575 Webwww.piamedical.com [email protected] Precision Image Analysis (PIA) provides an innovative image postprocessing analysis service for use in diagnostic medical studies, including CT and MRI. The HIPAA compliant, cloud-based architecture enables images to be uploaded, monitored, tracked, and analyses retrieved remotely. Precision Image Analysis expertly-trained analysts deliver consistently reproducible results in a timely manner. Webwww.springer.com PIA can help improve scanner throughput, decrease internal training time and save money. Visit www.piamedical.com today. Siemens Healthcare Booth# 23 Booth #1 40 Liberty Boulevard Malvern, PA 19355 USA Phone (610) 448-4500 Webhttp://usa.healthcare.siemens.com/ Siemens Healthcare develops innovations that support better patient outcomes with greater efficiencies, giving providers the confidence they need to meet the clinical, operational and financial challenges of a changing healthcare landscape. As a global leader in medical imaging, laboratory diagnostics, and healthcare information technology, we have a keen understanding of the entire patient care continuum--from prevention and early detection to diagnosis and treatment. Booth #9 BioMed Central is an online STM publisher of more than 270 peerreviewed, open access journals. Our portfolio of journals spans all areas of biology, biomedicine and medicine, with many journals publishing content related to medical imaging and cardiovascular systems. Examples of such journals include: Journal of Cardiovascular Magnetic Resonance, Cardiovascular Ultrasound, BMC Medical Imaging, Journal of Therapeutic Ultrasound and BMC Cardiovascular Disorders. All original research articles published by BioMed Central are made freely accessible online immediately upon publication. Authors publishing with BioMed Central retain copyright of their work under the Creative Commons Attribution License, which allows articles to be re-used and re-distributed without restriction provided the original work is correctly cited. BioMed Central is owned by Springer Nature, and also hosts the SpringerOpen platform. Toshiba America Medical Systems, Inc Booth #6 2441 Michelle Drive Tustin, CA 92780 Phone (800) 421-1968 Fax (714) 734-0362 [email protected] Webmedical.toshiba.com Toshiba America Medical Systems, Inc understands today’s healthcare business and delivers diagnostic imaging and interventional solutions that put customers first. Toshiba markets, sells, distributes, and services throughout the U.S. It is committed to listening to customers and giving them a voice through patient-focused technology and superior customer service. www.scmr.org EXHIBITOR DIRECTORY Pie Medical Imaging B.V. 79 EXIT L-UP ROL OR DO S BAR 80 EXIT L-UP ROL OR DO ONS STATI FE FA S FE E S S 6 S HYATT REGENCY CENTURY PLAZA HOTEL CALIFORNIA BALLROOM LOS ANGELES, CALIFORNIA EXIT S FA S S FA NS TATIO EE S EXIT FE FA S F 8 10 5 S 6 S S S 1 11 20' 7 12 20' 13 8 S S S 14 S EXIT 9 S FA S S FA 10 POSTER AREA / C OF BAR S S 7 9 FA 2 S 20' S S 3 S 1 11 20' 12 170 - D/S Poster Boards 98 - S/S Poster Boards 438 Sides 20' 13 20' 20' 20' FA S S S S 14 S S 15 S S 4 16 2 S S FA FA 19 S 20 EXIT 21 S S 3 S 170 - D/S Poster Boards 98 - S/S Poster Boards 438 Sides 20' 20' 20' S ENTRANCE S 20' 18 20' 20' 17 22 S S S S S 23 ge S 15 Sta 24 S S S / CO 4 16 EXIT FE FA BAR 20' 17 S 20' 18 FFE ES TAT ION S S S S S EXIT FA FA 19 ROLL DOO-UP R S 20 EXIT S 21 22 S S S 23 Sta ge 24 E X H I BITO R FLOO R PL A N EXIT / C OF S 5 S S ENTRANCE S S / CO EXIT FE FA BAR From Innovation to Impact in Cardiovascular Care HYATT REGENCY CENTURY PLAZA HOTEL CALIFORNIA BALLROOM LOS ANGELES, CALIFORNIA 19th Annual Scientific Sessions • January 27-30, 2016 FF From Innovation to Impact in Cardiovascular Care CO N V ENTIO N C ENTER FLOO R PL A N S HYATT REGENCY CENTURY PLAZA HYATT REGENCY CENTURY PLAZA 2025 Avenue of the Stars LosCalifornia Angeles, CALevel 90067 USA T: +1 310 228 1234 F: +1 310 551 7548 E: [email protected] centuryplaza.hyatt.com FLOOR PLAN Plaza Level 12.12 FLOOR PLANS Plaza Level PLAZA TERRACE www.scmr.org 12.12 81 Precession powered by WebPAX Technology “Opinion is good, but evidence is better...” CloudCMR World-wide collaboration using any Web Browser! With any distant colleague! 30,000+ Scans with Finalized de-identified structured reports! SCMR Booth # 4 National Institutes of Health, Bethesda, USA 2000 ms 0 ms siemens.com/cmr Cardiovascular MRI Efficient, reliable, ready. Add a new layer of pixel-based diagnostic information to cardiac diagnoses. Based on HeartFreeze Inline Motion Correction (Siemens unique), MyoMaps provides pixel-based myocardial quantification, on the fly. Now you can better detect global, diffuse, myocardial pathologies (T1 Map). Or better depict cardiac edema (T2 Map) and improve early detection of iron overload (T2* Map). • Designed to evolve visual assessment to pixel based quantification of tissue characteristics • Based on Siemens-unique HeartFreeze Inline Motion Correction • Guide cardiovascular therapy, starting earlier and more efficiently MyoMaps – now available on the powerful software platform syngo MR E11. Leading. With MAGNETOM. Delivering Catheters and other Devices for MR-Guided Interventions Electrophysiology Structural Heart Renal Denervation Oncology The Advantage-MR EP Recorder/Stimulator System and Vision-MR Ablation Catheter have been approved for use in human clinical investigations in Europe. All other Imricor products are not yet approved for use in humans. Download the Mobile App Now! Search: SCMR 2016 ( in the Apple App Store or Google Play ) Enter: http://m.core-apps.com/scmr2016 ( in your mobile browser ) Or Scan: the QR code below ViosWorks A S T O N I S H . C H A N G E T H E C A R D I A C I M A G I N G PA R A D I G M . ViosWorks* extends cardiac MR assessment beyond the anatomy by bringing automatic quantitative data & deep learning to cardiac imaging in a fraction of the time of conventional cardiac scans. Providing whole-heart cardiac anatomy, function, and flow in 1-free breathing, 8 minute scan with cloud-based, real-time processing of images. Visit us at the GE Healthcare booth and at www.viosworks.gehealthcare.com *Not yet commercially available From Innovation to Impact in Cardiovascular Care N OTES ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ www.scmr.org 87 From Innovation to Impact in Cardiovascular Care N OTES ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ 88 19th Annual Scientific Sessions • January 27-30, 2016 From Innovation to Impact in Cardiovascular Care N OTES ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________ www.scmr.org 89 Gaylord National Resort & Convention Center at National Harbor Washington, DC FEB R U A R Y 1 – 4 , 2 0 1 7